Background  ||| S:24 E:43 ||| NN
The  ||| S:43 E:47 ||| DT
ubiquitin ||| S:47 E:56 ||| JJ
/ ||| S:56 E:57 ||| CD
proteasome-dependent  ||| S:57 E:78 ||| JJ
proteolysis  ||| S:78 E:90 ||| JJ
system  ||| S:90 E:105 ||| NN
has  ||| S:105 E:109 ||| VBZ
been  ||| S:109 E:114 ||| VBN
implicated  ||| S:114 E:125 ||| VBN
in  ||| S:125 E:128 ||| IN
a  ||| S:128 E:130 ||| DT
wide  ||| S:130 E:135 ||| JJ
variety  ||| S:135 E:143 ||| NN
of  ||| S:143 E:146 ||| IN
cellular  ||| S:146 E:163 ||| JJ
regulatory  ||| S:163 E:174 ||| JJ
mechanisms ||| S:174 E:184 ||| NNS
,  ||| S:184 E:186 ||| ,
including  ||| S:186 E:196 ||| VBG
transcription ||| S:196 E:209 ||| NN
,  ||| S:209 E:211 ||| ,
signal  ||| S:211 E:226 ||| NN
transduction ||| S:226 E:238 ||| NN
,  ||| S:238 E:240 ||| ,
and  ||| S:240 E:244 ||| CC
cell  ||| S:244 E:249 ||| NN
cycle  ||| S:249 E:255 ||| NN
control  ||| S:255 E:263 ||| NN
( ||| S:263 E:264 ||| -LRB-
reviewed  ||| S:264 E:273 ||| VBN
in  ||| S:273 E:276 ||| IN
[  ||| S:276 E:278 ||| -LRB-
1  ||| S:278 E:280 ||| LS
]  ||| S:280 E:282 ||| -RRB-
) ||| S:282 E:283 ||| -RRB-
.  ||| S:283 E:293 ||| .
The  ||| S:293 E:297 ||| DT
system  ||| S:297 E:304 ||| NN
employs  ||| S:304 E:312 ||| VBZ
a  ||| S:312 E:314 ||| DT
cascade  ||| S:314 E:322 ||| NN
of  ||| S:322 E:325 ||| IN
enzymatic  ||| S:325 E:335 ||| JJ
reactions  ||| S:335 E:345 ||| NNS
that  ||| S:345 E:358 ||| WDT
lead  ||| S:358 E:363 ||| VBP
to  ||| S:363 E:366 ||| TO
the  ||| S:366 E:370 ||| DT
covalent  ||| S:370 E:379 ||| JJ
attachment  ||| S:379 E:390 ||| NN
of  ||| S:390 E:393 ||| IN
a  ||| S:393 E:395 ||| DT
chain  ||| S:395 E:401 ||| NN
of  ||| S:401 E:404 ||| IN
multiple  ||| S:404 E:421 ||| JJ
ubiquitins  ||| S:421 E:432 ||| NN
to  ||| S:432 E:435 ||| TO
substrate  ||| S:435 E:445 ||| VB
proteins  ||| S:445 E:454 ||| NNS
[  ||| S:454 E:456 ||| -LRB-
2  ||| S:456 E:458 ||| LS
]  ||| S:458 E:460 ||| -RRB-
.  ||| S:460 E:462 ||| .
In  ||| S:462 E:465 ||| IN
many  ||| S:465 E:470 ||| JJ
cases ||| S:470 E:475 ||| NNS
,  ||| S:475 E:485 ||| ,
modification  ||| S:485 E:498 ||| NN
by  ||| S:498 E:501 ||| IN
ubiquityl  ||| S:501 E:511 ||| JJ
moieties  ||| S:511 E:520 ||| JJ
targets  ||| S:520 E:528 ||| NNS
proteins  ||| S:528 E:537 ||| NNS
to  ||| S:537 E:540 ||| TO
the  ||| S:540 E:552 ||| DT
proteasome ||| S:552 E:562 ||| NN
,  ||| S:562 E:564 ||| ,
ultimately  ||| S:564 E:575 ||| RB
resulting  ||| S:575 E:585 ||| VBG
in  ||| S:585 E:588 ||| IN
their  ||| S:588 E:594 ||| PRP$
degradation ||| S:594 E:605 ||| NN
.  ||| S:605 E:607 ||| .
The  ||| S:607 E:619 ||| DT
ubiquitylation  ||| S:619 E:634 ||| JJ
reaction  ||| S:634 E:643 ||| NN
involves  ||| S:643 E:652 ||| VBZ
a  ||| S:652 E:654 ||| DT
minimum  ||| S:654 E:662 ||| NN
of  ||| S:662 E:665 ||| IN
three  ||| S:665 E:679 ||| CD
enzymes ||| S:679 E:686 ||| NNS
:  ||| S:686 E:688 ||| :
An  ||| S:688 E:691 ||| DT
E1 ||| S:691 E:693 ||| NNP
,  ||| S:693 E:695 ||| ,
which  ||| S:695 E:701 ||| WDT
mediates  ||| S:701 E:710 ||| VBZ
the  ||| S:710 E:714 ||| DT
ATP-dependent  ||| S:714 E:728 ||| JJ
activation  ||| S:728 E:747 ||| NN
of  ||| S:747 E:750 ||| IN
ubiquitin ||| S:750 E:759 ||| NN
,  ||| S:759 E:761 ||| ,
and  ||| S:761 E:765 ||| CC
an  ||| S:765 E:768 ||| DT
E2 ||| S:768 E:770 ||| NNP
,  ||| S:770 E:772 ||| ,
or  ||| S:772 E:775 ||| CC
ubiquitin  ||| S:775 E:785 ||| FW
conjugating  ||| S:785 E:797 ||| FW
enzyme  ||| S:797 E:812 ||| FW
( ||| S:812 E:813 ||| -LRB-
UBC ||| S:813 E:816 ||| NNP
) ||| S:816 E:817 ||| -RRB-
,  ||| S:817 E:819 ||| ,
which ||| S:819 E:824 ||| WDT
,  ||| S:824 E:826 ||| ,
together  ||| S:826 E:835 ||| RB
with  ||| S:835 E:840 ||| IN
an  ||| S:840 E:843 ||| DT
E3  ||| S:843 E:846 ||| FW
ubiquitin  ||| S:846 E:856 ||| FW
ligase ||| S:856 E:862 ||| FW
,  ||| S:862 E:872 ||| ,
transfers  ||| S:872 E:882 ||| VBZ
ubiquitin  ||| S:882 E:892 ||| VBN
to  ||| S:892 E:895 ||| TO
the  ||| S:895 E:899 ||| DT
target  ||| S:899 E:906 ||| NN
protein ||| S:906 E:913 ||| NN
.  ||| S:913 E:915 ||| .
E3  ||| S:915 E:918 ||| NNP
enzymes  ||| S:918 E:926 ||| NNS
are  ||| S:926 E:938 ||| VBP
of  ||| S:938 E:941 ||| IN
particular  ||| S:941 E:952 ||| JJ
interest ||| S:952 E:960 ||| NN
,  ||| S:960 E:962 ||| ,
as  ||| S:962 E:965 ||| IN
they  ||| S:965 E:970 ||| PRP
mediate  ||| S:970 E:978 ||| VBD
the  ||| S:978 E:982 ||| DT
substrate  ||| S:982 E:1000 ||| JJ
specificity  ||| S:1000 E:1012 ||| NN
of  ||| S:1012 E:1015 ||| IN
ubiquitylation  ||| S:1015 E:1030 ||| JJ
reactions ||| S:1030 E:1039 ||| NNS
.  ||| S:1039 E:1049 ||| .
Studies  ||| S:1049 E:1057 ||| NNS
in  ||| S:1057 E:1060 ||| IN
budding  ||| S:1060 E:1068 ||| VBG
yeast  ||| S:1068 E:1074 ||| NN
identified  ||| S:1074 E:1085 ||| VBD
SCF  ||| S:1085 E:1089 ||| NNP
Cdc4p ||| S:1089 E:1094 ||| NNP
,  ||| S:1094 E:1096 ||| ,
an  ||| S:1096 E:1099 ||| DT
E3  ||| S:1099 E:1110 ||| JJ
ubiquitin  ||| S:1110 E:1120 ||| JJ
ligase  ||| S:1120 E:1127 ||| JJ
complex  ||| S:1127 E:1135 ||| NN
that  ||| S:1135 E:1140 ||| IN
mediates  ||| S:1140 E:1149 ||| VBG
the  ||| S:1149 E:1153 ||| DT
ubiquitylation  ||| S:1153 E:1176 ||| NN
of  ||| S:1176 E:1179 ||| IN
the  ||| S:1179 E:1183 ||| DT
CDK  ||| S:1183 E:1187 ||| FW
inhibitor  ||| S:1187 E:1197 ||| FW
Sic1p  ||| S:1197 E:1203 ||| FW
[  ||| S:1203 E:1205 ||| -LRB-
3  ||| S:1205 E:1207 ||| CD
4  ||| S:1207 E:1209 ||| CD
]  ||| S:1209 E:1211 ||| -RRB-
.  ||| S:1211 E:1213 ||| .
SCF  ||| S:1213 E:1217 ||| NNP
Cdc4pconsists  ||| S:1217 E:1231 ||| NNP
of  ||| S:1231 E:1242 ||| IN
at  ||| S:1242 E:1245 ||| IN
least  ||| S:1245 E:1251 ||| JJS
four  ||| S:1251 E:1256 ||| CD
proteins ||| S:1256 E:1264 ||| NNS
:  ||| S:1264 E:1266 ||| :
the  ||| S:1266 E:1270 ||| DT
cullin  ||| S:1270 E:1277 ||| JJ
Cdc53p ||| S:1277 E:1283 ||| NN
,  ||| S:1283 E:1285 ||| ,
the  ||| S:1285 E:1289 ||| DT
RING  ||| S:1289 E:1294 ||| FW
domain  ||| S:1294 E:1309 ||| FW
protein  ||| S:1309 E:1317 ||| FW
Hrt1p ||| S:1317 E:1322 ||| FW
/ ||| S:1322 E:1323 ||| FW
Rbx1p ||| S:1323 E:1328 ||| FW
/ ||| S:1328 E:1329 ||| FW
Roc1p ||| S:1329 E:1334 ||| FW
,  ||| S:1334 E:1336 ||| ,
the  ||| S:1336 E:1340 ||| DT
adapter  ||| S:1340 E:1348 ||| JJ
protein  ||| S:1348 E:1356 ||| NN
Skp1p ||| S:1356 E:1361 ||| NN
,  ||| S:1361 E:1363 ||| ,
and  ||| S:1363 E:1375 ||| CC
Cdc4p  ||| S:1375 E:1381 ||| NNP
( ||| S:1381 E:1382 ||| -LRB-
reviewed  ||| S:1382 E:1391 ||| VBN
in  ||| S:1391 E:1394 ||| IN
[  ||| S:1394 E:1396 ||| -LRB-
1  ||| S:1396 E:1398 ||| LS
]  ||| S:1398 E:1400 ||| -RRB-
) ||| S:1400 E:1401 ||| -RRB-
.  ||| S:1401 E:1403 ||| .
Cdc4p  ||| S:1403 E:1409 ||| NNP
contains  ||| S:1409 E:1418 ||| VBZ
two  ||| S:1418 E:1422 ||| CD
sequence  ||| S:1422 E:1439 ||| NN
motifs ||| S:1439 E:1445 ||| NNS
,  ||| S:1445 E:1447 ||| ,
which  ||| S:1447 E:1453 ||| WDT
are  ||| S:1453 E:1457 ||| VBP
conserved  ||| S:1457 E:1467 ||| VBN
in  ||| S:1467 E:1470 ||| IN
a  ||| S:1470 E:1472 ||| DT
wide  ||| S:1472 E:1477 ||| JJ
variety  ||| S:1477 E:1485 ||| NN
of  ||| S:1485 E:1488 ||| IN
so-called  ||| S:1488 E:1506 ||| JJ
F-box  ||| S:1506 E:1512 ||| JJ
proteins ||| S:1512 E:1520 ||| NNS
:  ||| S:1520 E:1522 ||| :
C-terminal  ||| S:1522 E:1533 ||| JJ
WD-repeats  ||| S:1533 E:1544 ||| NN
that  ||| S:1544 E:1549 ||| WDT
are  ||| S:1549 E:1553 ||| VBP
involved  ||| S:1553 E:1562 ||| VBN
in  ||| S:1562 E:1573 ||| IN
binding  ||| S:1573 E:1581 ||| VBG
the  ||| S:1581 E:1585 ||| DT
substrate  ||| S:1585 E:1595 ||| JJ
Sic1p  ||| S:1595 E:1601 ||| NN
in  ||| S:1601 E:1604 ||| IN
a  ||| S:1604 E:1606 ||| DT
phosphorylation-dependent  ||| S:1606 E:1640 ||| JJ
manner ||| S:1640 E:1646 ||| NN
,  ||| S:1646 E:1648 ||| ,
and  ||| S:1648 E:1652 ||| CC
a  ||| S:1652 E:1654 ||| DT
central  ||| S:1654 E:1662 ||| JJ
F-box  ||| S:1662 E:1668 ||| NN
[  ||| S:1668 E:1670 ||| -LRB-
5  ||| S:1670 E:1672 ||| LS
]  ||| S:1672 E:1674 ||| -RRB-
that  ||| S:1674 E:1679 ||| IN
interacts  ||| S:1679 E:1689 ||| NN
with  ||| S:1689 E:1694 ||| IN
Skp1p  ||| S:1694 E:1708 ||| NNP
[  ||| S:1708 E:1710 ||| -LRB-
6  ||| S:1710 E:1712 ||| CD
7  ||| S:1712 E:1714 ||| CD
]  ||| S:1714 E:1716 ||| -RRB-
.  ||| S:1716 E:1718 ||| .
Cdc53p  ||| S:1718 E:1725 ||| NNP
in  ||| S:1725 E:1728 ||| IN
turn  ||| S:1728 E:1733 ||| NN
binds  ||| S:1733 E:1739 ||| NN
to  ||| S:1739 E:1742 ||| TO
Skp1p  ||| S:1742 E:1748 ||| CD
and  ||| S:1748 E:1760 ||| CC
Hrt1p ||| S:1760 E:1765 ||| CD
/ ||| S:1765 E:1766 ||| CD
Rbx1p ||| S:1766 E:1771 ||| CD
/ ||| S:1771 E:1772 ||| CD
Roc1p ||| S:1772 E:1777 ||| CD
,  ||| S:1777 E:1779 ||| ,
which  ||| S:1779 E:1785 ||| WDT
bridges  ||| S:1785 E:1793 ||| VBD
Cdc53p  ||| S:1793 E:1800 ||| CD
with  ||| S:1800 E:1805 ||| IN
the  ||| S:1805 E:1817 ||| DT
ubiquitin-conjugating  ||| S:1817 E:1839 ||| JJ
enzyme  ||| S:1839 E:1846 ||| FW
Cdc34p ||| S:1846 E:1852 ||| FW
/ ||| S:1852 E:1853 ||| FW
Ubc3p  ||| S:1853 E:1859 ||| FW
[  ||| S:1859 E:1861 ||| -LRB-
6  ||| S:1861 E:1863 ||| CD
8  ||| S:1863 E:1865 ||| CD
9  ||| S:1865 E:1867 ||| CD
10  ||| S:1867 E:1870 ||| CD
11  ||| S:1870 E:1873 ||| CD
12  ||| S:1873 E:1884 ||| CD
]  ||| S:1884 E:1886 ||| -RRB-
.  ||| S:1886 E:1897 ||| .
In  ||| S:1897 E:1900 ||| IN
vitro  ||| S:1900 E:1906 ||| NNS
reconstitution  ||| S:1906 E:1921 ||| VBP
demonstrated  ||| S:1921 E:1942 ||| VBN
that  ||| S:1942 E:1947 ||| IN
SCF  ||| S:1947 E:1951 ||| NNP
Cdc4p ||| S:1951 E:1956 ||| NNP
,  ||| S:1956 E:1958 ||| ,
Cdc34p ||| S:1958 E:1964 ||| NNP
,  ||| S:1964 E:1966 ||| ,
E1 ||| S:1966 E:1968 ||| NNP
,  ||| S:1968 E:1970 ||| ,
ubiquitin ||| S:1970 E:1979 ||| NN
,  ||| S:1979 E:1981 ||| ,
and  ||| S:1981 E:1985 ||| CC
ATP  ||| S:1985 E:1989 ||| NNP
are  ||| S:1989 E:2001 ||| VBP
sufficient  ||| S:2001 E:2012 ||| JJ
to  ||| S:2012 E:2015 ||| TO
mediate  ||| S:2015 E:2023 ||| VB
Sic1p  ||| S:2023 E:2029 ||| CD
polyubiquitylation  ||| S:2029 E:2048 ||| NNS
[  ||| S:2048 E:2050 ||| -LRB-
6  ||| S:2050 E:2052 ||| CD
7  ||| S:2052 E:2054 ||| CD
]  ||| S:2054 E:2064 ||| -RRB-
.  ||| S:2064 E:2074 ||| .
Components  ||| S:2074 E:2085 ||| NNS
of  ||| S:2085 E:2088 ||| IN
the  ||| S:2088 E:2092 ||| DT
SCF  ||| S:2092 E:2096 ||| NNP
system  ||| S:2096 E:2103 ||| NN
are  ||| S:2103 E:2107 ||| VBP
widely  ||| S:2107 E:2114 ||| RB
conserved  ||| S:2114 E:2124 ||| VBN
in  ||| S:2124 E:2135 ||| IN
eukaryotes  ||| S:2135 E:2146 ||| NNS
[  ||| S:2146 E:2148 ||| -LRB-
1  ||| S:2148 E:2150 ||| CD
3  ||| S:2150 E:2152 ||| CD
]  ||| S:2152 E:2154 ||| -RRB-
.  ||| S:2154 E:2156 ||| .
In  ||| S:2156 E:2159 ||| IN
human  ||| S:2159 E:2165 ||| JJ
cells ||| S:2165 E:2170 ||| NNS
,  ||| S:2170 E:2172 ||| ,
for  ||| S:2172 E:2176 ||| IN
example ||| S:2176 E:2183 ||| NN
,  ||| S:2183 E:2185 ||| ,
SCF  ||| S:2185 E:2197 ||| NNP
Skp2mediates  ||| S:2197 E:2210 ||| NNP
destruction  ||| S:2210 E:2222 ||| NN
of  ||| S:2222 E:2225 ||| IN
the  ||| S:2225 E:2229 ||| DT
CDK  ||| S:2229 E:2233 ||| FW
inhibitor  ||| S:2233 E:2243 ||| FW
p27  ||| S:2243 E:2247 ||| FW
[  ||| S:2247 E:2249 ||| -LRB-
13  ||| S:2249 E:2252 ||| CD
14  ||| S:2252 E:2255 ||| CD
]  ||| S:2255 E:2265 ||| -RRB-
,  ||| S:2265 E:2267 ||| ,
while  ||| S:2267 E:2273 ||| IN
SCF  ||| S:2273 E:2277 ||| NNP
β-TRCPtargets  ||| S:2277 E:2291 ||| NNP
IκB  ||| S:2291 E:2295 ||| NNP
[  ||| S:2295 E:2297 ||| -LRB-
15  ||| S:2297 E:2300 ||| CD
16  ||| S:2300 E:2303 ||| CD
17  ||| S:2303 E:2306 ||| CD
]  ||| S:2306 E:2308 ||| -RRB-
.  ||| S:2308 E:2310 ||| .
All  ||| S:2310 E:2314 ||| DT
of  ||| S:2314 E:2317 ||| IN
these  ||| S:2317 E:2331 ||| DT
SCF  ||| S:2331 E:2335 ||| NNP
complexes  ||| S:2335 E:2345 ||| JJ
share  ||| S:2345 E:2351 ||| NN
homologues  ||| S:2351 E:2362 ||| NN
of  ||| S:2362 E:2365 ||| IN
the  ||| S:2365 E:2369 ||| DT
core  ||| S:2369 E:2374 ||| NN
components  ||| S:2374 E:2393 ||| NNS
CDC53 ||| S:2393 E:2398 ||| CD
/ ||| S:2398 E:2399 ||| CD
CUL1 ||| S:2399 E:2403 ||| CD
,  ||| S:2403 E:2405 ||| ,
SKP1 ||| S:2405 E:2409 ||| NNP
,  ||| S:2409 E:2411 ||| ,
and  ||| S:2411 E:2415 ||| CC
HRT1 ||| S:2415 E:2419 ||| CD
/ ||| S:2419 E:2420 ||| CD
RBX1 ||| S:2420 E:2424 ||| CD
/ ||| S:2424 E:2425 ||| CD
ROC1 ||| S:2425 E:2429 ||| CD
,  ||| S:2429 E:2431 ||| ,
which  ||| S:2431 E:2437 ||| WDT
associate  ||| S:2437 E:2447 ||| VBP
with  ||| S:2447 E:2460 ||| IN
different  ||| S:2460 E:2470 ||| JJ
F-box  ||| S:2470 E:2476 ||| JJ
proteins ||| S:2476 E:2484 ||| NNS
.  ||| S:2484 E:2494 ||| .
Several  ||| S:2494 E:2502 ||| JJ
lines  ||| S:2502 E:2508 ||| NNS
of  ||| S:2508 E:2511 ||| IN
evidence  ||| S:2511 E:2520 ||| NN
suggest  ||| S:2520 E:2528 ||| VBP
that  ||| S:2528 E:2533 ||| IN
the  ||| S:2533 E:2537 ||| DT
SCF  ||| S:2537 E:2541 ||| NNP
pathway  ||| S:2541 E:2557 ||| NN
is  ||| S:2557 E:2560 ||| VBZ
also  ||| S:2560 E:2565 ||| RB
conserved  ||| S:2565 E:2575 ||| VBN
in  ||| S:2575 E:2578 ||| IN
the  ||| S:2578 E:2582 ||| DT
fission  ||| S:2582 E:2590 ||| FW
yeast  ||| S:2590 E:2605 ||| FW
Schizosaccharomyces  ||| S:2605 E:2625 ||| FW
pombe  ||| S:2625 E:2631 ||| FW
.  ||| S:2631 E:2633 ||| .
Pcu1p ||| S:2633 E:2638 ||| NNP
,  ||| S:2638 E:2640 ||| ,
a  ||| S:2640 E:2650 ||| DT
Cdc53p ||| S:2650 E:2656 ||| CD
/ ||| S:2656 E:2657 ||| CD
CUL1-related  ||| S:2657 E:2670 ||| CD
protein ||| S:2670 E:2677 ||| NN
,  ||| S:2677 E:2679 ||| ,
was  ||| S:2679 E:2683 ||| VBD
shown  ||| S:2683 E:2689 ||| VBN
to  ||| S:2689 E:2692 ||| TO
associate  ||| S:2692 E:2702 ||| NN
with  ||| S:2702 E:2715 ||| IN
two  ||| S:2715 E:2719 ||| CD
different  ||| S:2719 E:2729 ||| JJ
F-box ||| S:2729 E:2734 ||| JJ
/ ||| S:2734 E:2735 ||| NNP
WD  ||| S:2735 E:2738 ||| NNP
repeat  ||| S:2738 E:2745 ||| NN
proteins ||| S:2745 E:2753 ||| NNS
,  ||| S:2753 E:2755 ||| ,
Pop1p  ||| S:2755 E:2761 ||| NNP
and  ||| S:2761 E:2765 ||| CC
Pop2p ||| S:2765 E:2770 ||| NNP
,  ||| S:2770 E:2780 ||| ,
when  ||| S:2780 E:2785 ||| WRB
overexpressed  ||| S:2785 E:2799 ||| NNS
[  ||| S:2799 E:2801 ||| -LRB-
18  ||| S:2801 E:2804 ||| CD
]  ||| S:2804 E:2806 ||| -RRB-
.  ||| S:2806 E:2808 ||| .
In  ||| S:2808 E:2811 ||| IN
addition ||| S:2811 E:2819 ||| NN
,  ||| S:2819 E:2821 ||| ,
genetic  ||| S:2821 E:2829 ||| JJ
studies  ||| S:2829 E:2845 ||| NNS
demonstrated  ||| S:2845 E:2858 ||| VBN
that  ||| S:2858 E:2863 ||| IN
both  ||| S:2863 E:2868 ||| DT
of  ||| S:2868 E:2871 ||| IN
these  ||| S:2871 E:2877 ||| DT
F-box  ||| S:2877 E:2883 ||| JJ
proteins  ||| S:2883 E:2892 ||| NNS
are  ||| S:2892 E:2904 ||| VBP
simultaneously  ||| S:2904 E:2919 ||| RB
required  ||| S:2919 E:2928 ||| VBN
for  ||| S:2928 E:2932 ||| IN
efficient  ||| S:2932 E:2942 ||| JJ
destruction  ||| S:2942 E:2954 ||| NN
of  ||| S:2954 E:2957 ||| IN
Rum1p  ||| S:2957 E:2971 ||| NNP
and  ||| S:2971 E:2975 ||| CC
the  ||| S:2975 E:2979 ||| DT
replication  ||| S:2979 E:2991 ||| FW
initiator  ||| S:2991 E:3001 ||| FW
Cdc18p  ||| S:3001 E:3008 ||| FW
[  ||| S:3008 E:3010 ||| -LRB-
18  ||| S:3010 E:3013 ||| CD
19  ||| S:3013 E:3016 ||| CD
20  ||| S:3016 E:3019 ||| CD
]  ||| S:3019 E:3021 ||| -RRB-
.  ||| S:3021 E:3023 ||| .
Rum1p  ||| S:3023 E:3037 ||| NNP
is  ||| S:3037 E:3040 ||| VBZ
a  ||| S:3040 E:3042 ||| DT
Sic1p-analogous  ||| S:3042 E:3058 ||| NNP
CDK  ||| S:3058 E:3062 ||| NNP
inhibitor ||| S:3062 E:3071 ||| NN
,  ||| S:3071 E:3073 ||| ,
which  ||| S:3073 E:3079 ||| WDT
accumulates  ||| S:3079 E:3091 ||| VBZ
in  ||| S:3091 E:3102 ||| IN
G1 ||| S:3102 E:3104 ||| NNP
,  ||| S:3104 E:3106 ||| ,
but  ||| S:3106 E:3110 ||| CC
is  ||| S:3110 E:3113 ||| VBZ
degraded  ||| S:3113 E:3122 ||| VBN
as  ||| S:3122 E:3125 ||| IN
cells  ||| S:3125 E:3131 ||| NNS
enter  ||| S:3131 E:3137 ||| VBP
S  ||| S:3137 E:3139 ||| NNP
phase  ||| S:3139 E:3145 ||| NN
[  ||| S:3145 E:3147 ||| -LRB-
21  ||| S:3147 E:3150 ||| CD
22  ||| S:3150 E:3153 ||| CD
]  ||| S:3153 E:3155 ||| -RRB-
.  ||| S:3155 E:3165 ||| .
Failure  ||| S:3165 E:3173 ||| NN
to  ||| S:3173 E:3176 ||| TO
degrade  ||| S:3176 E:3184 ||| VB
Rum1p  ||| S:3184 E:3190 ||| NNP
is  ||| S:3190 E:3193 ||| VBZ
the  ||| S:3193 E:3197 ||| DT
major  ||| S:3197 E:3203 ||| JJ
phenotypic  ||| S:3203 E:3214 ||| JJ
defect  ||| S:3214 E:3221 ||| NN
of  ||| S:3221 E:3233 ||| IN
pop1  ||| S:3233 E:3238 ||| NNP
and  ||| S:3238 E:3251 ||| CC
pop2  ||| S:3251 E:3256 ||| CD
deletion  ||| S:3256 E:3265 ||| CD
strains ||| S:3265 E:3272 ||| NNS
,  ||| S:3272 E:3274 ||| ,
which  ||| S:3274 E:3280 ||| WDT
leads  ||| S:3280 E:3286 ||| VBZ
to  ||| S:3286 E:3297 ||| TO
disturbance  ||| S:3297 E:3309 ||| VB
of  ||| S:3309 E:3312 ||| IN
normal  ||| S:3312 E:3319 ||| JJ
cell  ||| S:3319 E:3324 ||| NN
cycle  ||| S:3324 E:3330 ||| NN
progression ||| S:3330 E:3341 ||| NN
,  ||| S:3341 E:3343 ||| ,
resulting  ||| S:3343 E:3353 ||| VBG
in  ||| S:3353 E:3364 ||| IN
polyploidy  ||| S:3364 E:3375 ||| NNS
[  ||| S:3375 E:3377 ||| -LRB-
18  ||| S:3377 E:3380 ||| CD
19  ||| S:3380 E:3383 ||| CD
20  ||| S:3383 E:3386 ||| CD
23  ||| S:3386 E:3389 ||| CD
]  ||| S:3389 E:3391 ||| -RRB-
.  ||| S:3391 E:3393 ||| .
Based  ||| S:3393 E:3399 ||| VBN
on  ||| S:3399 E:3402 ||| IN
the  ||| S:3402 E:3406 ||| DT
genetic  ||| S:3406 E:3414 ||| JJ
data  ||| S:3414 E:3419 ||| NNS
and  ||| S:3419 E:3431 ||| CC
the  ||| S:3431 E:3435 ||| DT
biochemical  ||| S:3435 E:3447 ||| JJ
observation  ||| S:3447 E:3459 ||| NN
that  ||| S:3459 E:3464 ||| IN
Pop1p  ||| S:3464 E:3470 ||| NNP
and  ||| S:3470 E:3474 ||| CC
Pop2p  ||| S:3474 E:3480 ||| CD
interact  ||| S:3480 E:3497 ||| NN
when  ||| S:3497 E:3502 ||| WRB
overexpressed ||| S:3502 E:3515 ||| NNS
,  ||| S:3515 E:3517 ||| ,
a  ||| S:3517 E:3519 ||| DT
putative  ||| S:3519 E:3528 ||| JJ
SCF  ||| S:3528 E:3532 ||| NNP
Pop1p-Pop2pcomplex  ||| S:3532 E:3551 ||| NNP
was  ||| S:3551 E:3563 ||| VBD
proposed ||| S:3563 E:3571 ||| VBN
,  ||| S:3571 E:3573 ||| ,
which  ||| S:3573 E:3579 ||| WDT
would  ||| S:3579 E:3585 ||| MD
contain  ||| S:3585 E:3593 ||| VB
the  ||| S:3593 E:3597 ||| DT
heterooligomerizing  ||| S:3597 E:3617 ||| JJ
F-box  ||| S:3617 E:3631 ||| JJ
proteins  ||| S:3631 E:3640 ||| NNS
Pop1p  ||| S:3640 E:3646 ||| NNP
and  ||| S:3646 E:3650 ||| CC
Pop2p  ||| S:3650 E:3656 ||| RB
bound  ||| S:3656 E:3662 ||| VBN
to  ||| S:3662 E:3665 ||| TO
SCF  ||| S:3665 E:3669 ||| NNP
core  ||| S:3669 E:3674 ||| NN
components  ||| S:3674 E:3685 ||| NNS
[  ||| S:3685 E:3687 ||| -LRB-
18  ||| S:3687 E:3698 ||| CD
20  ||| S:3698 E:3701 ||| CD
]  ||| S:3701 E:3703 ||| -RRB-
.  ||| S:3703 E:3713 ||| .
Whether  ||| S:3713 E:3721 ||| IN
this  ||| S:3721 E:3726 ||| DT
unusual  ||| S:3726 E:3734 ||| JJ
heterooligomeric  ||| S:3734 E:3751 ||| JJ
SCF  ||| S:3751 E:3763 ||| NNP
Pop1p-Pop2pcomplex  ||| S:3763 E:3782 ||| NNP
exists  ||| S:3782 E:3798 ||| VBZ
in  ||| S:3798 E:3801 ||| IN
vivo  ||| S:3801 E:3806 ||| NN
and  ||| S:3806 E:3810 ||| CC
whether  ||| S:3810 E:3818 ||| IN
it  ||| S:3818 E:3821 ||| PRP
mediates  ||| S:3821 E:3830 ||| VBD
Rum1p  ||| S:3830 E:3844 ||| CD
ubiquitylation ||| S:3844 E:3858 ||| NN
,  ||| S:3858 E:3860 ||| ,
remained  ||| S:3860 E:3869 ||| VBD
unproven ||| S:3869 E:3877 ||| CD
,  ||| S:3877 E:3879 ||| ,
as  ||| S:3879 E:3882 ||| RB
not  ||| S:3882 E:3886 ||| RB
all  ||| S:3886 E:3890 ||| DT
fission  ||| S:3890 E:3898 ||| JJ
yeast  ||| S:3898 E:3912 ||| NN
SCF  ||| S:3912 E:3916 ||| NNP
core  ||| S:3916 E:3921 ||| NN
subunits  ||| S:3921 E:3930 ||| NNS
were  ||| S:3930 E:3935 ||| VBD
identified ||| S:3935 E:3945 ||| VBN
.  ||| S:3945 E:3947 ||| .
In  ||| S:3947 E:3950 ||| IN
addition ||| S:3950 E:3958 ||| NN
,  ||| S:3958 E:3960 ||| ,
based  ||| S:3960 E:3966 ||| VBN
on  ||| S:3966 E:3977 ||| IN
overexpression ||| S:3977 E:3991 ||| NN
,  ||| S:3991 E:3993 ||| ,
distinct  ||| S:3993 E:4002 ||| JJ
SCF  ||| S:4002 E:4006 ||| NNP
Pop1pand  ||| S:4006 E:4015 ||| NNP
SCF  ||| S:4015 E:4019 ||| NNP
Pop2pcomplexes  ||| S:4019 E:4042 ||| NNP
were  ||| S:4042 E:4047 ||| VBD
proposed  ||| S:4047 E:4056 ||| VBN
to  ||| S:4056 E:4059 ||| TO
target  ||| S:4059 E:4066 ||| VB
unknown  ||| S:4066 E:4074 ||| JJ
substrates ||| S:4074 E:4084 ||| NN
,  ||| S:4084 E:4086 ||| ,
but  ||| S:4086 E:4090 ||| CC
no  ||| S:4090 E:4101 ||| DT
biochemical  ||| S:4101 E:4113 ||| JJ
evidence  ||| S:4113 E:4122 ||| NN
of  ||| S:4122 E:4125 ||| IN
their  ||| S:4125 E:4131 ||| PRP$
activity  ||| S:4131 E:4140 ||| NN
was  ||| S:4140 E:4144 ||| VBD
provided  ||| S:4144 E:4153 ||| VBN
[  ||| S:4153 E:4155 ||| -LRB-
18  ||| S:4155 E:4158 ||| CD
]  ||| S:4158 E:4168 ||| -RRB-
.  ||| S:4168 E:4170 ||| .
To  ||| S:4170 E:4173 ||| TO
address  ||| S:4173 E:4181 ||| VB
these  ||| S:4181 E:4187 ||| DT
questions ||| S:4187 E:4196 ||| NNS
,  ||| S:4196 E:4198 ||| ,
we  ||| S:4198 E:4201 ||| PRP
cloned  ||| S:4201 E:4208 ||| VBD
two  ||| S:4208 E:4212 ||| CD
additional  ||| S:4212 E:4231 ||| JJ
subunits  ||| S:4231 E:4240 ||| NN
of  ||| S:4240 E:4243 ||| IN
SCF  ||| S:4243 E:4247 ||| NNP
Popand  ||| S:4247 E:4254 ||| NNP
performed  ||| S:4254 E:4264 ||| VBD
a  ||| S:4264 E:4266 ||| DT
detailed  ||| S:4266 E:4283 ||| JJ
characterization  ||| S:4283 E:4300 ||| NN
of  ||| S:4300 E:4303 ||| IN
its  ||| S:4303 E:4307 ||| PRP$
activity  ||| S:4307 E:4325 ||| NN
in  ||| S:4325 E:4328 ||| IN
vitro  ||| S:4328 E:4334 ||| NN
and  ||| S:4334 E:4347 ||| CC
in  ||| S:4347 E:4350 ||| IN
vivo  ||| S:4350 E:4355 ||| NN
.  ||| S:4355 E:4357 ||| .
Our  ||| S:4357 E:4361 ||| PRP$
results  ||| S:4361 E:4369 ||| NNS
indicate  ||| S:4369 E:4378 ||| VBP
that  ||| S:4378 E:4391 ||| IN
heterooligomeric  ||| S:4391 E:4408 ||| FW
SCF  ||| S:4408 E:4412 ||| FW
Pop1p-Pop2pmediates  ||| S:4412 E:4432 ||| FW
Rum1p  ||| S:4432 E:4446 ||| FW
ubiquitylation  ||| S:4446 E:4461 ||| FW
whereas  ||| S:4461 E:4469 ||| FW
distinct  ||| S:4469 E:4478 ||| FW
SCF  ||| S:4478 E:4482 ||| FW
Pop1pand  ||| S:4482 E:4491 ||| FW
SCF  ||| S:4491 E:4503 ||| FW
Pop2pcomplexes  ||| S:4503 E:4518 ||| FW
target  ||| S:4518 E:4525 ||| FW
unknown  ||| S:4525 E:4533 ||| FW
nuclear  ||| S:4533 E:4541 ||| JJ
and  ||| S:4541 E:4545 ||| CC
cytoplasmic  ||| S:4545 E:4565 ||| JJ
substrates ||| S:4565 E:4575 ||| NN
,  ||| S:4575 E:4577 ||| ,
thereby  ||| S:4577 E:4585 ||| RB
generating  ||| S:4585 E:4596 ||| VBG
combinatorial  ||| S:4596 E:4610 ||| JJ
diversity  ||| S:4610 E:4620 ||| NN
of  ||| S:4620 E:4631 ||| IN
SCF  ||| S:4631 E:4635 ||| NNP
function  ||| S:4635 E:4644 ||| NN
in  ||| S:4644 E:4647 ||| IN
fission  ||| S:4647 E:4655 ||| JJ
yeast ||| S:4655 E:4660 ||| NN
.  ||| S:4660 E:4684 ||| .
Results  ||| S:4684 E:4711 ||| NNP
Composition  ||| S:4711 E:4723 ||| NNP
of  ||| S:4723 E:4726 ||| IN
SCF  ||| S:4726 E:4730 ||| NNP
Pop1p-Pop2p  ||| S:4730 E:4752 ||| VBZ
Based  ||| S:4752 E:4758 ||| VBN
on  ||| S:4758 E:4761 ||| IN
the  ||| S:4761 E:4765 ||| DT
composition  ||| S:4765 E:4777 ||| NN
of  ||| S:4777 E:4780 ||| IN
known  ||| S:4780 E:4786 ||| VBN
SCF  ||| S:4786 E:4790 ||| NNP
complexes ||| S:4790 E:4799 ||| NNS
,  ||| S:4799 E:4801 ||| ,
we  ||| S:4801 E:4814 ||| PRP
identified  ||| S:4814 E:4825 ||| VBD
in  ||| S:4825 E:4828 ||| IN
the  ||| S:4828 E:4843 ||| DT
S.  ||| S:4843 E:4846 ||| NNP
pombe  ||| S:4846 E:4852 ||| FW
genome  ||| S:4852 E:4859 ||| FW
database  ||| S:4859 E:4879 ||| FW
psh1  ||| S:4879 E:4884 ||| FW
( ||| S:4884 E:4885 ||| -LRB-
pombe  ||| S:4885 E:4891 ||| FW
skp1  ||| S:4891 E:4896 ||| FW
homologue ||| S:4896 E:4905 ||| FW
)  ||| S:4905 E:4907 ||| -RRB-
and  ||| S:4907 E:4922 ||| CC
pip1  ||| S:4922 E:4927 ||| NNP
( ||| S:4927 E:4928 ||| -LRB-
pop  ||| S:4928 E:4932 ||| FW
interacting  ||| S:4932 E:4944 ||| FW
protein  ||| S:4944 E:4952 ||| FW
1 ||| S:4952 E:4953 ||| LS
) ||| S:4953 E:4954 ||| -RRB-
,  ||| S:4954 E:4966 ||| ,
two  ||| S:4966 E:4970 ||| CD
genes  ||| S:4970 E:4976 ||| NNS
encoding  ||| S:4976 E:4985 ||| JJ
proteins  ||| S:4985 E:4994 ||| NNS
with  ||| S:4994 E:4999 ||| IN
strong  ||| S:4999 E:5006 ||| JJ
similarity  ||| S:5006 E:5017 ||| NN
to  ||| S:5017 E:5030 ||| TO
human  ||| S:5030 E:5036 ||| JJ
SKP1  ||| S:5036 E:5041 ||| NN
and  ||| S:5041 E:5045 ||| CC
HRT1 ||| S:5045 E:5049 ||| CD
/ ||| S:5049 E:5050 ||| CD
RBX1 ||| S:5050 E:5054 ||| CD
/ ||| S:5054 E:5055 ||| CD
ROC1 ||| S:5055 E:5059 ||| CD
,  ||| S:5059 E:5061 ||| ,
respectively  ||| S:5061 E:5074 ||| RB
( ||| S:5074 E:5075 ||| -LRB-
data  ||| S:5075 E:5080 ||| NNS
not  ||| S:5080 E:5094 ||| RB
shown ||| S:5094 E:5099 ||| VBN
) ||| S:5099 E:5100 ||| -RRB-
.  ||| S:5100 E:5102 ||| .
Consistent  ||| S:5102 E:5113 ||| JJ
with  ||| S:5113 E:5118 ||| IN
these  ||| S:5118 E:5124 ||| DT
proteins  ||| S:5124 E:5133 ||| NNS
being  ||| S:5133 E:5139 ||| VBG
components  ||| S:5139 E:5160 ||| NNS
of  ||| S:5160 E:5163 ||| IN
the  ||| S:5163 E:5167 ||| DT
putative  ||| S:5167 E:5176 ||| JJ
SCF  ||| S:5176 E:5180 ||| NNP
Pop1p-Pop2pcomplex ||| S:5180 E:5198 ||| NNP
,  ||| S:5198 E:5200 ||| ,
they  ||| S:5200 E:5205 ||| PRP
all  ||| S:5205 E:5219 ||| DT
co-purified  ||| S:5219 E:5231 ||| JJ
with  ||| S:5231 E:5236 ||| IN
Pop1p ||| S:5236 E:5241 ||| NNP
,  ||| S:5241 E:5243 ||| ,
Pop2p ||| S:5243 E:5248 ||| NNP
,  ||| S:5248 E:5250 ||| ,
and  ||| S:5250 E:5254 ||| CC
Pcu1p  ||| S:5254 E:5260 ||| NNP
when  ||| S:5260 E:5275 ||| WRB
overexpressed  ||| S:5275 E:5289 ||| JJ
pairwise  ||| S:5289 E:5298 ||| NNS
( ||| S:5298 E:5299 ||| -LRB-
data  ||| S:5299 E:5304 ||| NNS
not  ||| S:5304 E:5308 ||| RB
shown ||| S:5308 E:5313 ||| VBN
) ||| S:5313 E:5314 ||| -RRB-
.  ||| S:5314 E:5326 ||| .
Co-immunoprecipitation  ||| S:5326 E:5349 ||| JJ
experiments  ||| S:5349 E:5361 ||| NNS
using  ||| S:5361 E:5367 ||| VBG
affinity  ||| S:5367 E:5386 ||| JJ
purified  ||| S:5386 E:5395 ||| JJ
rabbit  ||| S:5395 E:5402 ||| NN
antisera  ||| S:5402 E:5411 ||| NNS
confirmed  ||| S:5411 E:5421 ||| VBD
these  ||| S:5421 E:5427 ||| DT
interactions  ||| S:5427 E:5440 ||| NN
at  ||| S:5440 E:5453 ||| IN
the  ||| S:5453 E:5457 ||| DT
level  ||| S:5457 E:5463 ||| NN
of  ||| S:5463 E:5466 ||| IN
the  ||| S:5466 E:5470 ||| DT
endogenous  ||| S:5470 E:5481 ||| JJ
proteins ||| S:5481 E:5489 ||| NNS
.  ||| S:5489 E:5491 ||| .
While  ||| S:5491 E:5497 ||| IN
each  ||| S:5497 E:5502 ||| DT
of  ||| S:5502 E:5505 ||| IN
the  ||| S:5505 E:5519 ||| DT
five  ||| S:5519 E:5524 ||| CD
antisera  ||| S:5524 E:5533 ||| JJ
co-precipitated  ||| S:5533 E:5549 ||| NN
at  ||| S:5549 E:5552 ||| IN
least  ||| S:5552 E:5558 ||| JJS
one  ||| S:5558 E:5562 ||| CD
of  ||| S:5562 E:5565 ||| IN
the  ||| S:5565 E:5569 ||| DT
other  ||| S:5569 E:5585 ||| JJ
subunits ||| S:5585 E:5593 ||| NN
,  ||| S:5593 E:5595 ||| ,
Pip1p ||| S:5595 E:5600 ||| NNP
,  ||| S:5600 E:5602 ||| ,
Pop1p ||| S:5602 E:5607 ||| NNP
,  ||| S:5607 E:5609 ||| ,
and  ||| S:5609 E:5613 ||| CC
Pop2p  ||| S:5613 E:5619 ||| CD
antisera  ||| S:5619 E:5638 ||| CD
co-precipitated  ||| S:5638 E:5654 ||| JJ
all  ||| S:5654 E:5658 ||| DT
five  ||| S:5658 E:5663 ||| CD
proteins  ||| S:5663 E:5672 ||| NNS
from  ||| S:5672 E:5677 ||| IN
wild-type  ||| S:5677 E:5687 ||| JJ
cell  ||| S:5687 E:5702 ||| NN
lysate  ||| S:5702 E:5709 ||| NNS
( ||| S:5709 E:5710 ||| -LRB-
Fig.  ||| S:5710 E:5715 ||| NNP
1A ||| S:5715 E:5717 ||| NNP
) ||| S:5717 E:5718 ||| -RRB-
.  ||| S:5718 E:5720 ||| .
Size  ||| S:5720 E:5725 ||| NN
fractionation  ||| S:5725 E:5739 ||| NN
of  ||| S:5739 E:5742 ||| IN
total  ||| S:5742 E:5748 ||| JJ
cell  ||| S:5748 E:5763 ||| NN
lysates  ||| S:5763 E:5771 ||| VBZ
prior  ||| S:5771 E:5777 ||| RB
to  ||| S:5777 E:5780 ||| TO
immunoprecipitation  ||| S:5780 E:5800 ||| VB
revealed  ||| S:5800 E:5809 ||| VBN
co-elution  ||| S:5809 E:5830 ||| JJ
of  ||| S:5830 E:5833 ||| IN
Pip1p  ||| S:5833 E:5839 ||| CD
with  ||| S:5839 E:5844 ||| IN
Pop1p ||| S:5844 E:5849 ||| NNP
,  ||| S:5849 E:5851 ||| ,
Pop2p ||| S:5851 E:5856 ||| NNP
,  ||| S:5856 E:5858 ||| ,
Pcu1p ||| S:5858 E:5863 ||| NNP
,  ||| S:5863 E:5865 ||| ,
and  ||| S:5865 E:5869 ||| CC
Psh1p  ||| S:5869 E:5875 ||| CD
in  ||| S:5875 E:5878 ||| IN
a  ||| S:5878 E:5880 ||| DT
high  ||| S:5880 E:5895 ||| JJ
molecular  ||| S:5895 E:5905 ||| JJ
weight  ||| S:5905 E:5912 ||| NN
complex  ||| S:5912 E:5920 ||| NN
of  ||| S:5920 E:5923 ||| IN
approximately  ||| S:5923 E:5937 ||| RB
500  ||| S:5937 E:5941 ||| CD
kDa ||| S:5941 E:5944 ||| NN
,  ||| S:5944 E:5946 ||| ,
which  ||| S:5946 E:5962 ||| WDT
we  ||| S:5962 E:5965 ||| PRP
refer  ||| S:5965 E:5971 ||| VBP
to  ||| S:5971 E:5974 ||| TO
as  ||| S:5974 E:5977 ||| IN
SCF  ||| S:5977 E:5981 ||| NNP
Pop1p-Pop2p ||| S:5981 E:5992 ||| NNP
( ||| S:5992 E:5993 ||| -LRB-
Fig.  ||| S:5993 E:5998 ||| NNP
1B ||| S:5998 E:6000 ||| NNP
) ||| S:6000 E:6001 ||| -RRB-
.  ||| S:6001 E:6003 ||| .
The  ||| S:6003 E:6007 ||| DT
composition  ||| S:6007 E:6029 ||| NN
of  ||| S:6029 E:6032 ||| IN
the  ||| S:6032 E:6036 ||| DT
core  ||| S:6036 E:6041 ||| JJ
complex  ||| S:6041 E:6049 ||| JJ
Pip1p ||| S:6049 E:6054 ||| NNP
/ ||| S:6054 E:6055 ||| NNP
Pcu1p ||| S:6055 E:6060 ||| NNP
/ ||| S:6060 E:6061 ||| NNP
Psh1p  ||| S:6061 E:6067 ||| NNP
did  ||| S:6067 E:6071 ||| VBD
not  ||| S:6071 E:6075 ||| RB
undergo  ||| S:6075 E:6093 ||| VB
major  ||| S:6093 E:6099 ||| JJ
variations  ||| S:6099 E:6110 ||| NNS
during  ||| S:6110 E:6117 ||| IN
the  ||| S:6117 E:6121 ||| DT
cell  ||| S:6121 E:6126 ||| NN
cycle  ||| S:6126 E:6132 ||| NN
( ||| S:6132 E:6133 ||| -LRB-
Fig.  ||| S:6133 E:6138 ||| NNP
1C ||| S:6138 E:6140 ||| NNP
) ||| S:6140 E:6141 ||| -RRB-
.  ||| S:6141 E:6143 ||| .
We  ||| S:6143 E:6146 ||| PRP
have  ||| S:6146 E:6161 ||| VBP
carefully  ||| S:6161 E:6171 ||| RB
reexamined  ||| S:6171 E:6182 ||| JJ
potential  ||| S:6182 E:6192 ||| JJ
cell  ||| S:6192 E:6197 ||| NN
cycle  ||| S:6197 E:6203 ||| NN
variations  ||| S:6203 E:6214 ||| NNS
of  ||| S:6214 E:6227 ||| IN
Pcu1p  ||| S:6227 E:6233 ||| CD
neddylation  ||| S:6233 E:6245 ||| CD
apparent  ||| S:6245 E:6254 ||| JJ
in  ||| S:6254 E:6257 ||| IN
the  ||| S:6257 E:6261 ||| DT
IP ||| S:6261 E:6263 ||| NNP
/ ||| S:6263 E:6264 ||| NNP
immunoblotting  ||| S:6264 E:6289 ||| JJ
experiment  ||| S:6289 E:6300 ||| NN
in  ||| S:6300 E:6303 ||| IN
Fig.  ||| S:6303 E:6308 ||| CD
1C ||| S:6308 E:6310 ||| CD
.  ||| S:6310 E:6312 ||| .
These  ||| S:6312 E:6318 ||| DT
variations  ||| S:6318 E:6329 ||| NNS
were  ||| S:6329 E:6334 ||| VBD
not  ||| S:6334 E:6338 ||| RB
seen  ||| S:6338 E:6353 ||| VBN
when  ||| S:6353 E:6358 ||| WRB
samples  ||| S:6358 E:6366 ||| NNS
were  ||| S:6366 E:6371 ||| VBD
denatured  ||| S:6371 E:6381 ||| VBN
in  ||| S:6381 E:6384 ||| IN
SDS  ||| S:6384 E:6388 ||| NNP
immediately  ||| S:6388 E:6400 ||| RB
following  ||| S:6400 E:6420 ||| VBG
extract  ||| S:6420 E:6428 ||| JJ
preparation  ||| S:6428 E:6440 ||| NN
( ||| S:6440 E:6441 ||| -LRB-
data  ||| S:6441 E:6446 ||| NNS
not  ||| S:6446 E:6450 ||| RB
shown ||| S:6450 E:6455 ||| VBN
) ||| S:6455 E:6456 ||| -RRB-
,  ||| S:6456 E:6458 ||| ,
suggesting  ||| S:6458 E:6469 ||| VBG
that  ||| S:6469 E:6484 ||| IN
they  ||| S:6484 E:6489 ||| PRP
arise  ||| S:6489 E:6495 ||| VBP
from  ||| S:6495 E:6500 ||| IN
varying  ||| S:6500 E:6508 ||| VBG
degrees  ||| S:6508 E:6516 ||| NNS
of  ||| S:6516 E:6519 ||| IN
deneddylation  ||| S:6519 E:6543 ||| VBG
presumably  ||| S:6543 E:6554 ||| RB
occuring  ||| S:6554 E:6563 ||| VBN
during  ||| S:6563 E:6570 ||| IN
the  ||| S:6570 E:6574 ||| DT
immunoprecipitation  ||| S:6574 E:6594 ||| JJ
step ||| S:6594 E:6598 ||| NN
.  ||| S:6598 E:6610 ||| .
In  ||| S:6610 E:6613 ||| IN
addition ||| S:6613 E:6621 ||| NN
,  ||| S:6621 E:6623 ||| ,
in  ||| S:6623 E:6626 ||| IN
a  ||| S:6626 E:6628 ||| DT
separate  ||| S:6628 E:6637 ||| JJ
experiment ||| S:6637 E:6647 ||| NN
,  ||| S:6647 E:6649 ||| ,
Pop1p-Pop2p  ||| S:6649 E:6671 ||| CD
heterooligomerization  ||| S:6671 E:6693 ||| NNS
was  ||| S:6693 E:6697 ||| VBD
largely  ||| S:6697 E:6705 ||| RB
constant  ||| S:6705 E:6714 ||| JJ
during  ||| S:6714 E:6721 ||| IN
the  ||| S:6721 E:6735 ||| DT
cell  ||| S:6735 E:6740 ||| NN
cycle  ||| S:6740 E:6746 ||| NN
( ||| S:6746 E:6747 ||| -LRB-
Fig.  ||| S:6747 E:6752 ||| NNP
1C ||| S:6752 E:6754 ||| NNP
) ||| S:6754 E:6755 ||| -RRB-
.  ||| S:6755 E:6757 ||| .
These  ||| S:6757 E:6763 ||| DT
findings  ||| S:6763 E:6772 ||| NNS
indicated  ||| S:6772 E:6782 ||| VBD
that  ||| S:6782 E:6787 ||| DT
cell  ||| S:6787 E:6802 ||| NN
cycle-dependent  ||| S:6802 E:6818 ||| JJ
substrate  ||| S:6818 E:6828 ||| JJ
degradation  ||| S:6828 E:6840 ||| NN
is  ||| S:6840 E:6843 ||| VBZ
unlikely  ||| S:6843 E:6852 ||| JJ
to  ||| S:6852 E:6855 ||| TO
be  ||| S:6855 E:6868 ||| VB
controlled  ||| S:6868 E:6879 ||| VBN
at  ||| S:6879 E:6882 ||| IN
the  ||| S:6882 E:6886 ||| DT
level  ||| S:6886 E:6892 ||| NN
of  ||| S:6892 E:6895 ||| IN
SCF  ||| S:6895 E:6899 ||| NNP
Pop1p-Pop2pcomplex  ||| S:6899 E:6928 ||| NNP
formation ||| S:6928 E:6937 ||| NN
.  ||| S:6937 E:6967 ||| .
SCF  ||| S:6967 E:6971 ||| NNP
Pop1p-Pop2pmediates  ||| S:6971 E:6991 ||| NNP
polyubiquitylation  ||| S:6991 E:7010 ||| NN
of  ||| S:7010 E:7013 ||| IN
Rum1p  ||| S:7013 E:7029 ||| CD
in  ||| S:7029 E:7032 ||| IN
vitro  ||| S:7032 E:7048 ||| JJ
Genetic  ||| S:7048 E:7056 ||| JJ
experiments  ||| S:7056 E:7068 ||| NNS
suggested  ||| S:7068 E:7078 ||| VBD
that  ||| S:7078 E:7083 ||| DT
degradation  ||| S:7083 E:7095 ||| NN
of  ||| S:7095 E:7108 ||| IN
Rum1p  ||| S:7108 E:7114 ||| NNP
depends  ||| S:7114 E:7122 ||| VBZ
on  ||| S:7122 E:7125 ||| IN
the  ||| S:7125 E:7129 ||| DT
Pop1p  ||| S:7129 E:7135 ||| NNP
and  ||| S:7135 E:7139 ||| CC
Pop2p  ||| S:7139 E:7145 ||| CD
F-box  ||| S:7145 E:7151 ||| JJ
proteins  ||| S:7151 E:7160 ||| NNS
[  ||| S:7160 E:7162 ||| -LRB-
18  ||| S:7162 E:7175 ||| CD
20  ||| S:7175 E:7178 ||| CD
]  ||| S:7178 E:7180 ||| -RRB-
,  ||| S:7180 E:7182 ||| ,
but  ||| S:7182 E:7186 ||| CC
also  ||| S:7186 E:7191 ||| RB
requires  ||| S:7191 E:7200 ||| VBZ
phosphorylation  ||| S:7200 E:7216 ||| VBN
of  ||| S:7216 E:7219 ||| IN
Rum1p  ||| S:7219 E:7225 ||| CD
on  ||| S:7225 E:7238 ||| IN
serine  ||| S:7238 E:7245 ||| CD
58  ||| S:7245 E:7248 ||| CD
and  ||| S:7248 E:7252 ||| CC
threonine  ||| S:7252 E:7262 ||| CD
62  ||| S:7262 E:7265 ||| CD
by  ||| S:7265 E:7268 ||| IN
cyclin-dependent  ||| S:7268 E:7285 ||| JJ
kinase  ||| S:7285 E:7302 ||| NNS
( ||| S:7302 E:7303 ||| -LRB-
CDK ||| S:7303 E:7306 ||| NNP
)  ||| S:7306 E:7308 ||| -RRB-
[  ||| S:7308 E:7310 ||| -LRB-
21  ||| S:7310 E:7313 ||| CD
]  ||| S:7313 E:7315 ||| -RRB-
.  ||| S:7315 E:7317 ||| .
Thus ||| S:7317 E:7321 ||| RB
,  ||| S:7321 E:7323 ||| ,
phosphorylated  ||| S:7323 E:7338 ||| JJ
Rum1p  ||| S:7338 E:7344 ||| NN
may  ||| S:7344 E:7348 ||| MD
be  ||| S:7348 E:7351 ||| VB
a  ||| S:7351 E:7363 ||| DT
substrate  ||| S:7363 E:7373 ||| NN
for  ||| S:7373 E:7377 ||| IN
SCF  ||| S:7377 E:7381 ||| NNP
Pop1p-Pop2p-mediated  ||| S:7381 E:7412 ||| NNP
polyubiquitylation ||| S:7412 E:7430 ||| NN
.  ||| S:7430 E:7432 ||| .
To  ||| S:7432 E:7435 ||| TO
test  ||| S:7435 E:7440 ||| VB
this ||| S:7440 E:7444 ||| DT
,  ||| S:7444 E:7446 ||| ,
we  ||| S:7446 E:7449 ||| PRP
first  ||| S:7449 E:7455 ||| RB
confirmed  ||| S:7455 E:7465 ||| VBN
that  ||| S:7465 E:7480 ||| IN
Rum1p  ||| S:7480 E:7486 ||| NNP
is  ||| S:7486 E:7489 ||| VBZ
an  ||| S:7489 E:7503 ||| DT
in  ||| S:7503 E:7506 ||| IN
vitro  ||| S:7506 E:7512 ||| JJ
substrate  ||| S:7512 E:7522 ||| NN
for  ||| S:7522 E:7526 ||| IN
the  ||| S:7526 E:7530 ||| DT
Cdc2p  ||| S:7530 E:7546 ||| JJ
kinase  ||| S:7546 E:7553 ||| NN
in  ||| S:7553 E:7556 ||| IN
association  ||| S:7556 E:7568 ||| NN
with  ||| S:7568 E:7573 ||| IN
the  ||| S:7573 E:7577 ||| DT
cyclin  ||| S:7577 E:7584 ||| JJ
Cig1p  ||| S:7584 E:7590 ||| NNP
[  ||| S:7590 E:7592 ||| -LRB-
21  ||| S:7592 E:7595 ||| CD
]  ||| S:7595 E:7597 ||| -RRB-
as  ||| S:7597 E:7610 ||| RB
judged  ||| S:7610 E:7617 ||| VBN
by  ||| S:7617 E:7620 ||| IN
a  ||| S:7620 E:7622 ||| DT
mobility  ||| S:7622 E:7631 ||| JJ
shift  ||| S:7631 E:7637 ||| NN
on  ||| S:7637 E:7640 ||| IN
SDS  ||| S:7640 E:7644 ||| NNP
gels  ||| S:7644 E:7649 ||| NNS
( ||| S:7649 E:7650 ||| -LRB-
Fig.  ||| S:7650 E:7655 ||| NNP
2A ||| S:7655 E:7657 ||| NNP
) ||| S:7657 E:7658 ||| -RRB-
.  ||| S:7658 E:7670 ||| .
Bacterially  ||| S:7670 E:7682 ||| NNP
expressed  ||| S:7682 E:7692 ||| VBD
Rum1p  ||| S:7692 E:7698 ||| CD
purified  ||| S:7698 E:7707 ||| NN
to  ||| S:7707 E:7710 ||| TO
apparent  ||| S:7710 E:7729 ||| JJ
homogeneity  ||| S:7729 E:7741 ||| NN
was  ||| S:7741 E:7745 ||| VBD
also  ||| S:7745 E:7750 ||| RB
efficiently  ||| S:7750 E:7762 ||| RB
phosphorylated  ||| S:7762 E:7777 ||| VBN
by  ||| S:7777 E:7790 ||| IN
Cdc2p ||| S:7790 E:7795 ||| CD
/ ||| S:7795 E:7796 ||| CD
Cig1p  ||| S:7796 E:7802 ||| CD
complexes  ||| S:7802 E:7812 ||| NNS
( ||| S:7812 E:7813 ||| -LRB-
Fig.  ||| S:7813 E:7818 ||| NNP
2A ||| S:7818 E:7820 ||| NNP
) ||| S:7820 E:7821 ||| -RRB-
.  ||| S:7821 E:7833 ||| .
To  ||| S:7833 E:7836 ||| TO
determine  ||| S:7836 E:7846 ||| VB
whether  ||| S:7846 E:7854 ||| IN
phosphorylated  ||| S:7854 E:7869 ||| CD
Rum1p  ||| S:7869 E:7875 ||| CD
interacts  ||| S:7875 E:7895 ||| NN
with  ||| S:7895 E:7900 ||| IN
Pop1p  ||| S:7900 E:7906 ||| NNP
and  ||| S:7906 E:7910 ||| CC
Pop2p ||| S:7910 E:7915 ||| NNP
,  ||| S:7915 E:7917 ||| ,
protein  ||| S:7917 E:7925 ||| NN
lysate  ||| S:7925 E:7932 ||| NNS
was  ||| S:7932 E:7936 ||| VBD
prepared  ||| S:7936 E:7945 ||| VBN
from  ||| S:7945 E:7960 ||| IN
cells  ||| S:7960 E:7966 ||| NNS
co-overexpressing  ||| S:7966 E:7984 ||| JJ
epitope-tagged  ||| S:7984 E:7999 ||| JJ
combinations  ||| S:7999 E:8012 ||| NNS
of  ||| S:8012 E:8025 ||| IN
Pop1p  ||| S:8025 E:8031 ||| NNP
and  ||| S:8031 E:8035 ||| CC
Pop2p ||| S:8035 E:8040 ||| NNP
.  ||| S:8040 E:8042 ||| .
Upon  ||| S:8042 E:8047 ||| IN
affinity  ||| S:8047 E:8056 ||| JJ
purification  ||| S:8056 E:8069 ||| NN
on  ||| S:8069 E:8072 ||| IN
Ni-NTA  ||| S:8072 E:8089 ||| JJ
resin ||| S:8089 E:8094 ||| NN
,  ||| S:8094 E:8096 ||| ,
HA-Pop1p ||| S:8096 E:8104 ||| CD
/ ||| S:8104 E:8105 ||| CD
His-Myc-Pop2p  ||| S:8105 E:8119 ||| CD
complexes  ||| S:8119 E:8129 ||| NNS
were  ||| S:8129 E:8134 ||| VBD
incubated  ||| S:8134 E:8154 ||| VBN
with  ||| S:8154 E:8159 ||| IN
bacterially  ||| S:8159 E:8171 ||| NN
expressed ||| S:8171 E:8180 ||| VBD
,  ||| S:8180 E:8182 ||| ,
phosphorylated  ||| S:8182 E:8197 ||| CD
Rum1p ||| S:8197 E:8202 ||| CD
.  ||| S:8202 E:8204 ||| .
In  ||| S:8204 E:8207 ||| IN
this  ||| S:8207 E:8222 ||| DT
reaction ||| S:8222 E:8230 ||| NN
,  ||| S:8230 E:8232 ||| ,
Pop1p-Pop2p  ||| S:8232 E:8244 ||| FW
complexes  ||| S:8244 E:8254 ||| FW
specifically  ||| S:8254 E:8267 ||| FW
bound  ||| S:8267 E:8283 ||| FW
phosphorylated  ||| S:8283 E:8298 ||| FW
Rum1p  ||| S:8298 E:8304 ||| FW
( ||| S:8304 E:8305 ||| -LRB-
Fig.  ||| S:8305 E:8310 ||| NNP
2B ||| S:8310 E:8312 ||| NNP
,  ||| S:8312 E:8314 ||| ,
lane  ||| S:8314 E:8319 ||| CD
1 ||| S:8319 E:8320 ||| CD
) ||| S:8320 E:8321 ||| -RRB-
.  ||| S:8321 E:8323 ||| .
Consistent  ||| S:8323 E:8334 ||| JJ
with  ||| S:8334 E:8349 ||| IN
the  ||| S:8349 E:8353 ||| DT
genetic  ||| S:8353 E:8361 ||| JJ
data  ||| S:8361 E:8366 ||| NNS
[  ||| S:8366 E:8368 ||| -LRB-
20  ||| S:8368 E:8371 ||| CD
]  ||| S:8371 E:8373 ||| -RRB-
,  ||| S:8373 E:8375 ||| ,
His-Myc-Pop1p  ||| S:8375 E:8389 ||| NNP
and  ||| S:8389 E:8393 ||| CC
His-Myc-Pop2p  ||| S:8393 E:8417 ||| FW
individually  ||| S:8417 E:8430 ||| FW
purified  ||| S:8430 E:8439 ||| FW
upon  ||| S:8439 E:8444 ||| FW
overexpression  ||| S:8444 E:8459 ||| FW
in  ||| S:8459 E:8473 ||| FW
pop1  ||| S:8473 E:8478 ||| FW
pop2  ||| S:8478 E:8483 ||| FW
double  ||| S:8483 E:8490 ||| FW
mutants  ||| S:8490 E:8498 ||| FW
exhibited  ||| S:8498 E:8518 ||| FW
no  ||| S:8518 E:8521 ||| FW
Rum1p  ||| S:8521 E:8527 ||| FW
binding  ||| S:8527 E:8535 ||| FW
above  ||| S:8535 E:8541 ||| FW
background  ||| S:8541 E:8552 ||| FW
( ||| S:8552 E:8553 ||| -LRB-
Fig.  ||| S:8553 E:8558 ||| NNP
2B ||| S:8558 E:8560 ||| NNP
,  ||| S:8560 E:8562 ||| ,
lanes  ||| S:8562 E:8568 ||| CD
2  ||| S:8568 E:8570 ||| CD
and  ||| S:8570 E:8584 ||| CC
3 ||| S:8584 E:8585 ||| LS
) ||| S:8585 E:8586 ||| -RRB-
.  ||| S:8586 E:8598 ||| .
Given  ||| S:8598 E:8604 ||| VBN
our  ||| S:8604 E:8608 ||| PRP$
ability  ||| S:8608 E:8616 ||| NN
to  ||| S:8616 E:8619 ||| TO
prepare  ||| S:8619 E:8627 ||| VB
immunopurified  ||| S:8627 E:8642 ||| FW
SCF  ||| S:8642 E:8656 ||| FW
Pop1p-Pop2pthat  ||| S:8656 E:8672 ||| FW
bound  ||| S:8672 E:8678 ||| FW
phosphorylated  ||| S:8678 E:8693 ||| FW
Rum1p ||| S:8693 E:8698 ||| FW
,  ||| S:8698 E:8700 ||| ,
we  ||| S:8700 E:8703 ||| PRP
sought  ||| S:8703 E:8710 ||| VBD
to  ||| S:8710 E:8723 ||| TO
reconstitute  ||| S:8723 E:8736 ||| CD
Rum1p  ||| S:8736 E:8742 ||| CD
polyubiquitylation  ||| S:8742 E:8772 ||| NN
in  ||| S:8772 E:8775 ||| IN
vitro ||| S:8775 E:8780 ||| NN
.  ||| S:8780 E:8782 ||| .
In  ||| S:8782 E:8785 ||| IN
addition ||| S:8785 E:8793 ||| NN
,  ||| S:8793 E:8795 ||| ,
we  ||| S:8795 E:8798 ||| PRP
required  ||| S:8798 E:8817 ||| VBD
an  ||| S:8817 E:8820 ||| DT
ubiquitin  ||| S:8820 E:8830 ||| FW
activating  ||| S:8830 E:8841 ||| FW
enzyme  ||| S:8841 E:8848 ||| FW
( ||| S:8848 E:8849 ||| -LRB-
E1 ||| S:8849 E:8851 ||| NNP
)  ||| S:8851 E:8853 ||| -RRB-
and  ||| S:8853 E:8857 ||| CC
an  ||| S:8857 E:8860 ||| DT
ubiquitin  ||| S:8860 E:8880 ||| FW
conjugating  ||| S:8880 E:8892 ||| FW
enzyme  ||| S:8892 E:8899 ||| FW
( ||| S:8899 E:8900 ||| -LRB-
UBC ||| S:8900 E:8903 ||| NNP
) ||| S:8903 E:8904 ||| -RRB-
.  ||| S:8904 E:8906 ||| .
While  ||| S:8906 E:8912 ||| IN
human  ||| S:8912 E:8918 ||| JJ
E1  ||| S:8918 E:8921 ||| NN
is  ||| S:8921 E:8924 ||| VBZ
highly  ||| S:8924 E:8941 ||| RB
similar  ||| S:8941 E:8949 ||| JJ
to  ||| S:8949 E:8952 ||| TO
its  ||| S:8952 E:8956 ||| PRP$
fission  ||| S:8956 E:8964 ||| JJ
yeast  ||| S:8964 E:8970 ||| NN
counterpart  ||| S:8970 E:8982 ||| NN
( ||| S:8982 E:8983 ||| -LRB-
data  ||| S:8983 E:8988 ||| NNS
not  ||| S:8988 E:9002 ||| RB
shown ||| S:9002 E:9007 ||| VBN
) ||| S:9007 E:9008 ||| -RRB-
,  ||| S:9008 E:9010 ||| ,
inspection  ||| S:9010 E:9021 ||| NN
of  ||| S:9021 E:9024 ||| IN
the  ||| S:9024 E:9039 ||| DT
S.  ||| S:9039 E:9042 ||| NNP
pombe  ||| S:9042 E:9048 ||| FW
genome  ||| S:9048 E:9055 ||| FW
revealed  ||| S:9055 E:9064 ||| FW
fourteen  ||| S:9064 E:9083 ||| FW
potential  ||| S:9083 E:9093 ||| JJ
UBCs ||| S:9093 E:9097 ||| NN
,  ||| S:9097 E:9099 ||| ,
none  ||| S:9099 E:9104 ||| NN
of  ||| S:9104 E:9107 ||| IN
which  ||| S:9107 E:9113 ||| WDT
is  ||| S:9113 E:9116 ||| VBZ
an  ||| S:9116 E:9119 ||| DT
obvious  ||| S:9119 E:9127 ||| JJ
homologue  ||| S:9127 E:9137 ||| NN
of  ||| S:9137 E:9150 ||| IN
human  ||| S:9150 E:9156 ||| JJ
UBC3  ||| S:9156 E:9161 ||| NN
or  ||| S:9161 E:9164 ||| CC
budding  ||| S:9164 E:9172 ||| JJ
yeast  ||| S:9172 E:9178 ||| NN
Cdc34p ||| S:9178 E:9184 ||| NN
,  ||| S:9184 E:9186 ||| ,
since  ||| S:9186 E:9192 ||| IN
all  ||| S:9192 E:9196 ||| DT
lack  ||| S:9196 E:9201 ||| NN
the  ||| S:9201 E:9215 ||| DT
characteristic  ||| S:9215 E:9230 ||| JJ
C-terminal  ||| S:9230 E:9241 ||| JJ
extension  ||| S:9241 E:9251 ||| NN
( ||| S:9251 E:9252 ||| -LRB-
data  ||| S:9252 E:9257 ||| NNS
not  ||| S:9257 E:9261 ||| RB
shown ||| S:9261 E:9266 ||| VBN
) ||| S:9266 E:9267 ||| -RRB-
.  ||| S:9267 E:9269 ||| .
We  ||| S:9269 E:9282 ||| PRP
therefore  ||| S:9282 E:9292 ||| RB
purified  ||| S:9292 E:9301 ||| JJ
recombinant  ||| S:9301 E:9313 ||| JJ
human  ||| S:9313 E:9319 ||| JJ
E1  ||| S:9319 E:9322 ||| NN
and  ||| S:9322 E:9326 ||| CC
UBC3  ||| S:9326 E:9331 ||| NNP
( ||| S:9331 E:9332 ||| -LRB-
CDC34 ||| S:9332 E:9337 ||| NNP
)  ||| S:9337 E:9349 ||| -RRB-
upon  ||| S:9349 E:9354 ||| IN
expression  ||| S:9354 E:9365 ||| NN
in  ||| S:9365 E:9368 ||| IN
bacteria  ||| S:9368 E:9377 ||| NNS
( ||| S:9377 E:9378 ||| -LRB-
Fig.  ||| S:9378 E:9383 ||| NNP
2C ||| S:9383 E:9385 ||| NNP
) ||| S:9385 E:9386 ||| -RRB-
.  ||| S:9386 E:9398 ||| .
In  ||| S:9398 E:9401 ||| IN
the  ||| S:9401 E:9405 ||| DT
presence  ||| S:9405 E:9414 ||| NN
of  ||| S:9414 E:9417 ||| IN
human  ||| S:9417 E:9423 ||| JJ
E1 ||| S:9423 E:9425 ||| NN
,  ||| S:9425 E:9427 ||| ,
UBC3 ||| S:9427 E:9431 ||| NNP
,  ||| S:9431 E:9433 ||| ,
ubiquitin ||| S:9433 E:9442 ||| NN
,  ||| S:9442 E:9444 ||| ,
and  ||| S:9444 E:9448 ||| CC
ATP ||| S:9448 E:9451 ||| NNP
,  ||| S:9451 E:9463 ||| ,
SCF  ||| S:9463 E:9467 ||| NNP
Pop1p-Pop2pcomplexes  ||| S:9467 E:9488 ||| NNP
immunopurified  ||| S:9488 E:9503 ||| NN
with  ||| S:9503 E:9508 ||| IN
Pip1p  ||| S:9508 E:9524 ||| CD
antibodies  ||| S:9524 E:9535 ||| NNS
converted  ||| S:9535 E:9545 ||| VBD
a  ||| S:9545 E:9547 ||| DT
small  ||| S:9547 E:9553 ||| JJ
portion  ||| S:9553 E:9561 ||| NN
of  ||| S:9561 E:9564 ||| IN
phosphorylated  ||| S:9564 E:9589 ||| JJ
Rum1p  ||| S:9589 E:9595 ||| NN
into  ||| S:9595 E:9600 ||| IN
high  ||| S:9600 E:9605 ||| JJ
molecular  ||| S:9605 E:9615 ||| JJ
weight  ||| S:9615 E:9622 ||| NN
species  ||| S:9622 E:9630 ||| NNS
( ||| S:9630 E:9631 ||| -LRB-
Fig.  ||| S:9631 E:9636 ||| NNP
2D ||| S:9636 E:9638 ||| NNP
) ||| S:9638 E:9639 ||| -RRB-
.  ||| S:9639 E:9641 ||| .
This  ||| S:9641 E:9656 ||| DT
conversion  ||| S:9656 E:9667 ||| NN
was  ||| S:9667 E:9671 ||| VBD
dependent  ||| S:9671 E:9681 ||| JJ
on  ||| S:9681 E:9684 ||| IN
the  ||| S:9684 E:9688 ||| DT
addition  ||| S:9688 E:9697 ||| NN
of  ||| S:9697 E:9700 ||| IN
E1 ||| S:9700 E:9702 ||| NNP
,  ||| S:9702 E:9704 ||| ,
ATP  ||| S:9704 E:9708 ||| NNP
( ||| S:9708 E:9709 ||| -LRB-
data  ||| S:9709 E:9724 ||| NNS
not  ||| S:9724 E:9728 ||| RB
shown ||| S:9728 E:9733 ||| VBN
) ||| S:9733 E:9734 ||| -RRB-
,  ||| S:9734 E:9736 ||| ,
and  ||| S:9736 E:9740 ||| CC
wild-type  ||| S:9740 E:9750 ||| NNP
UBC3  ||| S:9750 E:9755 ||| NNP
( ||| S:9755 E:9756 ||| -LRB-
Fig.  ||| S:9756 E:9761 ||| NNP
2D ||| S:9761 E:9763 ||| NNP
,  ||| S:9763 E:9765 ||| ,
lanes  ||| S:9765 E:9771 ||| CD
2,4,6 ||| S:9771 E:9776 ||| CD
) ||| S:9776 E:9777 ||| -RRB-
.  ||| S:9777 E:9789 ||| .
The  ||| S:9789 E:9793 ||| DT
activity  ||| S:9793 E:9802 ||| NN
of  ||| S:9802 E:9805 ||| IN
SCF  ||| S:9805 E:9809 ||| NNP
Pop1p ||| S:9809 E:9814 ||| NNP
/ ||| S:9814 E:9815 ||| NNP
Pop2pwas  ||| S:9815 E:9824 ||| NNP
augmented  ||| S:9824 E:9834 ||| NN
when  ||| S:9834 E:9839 ||| WRB
Pip1p  ||| S:9839 E:9855 ||| JJ
complexes  ||| S:9855 E:9865 ||| NNS
where  ||| S:9865 E:9871 ||| WRB
purified  ||| S:9871 E:9880 ||| NNS
from  ||| S:9880 E:9896 ||| IN
csn5  ||| S:9896 E:9901 ||| CD
mutants  ||| S:9901 E:9909 ||| NNS
( ||| S:9909 E:9910 ||| -LRB-
Fig.  ||| S:9910 E:9915 ||| NNP
2D ||| S:9915 E:9917 ||| NNP
,  ||| S:9917 E:9919 ||| ,
lane  ||| S:9919 E:9924 ||| CD
5 ||| S:9924 E:9925 ||| CD
) ||| S:9925 E:9926 ||| -RRB-
.  ||| S:9926 E:9938 ||| .
This  ||| S:9938 E:9943 ||| DT
mutant  ||| S:9943 E:9950 ||| JJ
accumulates  ||| S:9950 E:9962 ||| NNS
Pcu1p  ||| S:9962 E:9968 ||| VBP
exclusively  ||| S:9968 E:9980 ||| RB
in  ||| S:9980 E:9983 ||| IN
a  ||| S:9983 E:9985 ||| DT
form  ||| S:9985 E:10000 ||| NN
carrying  ||| S:10000 E:10009 ||| VBG
the  ||| S:10009 E:10013 ||| DT
stimulatory  ||| S:10013 E:10025 ||| JJ
Nedd8p  ||| S:10025 E:10032 ||| CD
modification ||| S:10032 E:10044 ||| NN
,  ||| S:10044 E:10046 ||| ,
due  ||| S:10046 E:10050 ||| JJ
to  ||| S:10050 E:10053 ||| TO
a  ||| S:10053 E:10065 ||| DT
defect  ||| S:10065 E:10072 ||| NN
in  ||| S:10072 E:10075 ||| IN
COP9 ||| S:10075 E:10079 ||| FW
/ ||| S:10079 E:10080 ||| FW
signalosome-mediated  ||| S:10080 E:10101 ||| FW
cullin  ||| S:10101 E:10108 ||| FW
deneddylation  ||| S:10108 E:10132 ||| FW
[  ||| S:10132 E:10134 ||| -LRB-
24  ||| S:10134 E:10137 ||| CD
25  ||| S:10137 E:10140 ||| CD
]  ||| S:10140 E:10142 ||| -RRB-
.  ||| S:10142 E:10144 ||| .
Replacing  ||| S:10144 E:10154 ||| VBG
wild-type  ||| S:10154 E:10164 ||| JJ
ubiquitin  ||| S:10164 E:10174 ||| NN
by  ||| S:10174 E:10177 ||| IN
a  ||| S:10177 E:10179 ||| DT
mutant  ||| S:10179 E:10196 ||| NN
lacking  ||| S:10196 E:10204 ||| VBG
all  ||| S:10204 E:10208 ||| DT
lysine  ||| S:10208 E:10215 ||| JJ
residues  ||| S:10215 E:10224 ||| NNS
prevented  ||| S:10224 E:10234 ||| VBD
the  ||| S:10234 E:10238 ||| DT
formation  ||| S:10238 E:10248 ||| NN
of  ||| S:10248 E:10261 ||| IN
high  ||| S:10261 E:10266 ||| JJ
molecular  ||| S:10266 E:10276 ||| JJ
weight  ||| S:10276 E:10283 ||| NN
products  ||| S:10283 E:10292 ||| NNS
( ||| S:10292 E:10293 ||| -LRB-
Fig.  ||| S:10293 E:10298 ||| NNP
2D ||| S:10298 E:10300 ||| NNP
,  ||| S:10300 E:10302 ||| ,
lane  ||| S:10302 E:10307 ||| CD
7 ||| S:10307 E:10308 ||| CD
) ||| S:10308 E:10309 ||| -RRB-
,  ||| S:10309 E:10321 ||| ,
indicating  ||| S:10321 E:10332 ||| VBG
that  ||| S:10332 E:10337 ||| IN
they  ||| S:10337 E:10342 ||| PRP
represent  ||| S:10342 E:10352 ||| VBP
polyubiquitylated  ||| S:10352 E:10370 ||| RB
Rum1p  ||| S:10370 E:10386 ||| CD
species  ||| S:10386 E:10394 ||| NNS
generated  ||| S:10394 E:10404 ||| VBN
in  ||| S:10404 E:10407 ||| IN
the  ||| S:10407 E:10411 ||| DT
reaction ||| S:10411 E:10419 ||| NN
.  ||| S:10419 E:10421 ||| .
Similar  ||| S:10421 E:10439 ||| JJ
polyubiquitylated  ||| S:10439 E:10457 ||| JJ
reaction  ||| S:10457 E:10466 ||| NN
products  ||| S:10466 E:10475 ||| NNS
were  ||| S:10475 E:10480 ||| VBD
detected  ||| S:10480 E:10489 ||| VBN
upon  ||| S:10489 E:10504 ||| IN
incubation  ||| S:10504 E:10515 ||| NN
of  ||| S:10515 E:10518 ||| IN
phosphorylated  ||| S:10518 E:10533 ||| JJ
Rum1p  ||| S:10533 E:10539 ||| NN
with  ||| S:10539 E:10544 ||| IN
Pcu1p  ||| S:10544 E:10560 ||| CD
immunocomplexes ||| S:10560 E:10575 ||| NN
,  ||| S:10575 E:10577 ||| ,
further  ||| S:10577 E:10585 ||| RB
suggesting  ||| S:10585 E:10596 ||| VBG
that  ||| S:10596 E:10601 ||| IN
the  ||| S:10601 E:10605 ||| DT
activity  ||| S:10605 E:10614 ||| NN
is  ||| S:10614 E:10627 ||| VBZ
mediated  ||| S:10627 E:10636 ||| VBN
by  ||| S:10636 E:10639 ||| IN
SCF  ||| S:10639 E:10643 ||| NNP
Pop1p-Pop2p ||| S:10643 E:10654 ||| NNP
( ||| S:10654 E:10655 ||| -LRB-
data  ||| S:10655 E:10660 ||| NNS
not  ||| S:10660 E:10664 ||| RB
shown ||| S:10664 E:10669 ||| VBN
) ||| S:10669 E:10670 ||| -RRB-
.  ||| S:10670 E:10672 ||| .
Moreover ||| S:10672 E:10680 ||| RB
,  ||| S:10680 E:10692 ||| ,
Rum1p  ||| S:10692 E:10698 ||| CD
ubiquitylation  ||| S:10698 E:10713 ||| NNS
was  ||| S:10713 E:10717 ||| VBD
not  ||| S:10717 E:10721 ||| RB
obtained  ||| S:10721 E:10730 ||| VBN
with  ||| S:10730 E:10735 ||| IN
Pip1p  ||| S:10735 E:10751 ||| CD
complexes  ||| S:10751 E:10761 ||| NNS
prepared  ||| S:10761 E:10770 ||| VBN
from  ||| S:10770 E:10775 ||| IN
cell  ||| S:10775 E:10780 ||| NN
lysate  ||| S:10780 E:10787 ||| NN
of  ||| S:10787 E:10801 ||| IN
pop2  ||| S:10801 E:10806 ||| CD
deletion  ||| S:10806 E:10815 ||| CD
strains ||| S:10815 E:10822 ||| NNS
,  ||| S:10822 E:10824 ||| ,
proving  ||| S:10824 E:10832 ||| VBG
the  ||| S:10832 E:10846 ||| DT
F-box  ||| S:10846 E:10852 ||| JJ
protein  ||| S:10852 E:10860 ||| NN
dependency  ||| S:10860 E:10871 ||| NN
of  ||| S:10871 E:10874 ||| IN
this  ||| S:10874 E:10879 ||| DT
reaction  ||| S:10879 E:10888 ||| NN
( ||| S:10888 E:10889 ||| -LRB-
Fig.  ||| S:10889 E:10894 ||| NNP
2D ||| S:10894 E:10896 ||| NNP
,  ||| S:10896 E:10898 ||| ,
lane  ||| S:10898 E:10913 ||| CD
3 ||| S:10913 E:10914 ||| CD
) ||| S:10914 E:10915 ||| -RRB-
.  ||| S:10915 E:10917 ||| .
In  ||| S:10917 E:10920 ||| IN
addition ||| S:10920 E:10928 ||| NN
,  ||| S:10928 E:10930 ||| ,
the  ||| S:10930 E:10934 ||| DT
reaction  ||| S:10934 E:10943 ||| NN
was  ||| S:10943 E:10947 ||| VBD
specific  ||| S:10947 E:10956 ||| JJ
for  ||| S:10956 E:10960 ||| IN
human  ||| S:10960 E:10976 ||| JJ
UBC3 ||| S:10976 E:10980 ||| NN
,  ||| S:10980 E:10982 ||| ,
as  ||| S:10982 E:10985 ||| IN
no  ||| S:10985 E:10988 ||| DT
ubiquitylation  ||| S:10988 E:11003 ||| NN
was  ||| S:11003 E:11007 ||| VBD
obtained  ||| S:11007 E:11016 ||| VBN
with  ||| S:11016 E:11021 ||| IN
fission  ||| S:11021 E:11039 ||| JJ
yeast  ||| S:11039 E:11045 ||| NN
Ubc1p ||| S:11045 E:11050 ||| NN
,  ||| S:11050 E:11052 ||| ,
Ubc7p ||| S:11052 E:11057 ||| NNP
,  ||| S:11057 E:11059 ||| ,
Ubc11p ||| S:11059 E:11065 ||| NNP
,  ||| S:11065 E:11067 ||| ,
or  ||| S:11067 E:11070 ||| CC
Ubc13p  ||| S:11070 E:11077 ||| NNP
( ||| S:11077 E:11078 ||| -LRB-
Fig.  ||| S:11078 E:11083 ||| CD
2 ||| S:11083 E:11084 ||| CD
,  ||| S:11084 E:11086 ||| ,
lanes  ||| S:11086 E:11102 ||| CD
10,11 ||| S:11102 E:11107 ||| CD
) ||| S:11107 E:11108 ||| -RRB-
.  ||| S:11108 E:11110 ||| .
Taken  ||| S:11110 E:11116 ||| VBN
together  ||| S:11116 E:11125 ||| RP
these  ||| S:11125 E:11131 ||| DT
results  ||| S:11131 E:11139 ||| NNS
strongly  ||| S:11139 E:11148 ||| RB
suggest  ||| S:11148 E:11166 ||| VB
that  ||| S:11166 E:11171 ||| IN
SCF  ||| S:11171 E:11175 ||| NNP
Pop1p-Pop2pmediates  ||| S:11175 E:11195 ||| CD
the  ||| S:11195 E:11199 ||| DT
polyubiquitylation  ||| S:11199 E:11218 ||| NN
of  ||| S:11218 E:11231 ||| IN
CDK  ||| S:11231 E:11235 ||| NNP
phosphorylated  ||| S:11235 E:11250 ||| FW
Rum1p  ||| S:11250 E:11267 ||| FW
in  ||| S:11267 E:11270 ||| FW
vitro  ||| S:11270 E:11276 ||| FW
.  ||| S:11276 E:11306 ||| .
Differential  ||| S:11306 E:11319 ||| JJ
subcellular  ||| S:11319 E:11331 ||| JJ
localization  ||| S:11331 E:11344 ||| NN
of  ||| S:11344 E:11347 ||| IN
SCF  ||| S:11347 E:11361 ||| NNP
Pop1p-Pop2psubunits  ||| S:11361 E:11391 ||| CD
The  ||| S:11391 E:11395 ||| DT
co-purification  ||| S:11395 E:11411 ||| JJ
of  ||| S:11411 E:11414 ||| IN
the  ||| S:11414 E:11418 ||| DT
five  ||| S:11418 E:11423 ||| CD
identified  ||| S:11423 E:11434 ||| VBN
SCF  ||| S:11434 E:11448 ||| NNP
Pop1p-Pop2psubunits  ||| S:11448 E:11468 ||| NNP
and  ||| S:11468 E:11472 ||| CC
their  ||| S:11472 E:11489 ||| PRP$
in  ||| S:11489 E:11492 ||| IN
vitro  ||| S:11492 E:11498 ||| JJ
activity  ||| S:11498 E:11507 ||| NN
toward  ||| S:11507 E:11514 ||| IN
Rum1p  ||| S:11514 E:11530 ||| NNP
suggested  ||| S:11530 E:11540 ||| VBD
that  ||| S:11540 E:11545 ||| IN
they  ||| S:11545 E:11550 ||| PRP
coexist  ||| S:11550 E:11558 ||| VBD
in  ||| S:11558 E:11561 ||| IN
a  ||| S:11561 E:11563 ||| DT
common  ||| S:11563 E:11570 ||| JJ
subcellular  ||| S:11570 E:11592 ||| JJ
compartment ||| S:11592 E:11603 ||| NN
.  ||| S:11603 E:11605 ||| .
The  ||| S:11605 E:11609 ||| DT
nuclear  ||| S:11609 E:11617 ||| JJ
localization  ||| S:11617 E:11630 ||| NN
of  ||| S:11630 E:11633 ||| IN
the  ||| S:11633 E:11637 ||| DT
only  ||| S:11637 E:11642 ||| RB
known  ||| S:11642 E:11658 ||| VBN
substrates ||| S:11658 E:11668 ||| NN
,  ||| S:11668 E:11670 ||| ,
Cdc18p  ||| S:11670 E:11677 ||| NNP
[  ||| S:11677 E:11679 ||| -LRB-
26  ||| S:11679 E:11682 ||| CD
]  ||| S:11682 E:11684 ||| -RRB-
and  ||| S:11684 E:11688 ||| CC
Rum1p  ||| S:11688 E:11694 ||| NNP
( ||| S:11694 E:11695 ||| -LRB-
D.A.W. ||| S:11695 E:11701 ||| NNP
,  ||| S:11701 E:11713 ||| ,
unpublished ||| S:11713 E:11724 ||| JJ
) ||| S:11724 E:11725 ||| -RRB-
,  ||| S:11725 E:11727 ||| ,
indicated  ||| S:11727 E:11737 ||| VBD
that  ||| S:11737 E:11742 ||| IN
a  ||| S:11742 E:11744 ||| DT
substantial  ||| S:11744 E:11756 ||| JJ
portion  ||| S:11756 E:11764 ||| NN
of  ||| S:11764 E:11767 ||| IN
SCF  ||| S:11767 E:11781 ||| NNP
Pop1p-Pop2pis  ||| S:11781 E:11795 ||| NNP
enriched  ||| S:11795 E:11804 ||| NN
in  ||| S:11804 E:11807 ||| IN
the  ||| S:11807 E:11811 ||| DT
nucleus ||| S:11811 E:11818 ||| NN
.  ||| S:11818 E:11820 ||| .
To  ||| S:11820 E:11823 ||| TO
test  ||| S:11823 E:11828 ||| VB
this  ||| S:11828 E:11843 ||| DT
assumption ||| S:11843 E:11853 ||| NN
,  ||| S:11853 E:11855 ||| ,
all  ||| S:11855 E:11859 ||| DT
five  ||| S:11859 E:11864 ||| CD
SCF  ||| S:11864 E:11868 ||| NNP
Pop1p-Pop2psubunits  ||| S:11868 E:11888 ||| NNP
were  ||| S:11888 E:11903 ||| VBD
expressed  ||| S:11903 E:11913 ||| VBN
as  ||| S:11913 E:11916 ||| IN
fusion  ||| S:11916 E:11923 ||| NN
proteins  ||| S:11923 E:11932 ||| NNS
with  ||| S:11932 E:11937 ||| IN
green  ||| S:11937 E:11943 ||| JJ
fluorescent  ||| S:11943 E:11965 ||| JJ
protein  ||| S:11965 E:11973 ||| NN
( ||| S:11973 E:11974 ||| -LRB-
GFP ||| S:11974 E:11977 ||| NNP
)  ||| S:11977 E:11979 ||| -RRB-
at  ||| S:11979 E:11982 ||| IN
low  ||| S:11982 E:11986 ||| JJ
levels  ||| S:11986 E:11993 ||| NNS
from  ||| S:11993 E:11998 ||| IN
an  ||| S:11998 E:12001 ||| DT
inducible  ||| S:12001 E:12011 ||| JJ
pRep81  ||| S:12011 E:12028 ||| CD
plasmid ||| S:12028 E:12035 ||| NNS
.  ||| S:12035 E:12037 ||| .
While  ||| S:12037 E:12043 ||| IN
Pip1p ||| S:12043 E:12048 ||| NNP
,  ||| S:12048 E:12050 ||| ,
Psh1p ||| S:12050 E:12055 ||| NNP
,  ||| S:12055 E:12057 ||| ,
Pcu1p ||| S:12057 E:12062 ||| NNP
,  ||| S:12062 E:12064 ||| ,
and  ||| S:12064 E:12068 ||| CC
Pop2p  ||| S:12068 E:12074 ||| NNP
were  ||| S:12074 E:12089 ||| VBD
present  ||| S:12089 E:12097 ||| JJ
in  ||| S:12097 E:12100 ||| IN
both  ||| S:12100 E:12105 ||| PDT
the  ||| S:12105 E:12109 ||| DT
cytoplasm  ||| S:12109 E:12119 ||| NN
and  ||| S:12119 E:12123 ||| CC
the  ||| S:12123 E:12127 ||| DT
nucleus ||| S:12127 E:12134 ||| NN
,  ||| S:12134 E:12146 ||| ,
surprisingly ||| S:12146 E:12158 ||| RB
,  ||| S:12158 E:12160 ||| ,
GFP-Pop1p  ||| S:12160 E:12170 ||| NNP
was  ||| S:12170 E:12174 ||| VBD
largely  ||| S:12174 E:12182 ||| RB
restricted  ||| S:12182 E:12193 ||| VBN
to  ||| S:12193 E:12196 ||| TO
the  ||| S:12196 E:12210 ||| DT
nucleus  ||| S:12210 E:12218 ||| NN
( ||| S:12218 E:12219 ||| -LRB-
Fig.  ||| S:12219 E:12224 ||| NNP
3A ||| S:12224 E:12226 ||| NNP
) ||| S:12226 E:12227 ||| -RRB-
.  ||| S:12227 E:12229 ||| .
These  ||| S:12229 E:12235 ||| DT
localization  ||| S:12235 E:12248 ||| JJ
patterns  ||| S:12248 E:12257 ||| NNS
were  ||| S:12257 E:12272 ||| VBD
consistently  ||| S:12272 E:12285 ||| RB
observed  ||| S:12285 E:12294 ||| VBN
in  ||| S:12294 E:12297 ||| IN
each  ||| S:12297 E:12302 ||| DT
single  ||| S:12302 E:12309 ||| JJ
cell  ||| S:12309 E:12314 ||| NN
of  ||| S:12314 E:12317 ||| IN
an  ||| S:12317 E:12330 ||| DT
asynchronous  ||| S:12330 E:12343 ||| JJ
population ||| S:12343 E:12353 ||| NN
,  ||| S:12353 E:12355 ||| ,
excluding  ||| S:12355 E:12365 ||| VBG
major  ||| S:12365 E:12371 ||| JJ
variations  ||| S:12371 E:12392 ||| NNS
during  ||| S:12392 E:12399 ||| IN
the  ||| S:12399 E:12403 ||| DT
cell  ||| S:12403 E:12408 ||| NN
cycle ||| S:12408 E:12413 ||| NN
.  ||| S:12413 E:12425 ||| .
To  ||| S:12425 E:12428 ||| TO
rule  ||| S:12428 E:12433 ||| VB
out  ||| S:12433 E:12437 ||| RP
the  ||| S:12437 E:12441 ||| DT
possibility  ||| S:12441 E:12453 ||| NN
that  ||| S:12453 E:12458 ||| IN
overexpression  ||| S:12458 E:12473 ||| NN
or  ||| S:12473 E:12486 ||| CC
N-terminal  ||| S:12486 E:12497 ||| JJ
fusion  ||| S:12497 E:12504 ||| NN
to  ||| S:12504 E:12507 ||| TO
GFP  ||| S:12507 E:12511 ||| NNP
affects  ||| S:12511 E:12519 ||| VBZ
their  ||| S:12519 E:12525 ||| PRP$
localization ||| S:12525 E:12537 ||| NN
,  ||| S:12537 E:12549 ||| ,
Pop1p  ||| S:12549 E:12555 ||| NNP
and  ||| S:12555 E:12559 ||| CC
Pop2p  ||| S:12559 E:12565 ||| NNP
were  ||| S:12565 E:12570 ||| VBD
modified  ||| S:12570 E:12579 ||| VBN
with  ||| S:12579 E:12584 ||| IN
13  ||| S:12584 E:12587 ||| CD
C-terminal  ||| S:12587 E:12598 ||| JJ
Myc  ||| S:12598 E:12612 ||| NNP
epitope-tags  ||| S:12612 E:12625 ||| NNP
at  ||| S:12625 E:12628 ||| IN
the  ||| S:12628 E:12632 ||| DT
endogenous  ||| S:12632 E:12643 ||| JJ
genomic  ||| S:12643 E:12651 ||| JJ
locus ||| S:12651 E:12656 ||| NN
.  ||| S:12656 E:12668 ||| .
Immunoblotting  ||| S:12668 E:12683 ||| NNP
proved  ||| S:12683 E:12690 ||| VBD
the  ||| S:12690 E:12694 ||| DT
expression  ||| S:12694 E:12705 ||| NN
of  ||| S:12705 E:12708 ||| IN
correctly  ||| S:12708 E:12718 ||| RB
sized  ||| S:12718 E:12734 ||| JJ
proteins  ||| S:12734 E:12743 ||| NNS
and ||| S:12743 E:12746 ||| CC
,  ||| S:12746 E:12748 ||| ,
in  ||| S:12748 E:12751 ||| IN
addition ||| S:12751 E:12759 ||| NN
,  ||| S:12759 E:12761 ||| ,
showed  ||| S:12761 E:12768 ||| VBD
that  ||| S:12768 E:12773 ||| DT
endogenous  ||| S:12773 E:12784 ||| JJ
Pop1p  ||| S:12784 E:12800 ||| NN
is  ||| S:12800 E:12803 ||| VBZ
approximately  ||| S:12803 E:12817 ||| RB
twofold  ||| S:12817 E:12825 ||| VB
more  ||| S:12825 E:12830 ||| RBR
abundant  ||| S:12830 E:12839 ||| JJ
in  ||| S:12839 E:12853 ||| IN
S.  ||| S:12853 E:12856 ||| NNP
pombe  ||| S:12856 E:12862 ||| NN
cells  ||| S:12862 E:12868 ||| NNS
than  ||| S:12868 E:12873 ||| IN
Pop2p  ||| S:12873 E:12879 ||| NNP
( ||| S:12879 E:12880 ||| -LRB-
Fig.  ||| S:12880 E:12895 ||| NNP
3B ||| S:12895 E:12897 ||| NNP
) ||| S:12897 E:12898 ||| -RRB-
.  ||| S:12898 E:12900 ||| .
Indirect  ||| S:12900 E:12909 ||| JJ
immunofluorescence  ||| S:12909 E:12928 ||| JJ
staining  ||| S:12928 E:12937 ||| NN
with  ||| S:12937 E:12942 ||| IN
Myc  ||| S:12942 E:12956 ||| NNP
antibodies  ||| S:12956 E:12967 ||| NNS
confirmed  ||| S:12967 E:12977 ||| VBD
that  ||| S:12977 E:12982 ||| IN
Pop1p  ||| S:12982 E:12988 ||| NNP
is  ||| S:12988 E:12991 ||| VBZ
predominantly  ||| S:12991 E:13015 ||| RB
localized  ||| S:13015 E:13025 ||| VBN
to  ||| S:13025 E:13028 ||| TO
cell  ||| S:13028 E:13033 ||| NN
nuclei ||| S:13033 E:13039 ||| NN
,  ||| S:13039 E:13041 ||| ,
whereas  ||| S:13041 E:13049 ||| IN
Pop2p  ||| S:13049 E:13055 ||| NNP
is  ||| S:13055 E:13058 ||| VBZ
expressed  ||| S:13058 E:13068 ||| VBN
in  ||| S:13068 E:13081 ||| IN
both  ||| S:13081 E:13086 ||| PDT
the  ||| S:13086 E:13090 ||| DT
cytoplasm  ||| S:13090 E:13100 ||| NN
and  ||| S:13100 E:13104 ||| CC
the  ||| S:13104 E:13108 ||| DT
nucleus  ||| S:13108 E:13116 ||| NN
( ||| S:13116 E:13117 ||| -LRB-
Fig.  ||| S:13117 E:13122 ||| NNP
3C ||| S:13122 E:13124 ||| NNP
) ||| S:13124 E:13125 ||| -RRB-
.  ||| S:13125 E:13137 ||| .
To  ||| S:13137 E:13140 ||| TO
confirm  ||| S:13140 E:13148 ||| VB
these  ||| S:13148 E:13154 ||| DT
localization  ||| S:13154 E:13167 ||| JJ
patterns ||| S:13167 E:13175 ||| NNS
,  ||| S:13175 E:13177 ||| ,
cells  ||| S:13177 E:13183 ||| NNS
derived  ||| S:13183 E:13201 ||| VBN
from  ||| S:13201 E:13206 ||| IN
the  ||| S:13206 E:13210 ||| DT
epitope-tagged  ||| S:13210 E:13225 ||| JJ
strains  ||| S:13225 E:13233 ||| NNS
were  ||| S:13233 E:13238 ||| VBD
biochemically  ||| S:13238 E:13262 ||| JJ
fractionated  ||| S:13262 E:13275 ||| NN
into  ||| S:13275 E:13280 ||| IN
cytoplasmic  ||| S:13280 E:13292 ||| NN
and  ||| S:13292 E:13296 ||| CC
nuclear  ||| S:13296 E:13304 ||| JJ
components ||| S:13304 E:13314 ||| NNS
.  ||| S:13314 E:13316 ||| .
The  ||| S:13316 E:13330 ||| DT
efficiency  ||| S:13330 E:13341 ||| NN
of  ||| S:13341 E:13344 ||| IN
enrichment  ||| S:13344 E:13355 ||| NN
of  ||| S:13355 E:13358 ||| IN
nuclear  ||| S:13358 E:13366 ||| JJ
and  ||| S:13366 E:13370 ||| CC
cytoplasmic  ||| S:13370 E:13392 ||| JJ
components  ||| S:13392 E:13403 ||| NNS
was  ||| S:13403 E:13407 ||| VBD
estimated  ||| S:13407 E:13417 ||| VBN
by  ||| S:13417 E:13420 ||| IN
analyzing  ||| S:13420 E:13430 ||| VBG
fractions  ||| S:13430 E:13440 ||| NNS
with  ||| S:13440 E:13455 ||| IN
antibodies  ||| S:13455 E:13466 ||| NNS
recognizing  ||| S:13466 E:13478 ||| VBG
the  ||| S:13478 E:13482 ||| DT
nuclear  ||| S:13482 E:13490 ||| JJ
marker  ||| S:13490 E:13497 ||| JJ
PCNA  ||| S:13497 E:13502 ||| NNP
and  ||| S:13502 E:13516 ||| CC
cytoplasmic  ||| S:13516 E:13528 ||| JJ
tubulin  ||| S:13528 E:13536 ||| NNS
( ||| S:13536 E:13537 ||| -LRB-
Fig.  ||| S:13537 E:13542 ||| NNP
3D ||| S:13542 E:13544 ||| NNP
) ||| S:13544 E:13545 ||| -RRB-
.  ||| S:13545 E:13547 ||| .
Although  ||| S:13547 E:13556 ||| IN
both  ||| S:13556 E:13561 ||| DT
fractions  ||| S:13561 E:13581 ||| NN
showed  ||| S:13581 E:13588 ||| VBD
some  ||| S:13588 E:13593 ||| DT
contamination ||| S:13593 E:13606 ||| NN
,  ||| S:13606 E:13608 ||| ,
Pop1p  ||| S:13608 E:13614 ||| NNP
was  ||| S:13614 E:13618 ||| VBD
detected  ||| S:13618 E:13627 ||| VBN
mostly  ||| S:13627 E:13634 ||| RB
in  ||| S:13634 E:13647 ||| IN
nuclear  ||| S:13647 E:13655 ||| JJ
fractions ||| S:13655 E:13664 ||| NNS
,  ||| S:13664 E:13666 ||| ,
while  ||| S:13666 E:13672 ||| IN
Pop2p  ||| S:13672 E:13678 ||| NNP
was  ||| S:13678 E:13682 ||| VBD
apparent  ||| S:13682 E:13691 ||| JJ
in  ||| S:13691 E:13694 ||| IN
both  ||| S:13694 E:13709 ||| DT
nuclear  ||| S:13709 E:13717 ||| JJ
and  ||| S:13717 E:13721 ||| CC
cytoplasmic  ||| S:13721 E:13733 ||| JJ
fractions  ||| S:13733 E:13743 ||| NNS
( ||| S:13743 E:13744 ||| -LRB-
Fig.  ||| S:13744 E:13749 ||| NNP
3D ||| S:13749 E:13751 ||| NNP
) ||| S:13751 E:13752 ||| -RRB-
.  ||| S:13752 E:13754 ||| .
Thus ||| S:13754 E:13758 ||| RB
,  ||| S:13758 E:13760 ||| ,
all  ||| S:13760 E:13774 ||| DT
five  ||| S:13774 E:13779 ||| CD
SCF  ||| S:13779 E:13783 ||| NNP
Pop1p-Pop2psubunits  ||| S:13783 E:13803 ||| NNP
appear  ||| S:13803 E:13810 ||| VBP
to  ||| S:13810 E:13813 ||| TO
coexist  ||| S:13813 E:13821 ||| VB
in  ||| S:13821 E:13824 ||| IN
the  ||| S:13824 E:13838 ||| DT
nucleus ||| S:13838 E:13845 ||| NN
,  ||| S:13845 E:13847 ||| ,
although  ||| S:13847 E:13856 ||| IN
all  ||| S:13856 E:13860 ||| DT
but  ||| S:13860 E:13864 ||| CC
Pop1p  ||| S:13864 E:13870 ||| NNP
are  ||| S:13870 E:13874 ||| VBP
also  ||| S:13874 E:13879 ||| RB
present  ||| S:13879 E:13887 ||| VB
in  ||| S:13887 E:13890 ||| IN
the  ||| S:13890 E:13904 ||| DT
cytoplasm ||| S:13904 E:13913 ||| NN
.  ||| S:13913 E:13925 ||| .
Since  ||| S:13925 E:13931 ||| IN
Pop1p  ||| S:13931 E:13937 ||| NNP
and  ||| S:13937 E:13941 ||| CC
Pop2p  ||| S:13941 E:13947 ||| CD
interact  ||| S:13947 E:13956 ||| NN
with  ||| S:13956 E:13961 ||| IN
each  ||| S:13961 E:13966 ||| DT
other  ||| S:13966 E:13972 ||| JJ
[  ||| S:13972 E:13974 ||| -LRB-
20  ||| S:13974 E:13977 ||| CD
]  ||| S:13977 E:13989 ||| -RRB-
,  ||| S:13989 E:13991 ||| ,
we  ||| S:13991 E:13994 ||| PRP
asked  ||| S:13994 E:14000 ||| VBD
whether  ||| S:14000 E:14008 ||| IN
their  ||| S:14008 E:14014 ||| PRP$
localization  ||| S:14014 E:14027 ||| JJ
patterns  ||| S:14027 E:14036 ||| NNS
depended  ||| S:14036 E:14055 ||| VBD
on  ||| S:14055 E:14058 ||| IN
the  ||| S:14058 E:14062 ||| DT
presence  ||| S:14062 E:14071 ||| NN
of  ||| S:14071 E:14074 ||| IN
the  ||| S:14074 E:14078 ||| DT
respective  ||| S:14078 E:14089 ||| JJ
interaction  ||| S:14089 E:14101 ||| JJ
partner ||| S:14101 E:14108 ||| NN
.  ||| S:14108 E:14120 ||| .
For  ||| S:14120 E:14124 ||| IN
this ||| S:14124 E:14128 ||| DT
,  ||| S:14128 E:14130 ||| ,
we  ||| S:14130 E:14133 ||| PRP
created  ||| S:14133 E:14141 ||| VBD
a  ||| S:14141 E:14154 ||| DT
pop2  ||| S:14154 E:14159 ||| CD
deletion  ||| S:14159 E:14168 ||| NNS
strain  ||| S:14168 E:14175 ||| VBP
carrying  ||| S:14175 E:14184 ||| VBG
Pop1p  ||| S:14184 E:14200 ||| RB
modified  ||| S:14200 E:14209 ||| VBN
with  ||| S:14209 E:14214 ||| IN
13  ||| S:14214 E:14217 ||| CD
Myc  ||| S:14217 E:14221 ||| JJ
epitope  ||| S:14221 E:14229 ||| JJ
tags  ||| S:14229 E:14234 ||| NNS
at  ||| S:14234 E:14237 ||| IN
the  ||| S:14237 E:14241 ||| DT
endogenous  ||| S:14241 E:14262 ||| FW
genomic  ||| S:14262 E:14270 ||| FW
locus  ||| S:14270 E:14276 ||| FW
(  ||| S:14276 E:14289 ||| -LRB-
pop1-13myc  ||| S:14289 E:14300 ||| CD
Δpop2  ||| S:14300 E:14306 ||| CD
strain  ||| S:14306 E:14313 ||| NN
) ||| S:14313 E:14314 ||| -RRB-
.  ||| S:14314 E:14316 ||| .
In  ||| S:14316 E:14329 ||| IN
addition ||| S:14329 E:14337 ||| NN
,  ||| S:14337 E:14339 ||| ,
we  ||| S:14339 E:14342 ||| PRP
created  ||| S:14342 E:14350 ||| VBD
the  ||| S:14350 E:14354 ||| DT
reciprocal  ||| S:14354 E:14376 ||| FW
pop2-13myc  ||| S:14376 E:14387 ||| FW
Δpop1  ||| S:14387 E:14393 ||| FW
strain  ||| S:14393 E:14400 ||| FW
containing  ||| S:14400 E:14421 ||| FW
epitope-tagged  ||| S:14421 E:14436 ||| FW
endogenous  ||| S:14436 E:14447 ||| FW
Pop2p  ||| S:14447 E:14453 ||| FW
in  ||| S:14453 E:14456 ||| FW
a  ||| S:14456 E:14469 ||| FW
pop1  ||| S:14469 E:14474 ||| FW
deletion  ||| S:14474 E:14483 ||| FW
background ||| S:14483 E:14493 ||| FW
.  ||| S:14493 E:14495 ||| .
The  ||| S:14495 E:14509 ||| DT
distinct  ||| S:14509 E:14518 ||| JJ
localization  ||| S:14518 E:14531 ||| JJ
patterns  ||| S:14531 E:14540 ||| NNS
of  ||| S:14540 E:14543 ||| IN
Pop1p-13Myc  ||| S:14543 E:14555 ||| NNP
and  ||| S:14555 E:14569 ||| CC
Pop2p-13Myc  ||| S:14569 E:14581 ||| NNP
were  ||| S:14581 E:14586 ||| VBD
fully  ||| S:14586 E:14592 ||| RB
maintained  ||| S:14592 E:14603 ||| VBN
in  ||| S:14603 E:14606 ||| IN
these  ||| S:14606 E:14612 ||| DT
strains  ||| S:14612 E:14620 ||| NNS
( ||| S:14620 E:14621 ||| -LRB-
Fig.  ||| S:14621 E:14636 ||| NNP
3E ||| S:14636 E:14638 ||| NNP
) ||| S:14638 E:14639 ||| -RRB-
.  ||| S:14639 E:14641 ||| .
This  ||| S:14641 E:14646 ||| DT
observation  ||| S:14646 E:14658 ||| NN
was  ||| S:14658 E:14662 ||| VBD
confirmed  ||| S:14662 E:14672 ||| VBN
by  ||| S:14672 E:14675 ||| IN
overexpressing  ||| S:14675 E:14700 ||| JJ
GFP-tagged  ||| S:14700 E:14711 ||| JJ
Pop1p  ||| S:14711 E:14717 ||| NN
or  ||| S:14717 E:14720 ||| CC
Pop2p  ||| S:14720 E:14726 ||| CD
in  ||| S:14726 E:14740 ||| IN
pop1  ||| S:14740 E:14745 ||| FW
pop2  ||| S:14745 E:14750 ||| FW
double  ||| S:14750 E:14757 ||| FW
deletion  ||| S:14757 E:14766 ||| FW
mutants  ||| S:14766 E:14784 ||| FW
( ||| S:14784 E:14785 ||| -LRB-
data  ||| S:14785 E:14790 ||| NNS
not  ||| S:14790 E:14794 ||| RB
shown ||| S:14794 E:14799 ||| VBN
) ||| S:14799 E:14800 ||| -RRB-
.  ||| S:14800 E:14802 ||| .
These  ||| S:14802 E:14808 ||| DT
data  ||| S:14808 E:14813 ||| NNS
indicate  ||| S:14813 E:14822 ||| VBP
that  ||| S:14822 E:14827 ||| IN
Pop1p  ||| S:14827 E:14833 ||| NNP
and  ||| S:14833 E:14847 ||| CC
Pop2p  ||| S:14847 E:14853 ||| RB
assume  ||| S:14853 E:14860 ||| VB
their  ||| S:14860 E:14866 ||| PRP$
subcellular  ||| S:14866 E:14878 ||| JJ
localization  ||| S:14878 E:14891 ||| JJ
pattern  ||| S:14891 E:14909 ||| NN
independent  ||| S:14909 E:14921 ||| JJ
of  ||| S:14921 E:14924 ||| IN
each  ||| S:14924 E:14929 ||| DT
other ||| S:14929 E:14934 ||| JJ
,  ||| S:14934 E:14936 ||| ,
indicating  ||| S:14936 E:14947 ||| VBG
the  ||| S:14947 E:14951 ||| DT
possibility  ||| S:14951 E:14963 ||| NN
of  ||| S:14963 E:14976 ||| IN
distinct  ||| S:14976 E:14985 ||| JJ
nuclear  ||| S:14985 E:14993 ||| JJ
and  ||| S:14993 E:14997 ||| CC
cytoplasmic  ||| S:14997 E:15009 ||| FW
homooligomeric  ||| S:15009 E:15024 ||| FW
SCF  ||| S:15024 E:15038 ||| FW
Pop1pand  ||| S:15038 E:15047 ||| FW
SCF  ||| S:15047 E:15051 ||| FW
Pop2pcomplexes ||| S:15051 E:15065 ||| FW
.  ||| S:15065 E:15095 ||| .
Differential  ||| S:15095 E:15108 ||| JJ
F-box  ||| S:15108 E:15114 ||| JJ
requirements  ||| S:15114 E:15127 ||| NNS
of  ||| S:15127 E:15130 ||| IN
Pop1p  ||| S:15130 E:15136 ||| NNP
and  ||| S:15136 E:15150 ||| CC
Pop2p  ||| S:15150 E:15166 ||| CD
As  ||| S:15166 E:15169 ||| IN
shown  ||| S:15169 E:15175 ||| VBN
above  ||| S:15175 E:15181 ||| IN
and  ||| S:15181 E:15185 ||| CC
in  ||| S:15185 E:15188 ||| IN
previous  ||| S:15188 E:15197 ||| JJ
genetic  ||| S:15197 E:15205 ||| JJ
work  ||| S:15205 E:15210 ||| NN
[  ||| S:15210 E:15212 ||| -LRB-
18  ||| S:15212 E:15215 ||| CD
20  ||| S:15215 E:15218 ||| CD
]  ||| S:15218 E:15230 ||| -RRB-
,  ||| S:15230 E:15232 ||| ,
SCF  ||| S:15232 E:15236 ||| NNP
Pop1p-Pop2p-dependent  ||| S:15236 E:15258 ||| NNP
Rum1p  ||| S:15258 E:15264 ||| NNP
degradation  ||| S:15264 E:15276 ||| NN
requires  ||| S:15276 E:15295 ||| VBZ
two  ||| S:15295 E:15299 ||| CD
different  ||| S:15299 E:15309 ||| JJ
proteins  ||| S:15309 E:15318 ||| NNS
with  ||| S:15318 E:15323 ||| IN
highly  ||| S:15323 E:15330 ||| RB
conserved  ||| S:15330 E:15340 ||| JJ
F-boxes  ||| S:15340 E:15358 ||| NN
( ||| S:15358 E:15359 ||| -LRB-
Fig.  ||| S:15359 E:15364 ||| NNP
4A ||| S:15364 E:15366 ||| NNP
) ||| S:15366 E:15367 ||| -RRB-
.  ||| S:15367 E:15369 ||| .
To  ||| S:15369 E:15372 ||| TO
better  ||| S:15372 E:15379 ||| RB
understand  ||| S:15379 E:15390 ||| VB
the  ||| S:15390 E:15394 ||| DT
apparent  ||| S:15394 E:15403 ||| JJ
dual  ||| S:15403 E:15408 ||| JJ
F-box  ||| S:15408 E:15424 ||| JJ
requirement  ||| S:15424 E:15436 ||| NN
for  ||| S:15436 E:15440 ||| IN
SCF  ||| S:15440 E:15444 ||| NNP
Pop1p-Pop2pfunction ||| S:15444 E:15463 ||| NNP
,  ||| S:15463 E:15465 ||| ,
we  ||| S:15465 E:15468 ||| PRP
generated  ||| S:15468 E:15488 ||| VBD
mutants  ||| S:15488 E:15496 ||| VBN
of  ||| S:15496 E:15499 ||| IN
Pop1p  ||| S:15499 E:15505 ||| NNP
and  ||| S:15505 E:15509 ||| CC
Pop2p  ||| S:15509 E:15515 ||| RB
lacking  ||| S:15515 E:15523 ||| VBG
F-boxes  ||| S:15523 E:15531 ||| JJ
( ||| S:15531 E:15532 ||| -LRB-
Pop1p-ΔF ||| S:15532 E:15540 ||| NNP
,  ||| S:15540 E:15552 ||| ,
Pop2p-ΔF ||| S:15552 E:15560 ||| NNP
;  ||| S:15560 E:15562 ||| :
Fig.  ||| S:15562 E:15567 ||| CD
4B ||| S:15567 E:15569 ||| CD
) ||| S:15569 E:15570 ||| -RRB-
.  ||| S:15570 E:15572 ||| .
In  ||| S:15572 E:15575 ||| IN
addition ||| S:15575 E:15583 ||| NN
,  ||| S:15583 E:15585 ||| ,
we  ||| S:15585 E:15588 ||| PRP
prepared  ||| S:15588 E:15597 ||| VBD
a  ||| S:15597 E:15599 ||| DT
set  ||| S:15599 E:15603 ||| NN
of  ||| S:15603 E:15616 ||| IN
mutants ||| S:15616 E:15623 ||| NN
,  ||| S:15623 E:15625 ||| ,
in  ||| S:15625 E:15628 ||| IN
which  ||| S:15628 E:15634 ||| WDT
the  ||| S:15634 E:15638 ||| DT
F-boxes  ||| S:15638 E:15646 ||| JJ
of  ||| S:15646 E:15649 ||| IN
Pop1p  ||| S:15649 E:15655 ||| NNP
and  ||| S:15655 E:15659 ||| CC
Pop2p  ||| S:15659 E:15665 ||| NNP
were  ||| S:15665 E:15680 ||| VBD
swapped  ||| S:15680 E:15688 ||| VBN
( ||| S:15688 E:15689 ||| -LRB-
Pop1p-2F ||| S:15689 E:15697 ||| NNP
,  ||| S:15697 E:15699 ||| ,
Pop2p-1F ||| S:15699 E:15707 ||| NNP
;  ||| S:15707 E:15709 ||| :
Fig.  ||| S:15709 E:15714 ||| CD
4B ||| S:15714 E:15716 ||| CD
) ||| S:15716 E:15717 ||| -RRB-
.  ||| S:15717 E:15719 ||| .
The  ||| S:15719 E:15723 ||| DT
mutants  ||| S:15723 E:15731 ||| NN
were  ||| S:15731 E:15746 ||| VBD
tested  ||| S:15746 E:15753 ||| VBN
for  ||| S:15753 E:15757 ||| IN
their  ||| S:15757 E:15763 ||| PRP$
ability  ||| S:15763 E:15771 ||| NN
to  ||| S:15771 E:15774 ||| TO
suppress  ||| S:15774 E:15783 ||| VB
polyploidy  ||| S:15783 E:15794 ||| NNS
and  ||| S:15794 E:15798 ||| CC
Rum1p  ||| S:15798 E:15814 ||| CD
accumulation  ||| S:15814 E:15827 ||| NN
in  ||| S:15827 E:15830 ||| IN
the  ||| S:15830 E:15834 ||| DT
respective  ||| S:15834 E:15856 ||| JJ
pop  ||| S:15856 E:15860 ||| NN
mutant  ||| S:15860 E:15867 ||| NN
strains ||| S:15867 E:15874 ||| NNS
.  ||| S:15874 E:15886 ||| .
As  ||| S:15886 E:15889 ||| RB
described  ||| S:15889 E:15899 ||| VBN
previously  ||| S:15899 E:15910 ||| RB
[  ||| S:15910 E:15912 ||| -LRB-
20  ||| S:15912 E:15915 ||| CD
]  ||| S:15915 E:15917 ||| -RRB-
,  ||| S:15917 E:15919 ||| ,
wild-type  ||| S:15919 E:15929 ||| NNP
Pop1p  ||| S:15929 E:15945 ||| NNP
mildly  ||| S:15945 E:15952 ||| RB
overexpressed  ||| S:15952 E:15966 ||| VBN
from  ||| S:15966 E:15971 ||| IN
a  ||| S:15971 E:15973 ||| DT
pRep81  ||| S:15973 E:15980 ||| NNP
plasmid  ||| S:15980 E:15988 ||| VBD
fully  ||| S:15988 E:16004 ||| RB
complemented  ||| S:16004 E:16017 ||| VB
the  ||| S:16017 E:16021 ||| DT
polyploidization  ||| S:16021 E:16038 ||| JJ
phenotype  ||| S:16038 E:16048 ||| NN
of  ||| S:16048 E:16062 ||| IN
pop1  ||| S:16062 E:16067 ||| CD
mutants  ||| S:16067 E:16075 ||| NNS
as  ||| S:16075 E:16078 ||| RB
determined  ||| S:16078 E:16089 ||| VBN
by  ||| S:16089 E:16092 ||| IN
flow  ||| S:16092 E:16107 ||| NN
cytometric  ||| S:16107 E:16118 ||| NN
measurement  ||| S:16118 E:16130 ||| NN
of  ||| S:16130 E:16133 ||| IN
the  ||| S:16133 E:16137 ||| DT
cellular  ||| S:16137 E:16146 ||| JJ
DNA  ||| S:16146 E:16150 ||| NN
content  ||| S:16150 E:16158 ||| NN
( ||| S:16158 E:16159 ||| -LRB-
Fig  ||| S:16159 E:16173 ||| NNP
4C ||| S:16173 E:16175 ||| NNP
) ||| S:16175 E:16176 ||| -RRB-
.  ||| S:16176 E:16178 ||| .
In  ||| S:16178 E:16181 ||| IN
addition ||| S:16181 E:16189 ||| NN
,  ||| S:16189 E:16191 ||| ,
Rum1p  ||| S:16191 E:16197 ||| CD
accumulation  ||| S:16197 E:16210 ||| NN
in  ||| S:16210 E:16224 ||| IN
pop1  ||| S:16224 E:16229 ||| CD
mutants  ||| S:16229 E:16237 ||| NNS
was  ||| S:16237 E:16241 ||| VBD
efficiently  ||| S:16241 E:16263 ||| RB
reversed  ||| S:16263 E:16272 ||| VBN
by  ||| S:16272 E:16275 ||| IN
wild-type  ||| S:16275 E:16285 ||| NNP
Pop1p  ||| S:16285 E:16291 ||| NNP
( ||| S:16291 E:16292 ||| -LRB-
Fig.  ||| S:16292 E:16297 ||| NNP
4D ||| S:16297 E:16299 ||| NNP
) ||| S:16299 E:16300 ||| -RRB-
.  ||| S:16300 E:16302 ||| .
In  ||| S:16302 E:16305 ||| IN
contrast ||| S:16305 E:16313 ||| NN
,  ||| S:16313 E:16315 ||| ,
Pop1p  ||| S:16315 E:16331 ||| RB
lacking  ||| S:16331 E:16339 ||| VBG
its  ||| S:16339 E:16343 ||| PRP$
F-box  ||| S:16343 E:16349 ||| JJ
( ||| S:16349 E:16350 ||| -LRB-
Pop1p-ΔF ||| S:16350 E:16358 ||| NNP
)  ||| S:16358 E:16360 ||| -RRB-
or  ||| S:16360 E:16363 ||| CC
Pop1p ||| S:16363 E:16368 ||| NNP
,  ||| S:16368 E:16370 ||| ,
in  ||| S:16370 E:16373 ||| IN
which  ||| S:16373 E:16379 ||| WDT
the  ||| S:16379 E:16383 ||| DT
F-box  ||| S:16383 E:16399 ||| NN
was  ||| S:16399 E:16403 ||| VBD
replaced  ||| S:16403 E:16412 ||| VBN
by  ||| S:16412 E:16415 ||| IN
the  ||| S:16415 E:16419 ||| DT
F-box  ||| S:16419 E:16425 ||| JJ
of  ||| S:16425 E:16428 ||| IN
Pop2p  ||| S:16428 E:16434 ||| NNP
( ||| S:16434 E:16435 ||| -LRB-
Pop1p-2F ||| S:16435 E:16443 ||| NNP
)  ||| S:16443 E:16445 ||| -RRB-
were  ||| S:16445 E:16460 ||| VBD
largely  ||| S:16460 E:16468 ||| RB
inactive  ||| S:16468 E:16477 ||| VBN
in  ||| S:16477 E:16480 ||| IN
both  ||| S:16480 E:16485 ||| DT
assays  ||| S:16485 E:16492 ||| NN
( ||| S:16492 E:16493 ||| -LRB-
Fig.  ||| S:16493 E:16498 ||| NNP
4C ||| S:16498 E:16500 ||| NNP
, ||| S:16500 E:16501 ||| ,
4D ||| S:16501 E:16503 ||| CD
) ||| S:16503 E:16504 ||| -RRB-
.  ||| S:16504 E:16506 ||| .
Thus ||| S:16506 E:16510 ||| RB
,  ||| S:16510 E:16512 ||| ,
as  ||| S:16512 E:16525 ||| RB
with  ||| S:16525 E:16530 ||| IN
many  ||| S:16530 E:16535 ||| JJ
other  ||| S:16535 E:16541 ||| JJ
F-box  ||| S:16541 E:16547 ||| JJ
proteins ||| S:16547 E:16555 ||| NNS
,  ||| S:16555 E:16557 ||| ,
the  ||| S:16557 E:16561 ||| DT
F-box  ||| S:16561 E:16567 ||| JJ
of  ||| S:16567 E:16570 ||| IN
Pop1p  ||| S:16570 E:16576 ||| NNP
is  ||| S:16576 E:16589 ||| VBZ
essential  ||| S:16589 E:16599 ||| JJ
for  ||| S:16599 E:16603 ||| IN
its  ||| S:16603 E:16618 ||| PRP$
in  ||| S:16618 E:16621 ||| IN
vivo  ||| S:16621 E:16626 ||| JJ
functions ||| S:16626 E:16635 ||| NNS
.  ||| S:16635 E:16647 ||| .
In  ||| S:16647 E:16650 ||| IN
contrast ||| S:16650 E:16658 ||| NN
,  ||| S:16658 E:16660 ||| ,
wild-type  ||| S:16660 E:16670 ||| NNP
Pop2p ||| S:16670 E:16675 ||| NNP
,  ||| S:16675 E:16677 ||| ,
the  ||| S:16677 E:16681 ||| DT
corresponding  ||| S:16681 E:16695 ||| JJ
F-box  ||| S:16695 E:16711 ||| JJ
mutant ||| S:16711 E:16717 ||| NN
,  ||| S:16717 E:16719 ||| ,
and  ||| S:16719 E:16723 ||| CC
Pop2p  ||| S:16723 E:16729 ||| RB
containing  ||| S:16729 E:16740 ||| VBG
the  ||| S:16740 E:16744 ||| DT
Pop1p  ||| S:16744 E:16750 ||| NNP
F-box  ||| S:16750 E:16756 ||| NNP
were  ||| S:16756 E:16761 ||| VBD
equally  ||| S:16761 E:16779 ||| RB
effective  ||| S:16779 E:16789 ||| JJ
in  ||| S:16789 E:16792 ||| IN
preventing  ||| S:16792 E:16803 ||| VBG
Rum1p  ||| S:16803 E:16809 ||| CD
accumulation  ||| S:16809 E:16822 ||| NN
( ||| S:16822 E:16823 ||| -LRB-
Fig.  ||| S:16823 E:16828 ||| NNP
4D ||| S:16828 E:16830 ||| NNP
) ||| S:16830 E:16831 ||| -RRB-
.  ||| S:16831 E:16833 ||| .
The  ||| S:16833 E:16847 ||| DT
same  ||| S:16847 E:16852 ||| JJ
wild-type  ||| S:16852 E:16862 ||| JJ
and  ||| S:16862 E:16866 ||| CC
mutant  ||| S:16866 E:16873 ||| JJ
proteins  ||| S:16873 E:16882 ||| NNS
also  ||| S:16882 E:16887 ||| RB
reversed  ||| S:16887 E:16896 ||| VBD
the  ||| S:16896 E:16900 ||| DT
mild  ||| S:16900 E:16915 ||| JJ
polyploidy  ||| S:16915 E:16926 ||| JJ
phenotype  ||| S:16926 E:16936 ||| NN
of  ||| S:16936 E:16950 ||| IN
pop2  ||| S:16950 E:16955 ||| CD
disruptants  ||| S:16955 E:16967 ||| NNS
( ||| S:16967 E:16968 ||| -LRB-
Fig.  ||| S:16968 E:16973 ||| NNP
4C ||| S:16973 E:16975 ||| NNP
) ||| S:16975 E:16976 ||| -RRB-
.  ||| S:16976 E:16978 ||| .
Thus ||| S:16978 E:16982 ||| RB
,  ||| S:16982 E:16994 ||| ,
in  ||| S:16994 E:16997 ||| IN
contrast  ||| S:16997 E:17006 ||| NN
to  ||| S:17006 E:17009 ||| TO
Pop1p ||| S:17009 E:17014 ||| CD
,  ||| S:17014 E:17016 ||| ,
Pop2p  ||| S:17016 E:17022 ||| NNP
does  ||| S:17022 E:17027 ||| VBZ
not  ||| S:17027 E:17031 ||| RB
seem ||| S:17031 E:17035 ||| VB
,  ||| S:17035 E:17037 ||| ,
to  ||| S:17037 E:17040 ||| TO
require  ||| S:17040 E:17048 ||| VB
its  ||| S:17048 E:17062 ||| PRP$
F-box  ||| S:17062 E:17068 ||| JJ
to  ||| S:17068 E:17071 ||| TO
mediate  ||| S:17071 E:17079 ||| VB
Rum1p  ||| S:17079 E:17085 ||| CD
degradation  ||| S:17085 E:17108 ||| NN
in  ||| S:17108 E:17111 ||| IN
vivo  ||| S:17111 E:17116 ||| NN
.  ||| S:17116 E:17128 ||| .
To  ||| S:17128 E:17131 ||| TO
further  ||| S:17131 E:17139 ||| RB
substantiate  ||| S:17139 E:17152 ||| VB
this  ||| S:17152 E:17157 ||| DT
conclusion ||| S:17157 E:17167 ||| NN
,  ||| S:17167 E:17169 ||| ,
we  ||| S:17169 E:17172 ||| PRP
examined  ||| S:17172 E:17191 ||| VBD
Rum1p  ||| S:17191 E:17197 ||| CD
protein  ||| S:17197 E:17205 ||| NN
stability  ||| S:17205 E:17215 ||| NN
in  ||| S:17215 E:17218 ||| IN
wild-type  ||| S:17218 E:17228 ||| JJ
and  ||| S:17228 E:17243 ||| CC
pop  ||| S:17243 E:17247 ||| VB
mutant  ||| S:17247 E:17254 ||| JJ
strains  ||| S:17254 E:17262 ||| NNS
expressing  ||| S:17262 E:17283 ||| VBG
F-box-deleted  ||| S:17283 E:17297 ||| JJ
Pop  ||| S:17297 E:17301 ||| JJ
proteins  ||| S:17301 E:17310 ||| NNS
from  ||| S:17310 E:17315 ||| IN
the  ||| S:17315 E:17319 ||| DT
weak  ||| S:17319 E:17324 ||| JJ
pRep81  ||| S:17324 E:17331 ||| CD
promoter ||| S:17331 E:17339 ||| NN
.  ||| S:17339 E:17351 ||| .
Since  ||| S:17351 E:17357 ||| IN
the  ||| S:17357 E:17361 ||| DT
sensitivity  ||| S:17361 E:17373 ||| NN
of  ||| S:17373 E:17376 ||| IN
our  ||| S:17376 E:17380 ||| PRP$
Rum1p  ||| S:17380 E:17386 ||| JJ
sera  ||| S:17386 E:17391 ||| NN
was  ||| S:17391 E:17395 ||| VBD
insufficient  ||| S:17395 E:17418 ||| JJ
to  ||| S:17418 E:17421 ||| TO
detect  ||| S:17421 E:17428 ||| VB
the  ||| S:17428 E:17432 ||| DT
low  ||| S:17432 E:17436 ||| JJ
levels  ||| S:17436 E:17443 ||| NNS
present  ||| S:17443 E:17451 ||| JJ
in  ||| S:17451 E:17454 ||| IN
wild-type  ||| S:17454 E:17464 ||| JJ
cells  ||| S:17464 E:17470 ||| NNS
( ||| S:17470 E:17471 ||| -LRB-
see  ||| S:17471 E:17485 ||| VB
Fig.  ||| S:17485 E:17490 ||| CD
4D ||| S:17490 E:17492 ||| CD
,  ||| S:17492 E:17494 ||| ,
lane  ||| S:17494 E:17499 ||| CD
9 ||| S:17499 E:17500 ||| CD
) ||| S:17500 E:17501 ||| -RRB-
,  ||| S:17501 E:17503 ||| ,
these  ||| S:17503 E:17509 ||| DT
experiments  ||| S:17509 E:17521 ||| NNS
were  ||| S:17521 E:17526 ||| VBD
conducted  ||| S:17526 E:17536 ||| VBN
in  ||| S:17536 E:17539 ||| IN
a  ||| S:17539 E:17551 ||| DT
background  ||| S:17551 E:17562 ||| NN
where  ||| S:17562 E:17568 ||| WRB
endogenous  ||| S:17568 E:17579 ||| JJ
Rum1p  ||| S:17579 E:17585 ||| NN
was  ||| S:17585 E:17589 ||| VBD
modified  ||| S:17589 E:17598 ||| VBN
with  ||| S:17598 E:17603 ||| IN
13  ||| S:17603 E:17616 ||| CD
C-terminal  ||| S:17616 E:17627 ||| JJ
c-Myc  ||| S:17627 E:17633 ||| JJ
epitope  ||| S:17633 E:17641 ||| JJ
tags ||| S:17641 E:17645 ||| NNS
.  ||| S:17645 E:17647 ||| .
Rum1p  ||| S:17647 E:17653 ||| NNP
half-life  ||| S:17653 E:17663 ||| NN
was  ||| S:17663 E:17677 ||| VBD
increased  ||| S:17677 E:17687 ||| VBN
from  ||| S:17687 E:17692 ||| IN
~20  ||| S:17692 E:17696 ||| CD
minutes  ||| S:17696 E:17704 ||| NNS
in  ||| S:17704 E:17707 ||| IN
wild-type  ||| S:17707 E:17717 ||| JJ
to  ||| S:17717 E:17720 ||| TO
greater  ||| S:17720 E:17728 ||| JJR
than  ||| S:17728 E:17743 ||| IN
100  ||| S:17743 E:17747 ||| CD
minutes  ||| S:17747 E:17755 ||| NNS
in  ||| S:17755 E:17769 ||| IN
pop1  ||| S:17769 E:17774 ||| NNP
or  ||| S:17774 E:17788 ||| CC
pop2  ||| S:17788 E:17793 ||| CD
mutants  ||| S:17793 E:17801 ||| NNS
( ||| S:17801 E:17802 ||| -LRB-
Fig.  ||| S:17802 E:17807 ||| CD
5 ||| S:17807 E:17808 ||| CD
) ||| S:17808 E:17809 ||| -RRB-
.  ||| S:17809 E:17811 ||| .
While  ||| S:17811 E:17817 ||| IN
F-box  ||| S:17817 E:17833 ||| JJ
deleted  ||| S:17833 E:17841 ||| NNS
Pop2p  ||| S:17841 E:17847 ||| VBP
expressed  ||| S:17847 E:17857 ||| VBN
from  ||| S:17857 E:17862 ||| IN
plasmids  ||| S:17862 E:17871 ||| NN
reduced  ||| S:17871 E:17879 ||| VBD
Rum1p  ||| S:17879 E:17895 ||| CD
half-life  ||| S:17895 E:17905 ||| NN
to  ||| S:17905 E:17908 ||| TO
~20  ||| S:17908 E:17912 ||| CD
minutes  ||| S:17912 E:17920 ||| NNS
in  ||| S:17920 E:17934 ||| IN
pop2  ||| S:17934 E:17939 ||| CD
mutants ||| S:17939 E:17946 ||| NN
,  ||| S:17946 E:17948 ||| ,
F-box-deleted  ||| S:17948 E:17962 ||| NNP
Pop1p  ||| S:17962 E:17978 ||| NNP
was  ||| S:17978 E:17982 ||| VBD
completely  ||| S:17982 E:17993 ||| RB
defective  ||| S:17993 E:18003 ||| JJ
in  ||| S:18003 E:18006 ||| IN
rescuing  ||| S:18006 E:18015 ||| VBG
the  ||| S:18015 E:18019 ||| DT
Rum1p  ||| S:18019 E:18035 ||| JJ
proteolysis  ||| S:18035 E:18047 ||| JJ
defect  ||| S:18047 E:18054 ||| NN
of  ||| S:18054 E:18068 ||| IN
pop1  ||| S:18068 E:18073 ||| CD
mutants  ||| S:18073 E:18081 ||| NNS
( ||| S:18081 E:18082 ||| -LRB-
Fig.  ||| S:18082 E:18087 ||| CD
5 ||| S:18087 E:18088 ||| CD
) ||| S:18088 E:18089 ||| -RRB-
.  ||| S:18089 E:18091 ||| .
Instead ||| S:18091 E:18098 ||| RB
,  ||| S:18098 E:18110 ||| ,
expression  ||| S:18110 E:18121 ||| NN
of  ||| S:18121 E:18124 ||| IN
Pop1p-ΔF  ||| S:18124 E:18133 ||| CD
in  ||| S:18133 E:18147 ||| IN
pop1  ||| S:18147 E:18152 ||| NNP
mutants  ||| S:18152 E:18160 ||| VBD
led  ||| S:18160 E:18164 ||| VBN
to  ||| S:18164 E:18167 ||| TO
even  ||| S:18167 E:18172 ||| RB
greater  ||| S:18172 E:18190 ||| JJR
stabilization  ||| S:18190 E:18204 ||| NN
of  ||| S:18204 E:18207 ||| IN
Rum1p ||| S:18207 E:18212 ||| NNP
,  ||| S:18212 E:18214 ||| ,
potentially  ||| S:18214 E:18226 ||| RB
due  ||| S:18226 E:18230 ||| JJ
to  ||| S:18230 E:18233 ||| TO
dominant  ||| S:18233 E:18252 ||| JJ
negative  ||| S:18252 E:18261 ||| JJ
interference  ||| S:18261 E:18274 ||| NN
with  ||| S:18274 E:18279 ||| IN
the  ||| S:18279 E:18283 ||| DT
residual  ||| S:18283 E:18292 ||| JJ
activity  ||| S:18292 E:18301 ||| NN
of  ||| S:18301 E:18304 ||| IN
Pop2p  ||| S:18304 E:18320 ||| NNP
and ||| S:18320 E:18323 ||| CC
/ ||| S:18323 E:18324 ||| NNP
or  ||| S:18324 E:18327 ||| CC
other  ||| S:18327 E:18333 ||| JJ
F-box  ||| S:18333 E:18339 ||| JJ
proteins ||| S:18339 E:18347 ||| NNS
.  ||| S:18347 E:18377 ||| .
F-box  ||| S:18377 E:18383 ||| JJ
independent  ||| S:18383 E:18395 ||| JJ
interaction  ||| S:18395 E:18407 ||| NN
of  ||| S:18407 E:18410 ||| IN
Pop1p  ||| S:18410 E:18416 ||| NNP
and  ||| S:18416 E:18430 ||| CC
Pop2p  ||| S:18430 E:18446 ||| CD
The  ||| S:18446 E:18450 ||| DT
failure  ||| S:18450 E:18458 ||| NN
of  ||| S:18458 E:18461 ||| IN
the  ||| S:18461 E:18465 ||| DT
Pop2p  ||| S:18465 E:18471 ||| JJ
F-box  ||| S:18471 E:18477 ||| JJ
to  ||| S:18477 E:18480 ||| TO
replace  ||| S:18480 E:18488 ||| VB
the  ||| S:18488 E:18492 ||| DT
F-box  ||| S:18492 E:18498 ||| JJ
of  ||| S:18498 E:18511 ||| IN
Pop1p  ||| S:18511 E:18517 ||| CD
as  ||| S:18517 E:18520 ||| IN
well  ||| S:18520 E:18525 ||| RB
as  ||| S:18525 E:18528 ||| IN
the  ||| S:18528 E:18532 ||| DT
finding  ||| S:18532 E:18540 ||| NN
that  ||| S:18540 E:18545 ||| IN
it  ||| S:18545 E:18548 ||| PRP
is  ||| S:18548 E:18551 ||| VBZ
not  ||| S:18551 E:18555 ||| RB
essential  ||| S:18555 E:18565 ||| JJ
for  ||| S:18565 E:18579 ||| IN
Rum1p  ||| S:18579 E:18585 ||| CD
degradation  ||| S:18585 E:18597 ||| NNS
could  ||| S:18597 E:18603 ||| MD
be  ||| S:18603 E:18606 ||| VB
explained ||| S:18606 E:18615 ||| VBN
,  ||| S:18615 E:18617 ||| ,
if  ||| S:18617 E:18620 ||| IN
it  ||| S:18620 E:18623 ||| PRP
was  ||| S:18623 E:18627 ||| VBD
not  ||| S:18627 E:18641 ||| RB
critically  ||| S:18641 E:18652 ||| RB
involved  ||| S:18652 E:18661 ||| VBN
in  ||| S:18661 E:18664 ||| IN
SCF  ||| S:18664 E:18668 ||| NNP
Pop1p-Pop2pprotein  ||| S:18668 E:18697 ||| NNP
interactions ||| S:18697 E:18709 ||| NNS
.  ||| S:18709 E:18711 ||| .
We  ||| S:18711 E:18714 ||| PRP
therefore  ||| S:18714 E:18724 ||| RB
tested  ||| S:18724 E:18731 ||| VBN
the  ||| S:18731 E:18735 ||| DT
possibility  ||| S:18735 E:18747 ||| NN
that  ||| S:18747 E:18762 ||| IN
Pop2p  ||| S:18762 E:18768 ||| NNP
can  ||| S:18768 E:18772 ||| MD
be  ||| S:18772 E:18775 ||| VB
tethered  ||| S:18775 E:18784 ||| VBN
to  ||| S:18784 E:18787 ||| TO
the  ||| S:18787 E:18791 ||| DT
SCF  ||| S:18791 E:18795 ||| NNP
core  ||| S:18795 E:18800 ||| NN
complex  ||| S:18800 E:18818 ||| NN
independently  ||| S:18818 E:18832 ||| RB
of  ||| S:18832 E:18835 ||| IN
its  ||| S:18835 E:18839 ||| PRP$
F-box  ||| S:18839 E:18845 ||| JJ
via  ||| S:18845 E:18849 ||| IN
an  ||| S:18849 E:18852 ||| DT
interaction  ||| S:18852 E:18864 ||| NN
with  ||| S:18864 E:18869 ||| IN
Pop1p ||| S:18869 E:18874 ||| CD
.  ||| S:18874 E:18886 ||| .
Consistent  ||| S:18886 E:18897 ||| JJ
with  ||| S:18897 E:18902 ||| IN
this  ||| S:18902 E:18907 ||| DT
hypothesis ||| S:18907 E:18917 ||| NN
,  ||| S:18917 E:18919 ||| ,
co-immunoprecipitation  ||| S:18919 E:18952 ||| JJ
experiments  ||| S:18952 E:18964 ||| NNS
of  ||| S:18964 E:18967 ||| IN
overexpressed  ||| S:18967 E:18981 ||| JJ
proteins  ||| S:18981 E:18990 ||| NNS
revealed  ||| S:18990 E:18999 ||| VBD
that  ||| S:18999 E:19004 ||| IN
the  ||| S:19004 E:19018 ||| DT
Pop1p-Pop2p  ||| S:19018 E:19030 ||| JJ
interaction  ||| S:19030 E:19042 ||| NN
occurs  ||| S:19042 E:19049 ||| VBZ
independently  ||| S:19049 E:19063 ||| RB
of  ||| S:19063 E:19066 ||| IN
the  ||| S:19066 E:19080 ||| DT
F-boxes  ||| S:19080 E:19088 ||| JJ
of  ||| S:19088 E:19091 ||| IN
both  ||| S:19091 E:19096 ||| DT
Pop1p  ||| S:19096 E:19102 ||| NNP
and  ||| S:19102 E:19106 ||| CC
Pop2p  ||| S:19106 E:19112 ||| NNP
( ||| S:19112 E:19113 ||| -LRB-
Fig.  ||| S:19113 E:19118 ||| NNP
6A ||| S:19118 E:19120 ||| NNP
) ||| S:19120 E:19121 ||| -RRB-
.  ||| S:19121 E:19133 ||| .
We  ||| S:19133 E:19136 ||| PRP
had  ||| S:19136 E:19140 ||| VBD
previously  ||| S:19140 E:19151 ||| RB
mapped  ||| S:19151 E:19158 ||| VB
the  ||| S:19158 E:19162 ||| DT
domain  ||| S:19162 E:19169 ||| NN
of  ||| S:19169 E:19172 ||| IN
Pop2p  ||| S:19172 E:19178 ||| CD
that  ||| S:19178 E:19193 ||| IN
interacts  ||| S:19193 E:19203 ||| NN
with  ||| S:19203 E:19208 ||| IN
Pop1p  ||| S:19208 E:19214 ||| CD
to  ||| S:19214 E:19217 ||| TO
an  ||| S:19217 E:19220 ||| DT
N-terminal  ||| S:19220 E:19231 ||| JJ
fragment  ||| S:19231 E:19240 ||| NN
consisting  ||| S:19240 E:19261 ||| VBG
of  ||| S:19261 E:19264 ||| IN
the  ||| S:19264 E:19268 ||| DT
first  ||| S:19268 E:19274 ||| JJ
241  ||| S:19274 E:19278 ||| CD
amino  ||| S:19278 E:19284 ||| CD
acids  ||| S:19284 E:19290 ||| NNS
and  ||| S:19290 E:19294 ||| CC
lacking  ||| S:19294 E:19302 ||| VBG
the  ||| S:19302 E:19306 ||| DT
F-box  ||| S:19306 E:19312 ||| JJ
(  ||| S:19312 E:19314 ||| -LRB-
[  ||| S:19314 E:19316 ||| CD
20  ||| S:19316 E:19329 ||| CD
]  ||| S:19329 E:19331 ||| -RRB-
,  ||| S:19331 E:19333 ||| ,
Fig.  ||| S:19333 E:19338 ||| NNP
6B ||| S:19338 E:19340 ||| NNP
,  ||| S:19340 E:19342 ||| ,
lane  ||| S:19342 E:19347 ||| CD
8 ||| S:19347 E:19348 ||| CD
) ||| S:19348 E:19349 ||| -RRB-
.  ||| S:19349 E:19351 ||| .
In  ||| S:19351 E:19354 ||| IN
co-immunoprecipitation  ||| S:19354 E:19387 ||| JJ
experiments  ||| S:19387 E:19399 ||| NNS
with  ||| S:19399 E:19404 ||| IN
overexpressed  ||| S:19404 E:19418 ||| JJ
proteins ||| S:19418 E:19426 ||| NNS
,  ||| S:19426 E:19428 ||| ,
this  ||| S:19428 E:19433 ||| DT
fragment  ||| S:19433 E:19452 ||| NN
also  ||| S:19452 E:19457 ||| RB
bound  ||| S:19457 E:19463 ||| VBN
to  ||| S:19463 E:19466 ||| TO
an  ||| S:19466 E:19469 ||| DT
N-terminal  ||| S:19469 E:19480 ||| JJ
piece  ||| S:19480 E:19486 ||| NN
containing  ||| S:19486 E:19497 ||| VBG
the  ||| S:19497 E:19501 ||| DT
first  ||| S:19501 E:19517 ||| JJ
402  ||| S:19517 E:19521 ||| CD
residues  ||| S:19521 E:19530 ||| NNS
of  ||| S:19530 E:19533 ||| IN
Pop1p  ||| S:19533 E:19539 ||| NNP
( ||| S:19539 E:19540 ||| -LRB-
Fig.  ||| S:19540 E:19545 ||| NNP
6B ||| S:19545 E:19547 ||| NNP
,  ||| S:19547 E:19549 ||| ,
lane  ||| S:19549 E:19554 ||| CD
12 ||| S:19554 E:19556 ||| CD
) ||| S:19556 E:19557 ||| -RRB-
.  ||| S:19557 E:19559 ||| .
Thus ||| S:19559 E:19563 ||| RB
,  ||| S:19563 E:19565 ||| ,
the  ||| S:19565 E:19579 ||| DT
Pop1p-Pop2p  ||| S:19579 E:19591 ||| JJ
interaction  ||| S:19591 E:19603 ||| NN
is  ||| S:19603 E:19606 ||| VBZ
mediated  ||| S:19606 E:19615 ||| VBN
by  ||| S:19615 E:19618 ||| IN
their  ||| S:19618 E:19624 ||| PRP$
N-terminal  ||| S:19624 E:19645 ||| JJ
domains ||| S:19645 E:19652 ||| NN
.  ||| S:19652 E:19654 ||| .
A  ||| S:19654 E:19656 ||| DT
further  ||| S:19656 E:19664 ||| JJ
truncation  ||| S:19664 E:19675 ||| NNS
mutant  ||| S:19675 E:19682 ||| VBP
mapped  ||| S:19682 E:19689 ||| VBG
the  ||| S:19689 E:19693 ||| DT
Pop2p  ||| S:19693 E:19709 ||| JJ
binding  ||| S:19709 E:19717 ||| JJ
domain  ||| S:19717 E:19724 ||| NN
to  ||| S:19724 E:19727 ||| TO
a  ||| S:19727 E:19729 ||| DT
region  ||| S:19729 E:19736 ||| NN
between  ||| S:19736 E:19744 ||| IN
residues  ||| S:19744 E:19753 ||| CD
228  ||| S:19753 E:19757 ||| CD
and  ||| S:19757 E:19761 ||| CC
402  ||| S:19761 E:19775 ||| CD
of  ||| S:19775 E:19778 ||| IN
Pop1p  ||| S:19778 E:19784 ||| NNP
( ||| S:19784 E:19785 ||| -LRB-
Fig.  ||| S:19785 E:19790 ||| NNP
6B ||| S:19790 E:19792 ||| NNP
,  ||| S:19792 E:19794 ||| ,
lanes  ||| S:19794 E:19800 ||| CD
9,10 ||| S:19800 E:19804 ||| CD
) ||| S:19804 E:19805 ||| -RRB-
.  ||| S:19805 E:19835 ||| .
Individual  ||| S:19835 E:19846 ||| NNP
SCF  ||| S:19846 E:19850 ||| NNP
Pop1pand  ||| S:19850 E:19859 ||| FW
SCF  ||| S:19859 E:19863 ||| FW
Pop2pcomplexes  ||| S:19863 E:19878 ||| FW
bearing  ||| S:19878 E:19896 ||| FW
ubiquitin  ||| S:19896 E:19906 ||| FW
ligase  ||| S:19906 E:19913 ||| FW
activity  ||| S:19913 E:19932 ||| NN
The  ||| S:19932 E:19936 ||| DT
apparent  ||| S:19936 E:19945 ||| JJ
dispensibility  ||| S:19945 E:19960 ||| NN
of  ||| S:19960 E:19963 ||| IN
the  ||| S:19963 E:19967 ||| DT
F-box  ||| S:19967 E:19973 ||| JJ
of  ||| S:19973 E:19976 ||| IN
Pop2p  ||| S:19976 E:19982 ||| CD
for  ||| S:19982 E:19996 ||| IN
Rum1p  ||| S:19996 E:20002 ||| CD
degradation  ||| S:20002 E:20014 ||| NNS
and  ||| S:20014 E:20018 ||| CC
binding  ||| S:20018 E:20026 ||| VBG
to  ||| S:20026 E:20029 ||| TO
Pop1p  ||| S:20029 E:20035 ||| NNP
raised  ||| S:20035 E:20042 ||| VBD
the  ||| S:20042 E:20056 ||| DT
question  ||| S:20056 E:20065 ||| NN
of  ||| S:20065 E:20068 ||| IN
why  ||| S:20068 E:20072 ||| WRB
Pop2p  ||| S:20072 E:20078 ||| NNP
does  ||| S:20078 E:20083 ||| VBZ
contain  ||| S:20083 E:20091 ||| VB
an  ||| S:20091 E:20094 ||| DT
F-box ||| S:20094 E:20099 ||| JJ
.  ||| S:20099 E:20101 ||| .
Based  ||| S:20101 E:20107 ||| VBN
on  ||| S:20107 E:20110 ||| IN
the  ||| S:20110 E:20124 ||| DT
subcellular  ||| S:20124 E:20136 ||| JJ
localization  ||| S:20136 E:20149 ||| JJ
data ||| S:20149 E:20153 ||| NNS
,  ||| S:20153 E:20155 ||| ,
we  ||| S:20155 E:20158 ||| PRP
considered  ||| S:20158 E:20169 ||| VBD
the  ||| S:20169 E:20183 ||| DT
possibility  ||| S:20183 E:20195 ||| NN
that  ||| S:20195 E:20200 ||| IN
the  ||| S:20200 E:20204 ||| DT
F-box  ||| S:20204 E:20210 ||| JJ
of  ||| S:20210 E:20213 ||| IN
Pop2p  ||| S:20213 E:20219 ||| NNP
may  ||| S:20219 E:20223 ||| MD
mediate  ||| S:20223 E:20231 ||| VB
the  ||| S:20231 E:20245 ||| DT
assembly  ||| S:20245 E:20254 ||| NN
of  ||| S:20254 E:20257 ||| IN
a  ||| S:20257 E:20259 ||| DT
cytoplasmically  ||| S:20259 E:20275 ||| JJ
localized  ||| S:20275 E:20285 ||| JJ
SCF  ||| S:20285 E:20289 ||| NNP
Pop2pcomplex ||| S:20289 E:20301 ||| NNP
,  ||| S:20301 E:20313 ||| ,
independent  ||| S:20313 E:20325 ||| JJ
of  ||| S:20325 E:20328 ||| IN
Pop1p ||| S:20328 E:20333 ||| CD
.  ||| S:20333 E:20335 ||| .
To  ||| S:20335 E:20338 ||| TO
demonstrate  ||| S:20338 E:20350 ||| VB
this ||| S:20350 E:20354 ||| DT
,  ||| S:20354 E:20356 ||| ,
we  ||| S:20356 E:20359 ||| PRP
again  ||| S:20359 E:20365 ||| RB
used  ||| S:20365 E:20380 ||| VBN
the  ||| S:20380 E:20384 ||| DT
strain  ||| S:20384 E:20391 ||| NN
in  ||| S:20391 E:20394 ||| IN
which  ||| S:20394 E:20400 ||| WDT
endogenous  ||| S:20400 E:20411 ||| VBZ
Pop2p  ||| S:20411 E:20417 ||| NNP
was  ||| S:20417 E:20421 ||| VBD
modified  ||| S:20421 E:20430 ||| VBN
by  ||| S:20430 E:20433 ||| IN
13  ||| S:20433 E:20446 ||| CD
Myc  ||| S:20446 E:20450 ||| JJ
epitope  ||| S:20450 E:20458 ||| JJ
tags  ||| S:20458 E:20463 ||| NNS
in  ||| S:20463 E:20466 ||| IN
a  ||| S:20466 E:20479 ||| DT
pop1  ||| S:20479 E:20484 ||| JJ
deletion  ||| S:20484 E:20493 ||| JJ
background ||| S:20493 E:20503 ||| NN
.  ||| S:20503 E:20505 ||| .
The  ||| S:20505 E:20509 ||| DT
same  ||| S:20509 E:20524 ||| JJ
experiments  ||| S:20524 E:20536 ||| NNS
were  ||| S:20536 E:20541 ||| VBD
carried  ||| S:20541 E:20549 ||| VBN
out  ||| S:20549 E:20553 ||| RP
with  ||| S:20553 E:20558 ||| IN
the  ||| S:20558 E:20562 ||| DT
reverse  ||| S:20562 E:20570 ||| JJ
stain ||| S:20570 E:20575 ||| NN
,  ||| S:20575 E:20587 ||| ,
which  ||| S:20587 E:20593 ||| WDT
contained  ||| S:20593 E:20603 ||| VBD
Pop1p-13Myc  ||| S:20603 E:20615 ||| CD
in  ||| S:20615 E:20618 ||| IN
a  ||| S:20618 E:20631 ||| DT
pop2  ||| S:20631 E:20636 ||| JJ
background ||| S:20636 E:20646 ||| NN
.  ||| S:20646 E:20648 ||| .
As  ||| S:20648 E:20651 ||| IN
a  ||| S:20651 E:20653 ||| DT
reference  ||| S:20653 E:20663 ||| NN
for  ||| S:20663 E:20677 ||| IN
SCF  ||| S:20677 E:20681 ||| NNP
Popcomplex  ||| S:20681 E:20692 ||| NNP
formation ||| S:20692 E:20701 ||| NN
,  ||| S:20701 E:20703 ||| ,
we  ||| S:20703 E:20706 ||| PRP
used  ||| S:20706 E:20711 ||| VBD
strains  ||| S:20711 E:20719 ||| NNS
carrying  ||| S:20719 E:20728 ||| VBG
13Myc  ||| S:20728 E:20744 ||| NNP
epitope-tagged  ||| S:20744 E:20759 ||| NNP
Pop1p  ||| S:20759 E:20765 ||| NNP
or  ||| S:20765 E:20768 ||| CC
Pop2p  ||| S:20768 E:20774 ||| RB
integrated  ||| S:20774 E:20785 ||| VBN
into  ||| S:20785 E:20790 ||| IN
the  ||| S:20790 E:20794 ||| DT
genome  ||| S:20794 E:20811 ||| NN
of  ||| S:20811 E:20814 ||| IN
wild-type  ||| S:20814 E:20824 ||| JJ
cells ||| S:20824 E:20829 ||| NNS
.  ||| S:20829 E:20841 ||| .
Pip1p  ||| S:20841 E:20847 ||| NNP
immunoprecipitates  ||| S:20847 E:20866 ||| NN
were  ||| S:20866 E:20871 ||| VBD
prepared  ||| S:20871 E:20880 ||| VBN
from  ||| S:20880 E:20885 ||| IN
lysates  ||| S:20885 E:20893 ||| NN
of  ||| S:20893 E:20906 ||| IN
these  ||| S:20906 E:20912 ||| DT
four  ||| S:20912 E:20917 ||| CD
strains  ||| S:20917 E:20925 ||| NNS
and  ||| S:20925 E:20929 ||| CC
appropriate  ||| S:20929 E:20941 ||| JJ
controls ||| S:20941 E:20949 ||| NNS
,  ||| S:20949 E:20951 ||| ,
and  ||| S:20951 E:20965 ||| CC
co-purification  ||| S:20965 E:20981 ||| JJ
of  ||| S:20981 E:20984 ||| IN
SCF  ||| S:20984 E:20988 ||| NNP
components  ||| S:20988 E:20999 ||| NNS
was  ||| S:20999 E:21003 ||| VBD
determined  ||| S:21003 E:21014 ||| VBN
by  ||| S:21014 E:21027 ||| IN
immunoblotting ||| S:21027 E:21041 ||| NN
.  ||| S:21041 E:21043 ||| .
These  ||| S:21043 E:21049 ||| DT
experiments  ||| S:21049 E:21061 ||| NNS
showed  ||| S:21061 E:21068 ||| VBD
that  ||| S:21068 E:21073 ||| IN
both  ||| S:21073 E:21078 ||| DT
F-box  ||| S:21078 E:21094 ||| JJ
proteins ||| S:21094 E:21102 ||| NNS
,  ||| S:21102 E:21104 ||| ,
in  ||| S:21104 E:21107 ||| IN
the  ||| S:21107 E:21111 ||| DT
absence  ||| S:21111 E:21119 ||| NN
of  ||| S:21119 E:21122 ||| IN
their  ||| S:21122 E:21128 ||| PRP$
respective  ||| S:21128 E:21149 ||| JJ
heterooligomerization  ||| S:21149 E:21171 ||| JJ
partner ||| S:21171 E:21178 ||| NN
,  ||| S:21178 E:21180 ||| ,
could  ||| S:21180 E:21186 ||| MD
individually  ||| S:21186 E:21199 ||| RB
bind  ||| S:21199 E:21204 ||| VBN
to  ||| S:21204 E:21217 ||| TO
Pip1p  ||| S:21217 E:21223 ||| CD
in  ||| S:21223 E:21226 ||| IN
complexes  ||| S:21226 E:21236 ||| NNS
that  ||| S:21236 E:21241 ||| WDT
also  ||| S:21241 E:21246 ||| RB
contained  ||| S:21246 E:21256 ||| VBD
Psh1p  ||| S:21256 E:21262 ||| CD
and  ||| S:21262 E:21266 ||| CC
Pcu1p  ||| S:21266 E:21282 ||| NNP
( ||| S:21282 E:21283 ||| -LRB-
Fig.  ||| S:21283 E:21288 ||| NNP
7A ||| S:21288 E:21290 ||| NNP
) ||| S:21290 E:21291 ||| -RRB-
.  ||| S:21291 E:21293 ||| .
These  ||| S:21293 E:21299 ||| DT
findings  ||| S:21299 E:21308 ||| NNS
indicate  ||| S:21308 E:21317 ||| VBP
the  ||| S:21317 E:21321 ||| DT
existence  ||| S:21321 E:21331 ||| NN
of  ||| S:21331 E:21344 ||| IN
distinct  ||| S:21344 E:21353 ||| JJ
SCF  ||| S:21353 E:21357 ||| NNP
Pop1pand  ||| S:21357 E:21366 ||| NNP
SCF  ||| S:21366 E:21370 ||| NNP
Pop2pcomplexes  ||| S:21370 E:21396 ||| NNP
in  ||| S:21396 E:21399 ||| IN
vivo  ||| S:21399 E:21404 ||| NN
.  ||| S:21404 E:21416 ||| .
To  ||| S:21416 E:21419 ||| TO
further  ||| S:21419 E:21427 ||| RB
substantiate  ||| S:21427 E:21440 ||| VB
this  ||| S:21440 E:21445 ||| DT
conclusion ||| S:21445 E:21455 ||| NN
,  ||| S:21455 E:21457 ||| ,
we  ||| S:21457 E:21460 ||| PRP
used  ||| S:21460 E:21465 ||| VBD
gel  ||| S:21465 E:21479 ||| JJ
filtration  ||| S:21479 E:21490 ||| NN
to  ||| S:21490 E:21493 ||| TO
compare  ||| S:21493 E:21501 ||| VB
the  ||| S:21501 E:21505 ||| DT
elution  ||| S:21505 E:21513 ||| JJ
profiles  ||| S:21513 E:21522 ||| NNS
of  ||| S:21522 E:21525 ||| IN
Pop1p  ||| S:21525 E:21531 ||| NNP
and  ||| S:21531 E:21545 ||| CC
Pop2p  ||| S:21545 E:21551 ||| CD
in  ||| S:21551 E:21554 ||| IN
the  ||| S:21554 E:21558 ||| DT
presence  ||| S:21558 E:21567 ||| NN
or  ||| S:21567 E:21570 ||| CC
absence  ||| S:21570 E:21578 ||| NN
of  ||| S:21578 E:21581 ||| IN
their  ||| S:21581 E:21587 ||| PRP$
respective  ||| S:21587 E:21608 ||| JJ
dimerization  ||| S:21608 E:21621 ||| JJ
partners ||| S:21621 E:21629 ||| NNS
.  ||| S:21629 E:21631 ||| .
If  ||| S:21631 E:21634 ||| IN
recruitment  ||| S:21634 E:21646 ||| NN
of  ||| S:21646 E:21649 ||| IN
Pop2p  ||| S:21649 E:21655 ||| CD
into  ||| S:21655 E:21660 ||| IN
a  ||| S:21660 E:21672 ||| DT
high  ||| S:21672 E:21677 ||| JJ
molecular  ||| S:21677 E:21687 ||| JJ
weight  ||| S:21687 E:21694 ||| NN
SCF  ||| S:21694 E:21698 ||| NNP
complex  ||| S:21698 E:21706 ||| NN
required  ||| S:21706 E:21725 ||| VBD
heterooligomerization  ||| S:21725 E:21747 ||| VBN
with  ||| S:21747 E:21752 ||| IN
Pop1p ||| S:21752 E:21757 ||| NNP
,  ||| S:21757 E:21759 ||| ,
its  ||| S:21759 E:21763 ||| PRP$
elution  ||| S:21763 E:21771 ||| JJ
profile  ||| S:21771 E:21789 ||| NN
would  ||| S:21789 E:21795 ||| MD
be  ||| S:21795 E:21798 ||| VB
expected  ||| S:21798 E:21807 ||| VBN
to  ||| S:21807 E:21810 ||| TO
shift  ||| S:21810 E:21816 ||| VB
to  ||| S:21816 E:21819 ||| TO
a  ||| S:21819 E:21821 ||| DT
smaller  ||| S:21821 E:21829 ||| JJR
size  ||| S:21829 E:21834 ||| NN
in  ||| S:21834 E:21837 ||| IN
the  ||| S:21837 E:21851 ||| DT
absence  ||| S:21851 E:21859 ||| NN
of  ||| S:21859 E:21862 ||| IN
Pop1p ||| S:21862 E:21867 ||| CD
.  ||| S:21867 E:21869 ||| .
Consistent  ||| S:21869 E:21880 ||| JJ
with  ||| S:21880 E:21885 ||| IN
the  ||| S:21885 E:21889 ||| DT
results  ||| S:21889 E:21897 ||| NNS
presented  ||| S:21897 E:21917 ||| VBN
in  ||| S:21917 E:21920 ||| IN
Fig.  ||| S:21920 E:21925 ||| CD
1C ||| S:21925 E:21927 ||| CD
,  ||| S:21927 E:21929 ||| ,
Pop2p ||| S:21929 E:21934 ||| NNP
,  ||| S:21934 E:21936 ||| ,
together  ||| S:21936 E:21945 ||| RB
with  ||| S:21945 E:21950 ||| IN
SCF  ||| S:21950 E:21954 ||| NNP
core  ||| S:21954 E:21959 ||| NN
subunits ||| S:21959 E:21967 ||| NN
,  ||| S:21967 E:21979 ||| ,
eluted  ||| S:21979 E:21986 ||| VBG
in  ||| S:21986 E:21989 ||| IN
fractions  ||| S:21989 E:21999 ||| JJ
corresponding  ||| S:21999 E:22013 ||| JJ
to  ||| S:22013 E:22016 ||| TO
400  ||| S:22016 E:22020 ||| CD
-  ||| S:22020 E:22022 ||| :
600  ||| S:22022 E:22026 ||| CD
kDa ||| S:22026 E:22029 ||| NN
,  ||| S:22029 E:22041 ||| ,
irrespective  ||| S:22041 E:22054 ||| RB
of  ||| S:22054 E:22057 ||| IN
whether  ||| S:22057 E:22065 ||| IN
Pop1p  ||| S:22065 E:22071 ||| NNP
was  ||| S:22071 E:22075 ||| VBD
present  ||| S:22075 E:22083 ||| JJ
or  ||| S:22083 E:22086 ||| CC
not  ||| S:22086 E:22090 ||| RB
( ||| S:22090 E:22091 ||| -LRB-
Fig.  ||| S:22091 E:22106 ||| NNP
7B ||| S:22106 E:22108 ||| NNP
) ||| S:22108 E:22109 ||| -RRB-
.  ||| S:22109 E:22111 ||| .
In  ||| S:22111 E:22114 ||| IN
the  ||| S:22114 E:22118 ||| DT
reverse  ||| S:22118 E:22126 ||| JJ
experiment ||| S:22126 E:22136 ||| NN
,  ||| S:22136 E:22138 ||| ,
the  ||| S:22138 E:22142 ||| DT
elution  ||| S:22142 E:22150 ||| JJ
profile  ||| S:22150 E:22158 ||| NN
of  ||| S:22158 E:22171 ||| IN
Pop1p  ||| S:22171 E:22177 ||| NNP
was  ||| S:22177 E:22181 ||| VBD
found  ||| S:22181 E:22187 ||| VBN
to  ||| S:22187 E:22190 ||| TO
be  ||| S:22190 E:22193 ||| VB
independent  ||| S:22193 E:22205 ||| JJ
of  ||| S:22205 E:22208 ||| IN
the  ||| S:22208 E:22212 ||| DT
presence  ||| S:22212 E:22221 ||| NN
of  ||| S:22221 E:22234 ||| IN
Pop2p  ||| S:22234 E:22240 ||| NNP
( ||| S:22240 E:22241 ||| -LRB-
Fig.  ||| S:22241 E:22246 ||| NNP
7B ||| S:22246 E:22248 ||| NNP
) ||| S:22248 E:22249 ||| -RRB-
.  ||| S:22249 E:22261 ||| .
While  ||| S:22261 E:22267 ||| IN
these  ||| S:22267 E:22273 ||| DT
data  ||| S:22273 E:22278 ||| NNS
support  ||| S:22278 E:22286 ||| VBP
the  ||| S:22286 E:22290 ||| DT
existence  ||| S:22290 E:22300 ||| NN
of  ||| S:22300 E:22303 ||| IN
distinct  ||| S:22303 E:22312 ||| JJ
SCF  ||| S:22312 E:22326 ||| NNP
Pop1pand  ||| S:22326 E:22335 ||| NNP
SCF  ||| S:22335 E:22339 ||| NNP
Pop2pcomplexes ||| S:22339 E:22353 ||| NNP
,  ||| S:22353 E:22355 ||| ,
individual  ||| S:22355 E:22366 ||| JJ
binding  ||| S:22366 E:22374 ||| NN
of  ||| S:22374 E:22377 ||| IN
Pop1p  ||| S:22377 E:22393 ||| NNP
and  ||| S:22393 E:22397 ||| CC
Pop2p  ||| S:22397 E:22403 ||| CD
to  ||| S:22403 E:22406 ||| TO
SCF  ||| S:22406 E:22410 ||| NNP
core  ||| S:22410 E:22415 ||| NN
components  ||| S:22415 E:22426 ||| NNS
in  ||| S:22426 E:22429 ||| IN
the  ||| S:22429 E:22433 ||| DT
absence  ||| S:22433 E:22441 ||| NN
of  ||| S:22441 E:22444 ||| IN
their  ||| S:22444 E:22460 ||| PRP$
heterodimerizing  ||| S:22460 E:22477 ||| JJ
F-box  ||| S:22477 E:22483 ||| JJ
protein  ||| S:22483 E:22491 ||| NN
partners  ||| S:22491 E:22500 ||| NNS
does  ||| S:22500 E:22505 ||| VBZ
not  ||| S:22505 E:22509 ||| RB
rule  ||| S:22509 E:22514 ||| VB
out  ||| S:22514 E:22528 ||| RP
the  ||| S:22528 E:22532 ||| DT
possibility  ||| S:22532 E:22544 ||| NN
that  ||| S:22544 E:22549 ||| IN
these  ||| S:22549 E:22555 ||| DT
complexes  ||| S:22555 E:22565 ||| NNS
represent  ||| S:22565 E:22575 ||| VBP
inactive  ||| S:22575 E:22594 ||| JJ
intermediates  ||| S:22594 E:22608 ||| NNS
formed  ||| S:22608 E:22615 ||| VBN
during  ||| S:22615 E:22622 ||| IN
the  ||| S:22622 E:22626 ||| DT
normal  ||| S:22626 E:22633 ||| JJ
assembly  ||| S:22633 E:22642 ||| NN
of  ||| S:22642 E:22655 ||| IN
functional  ||| S:22655 E:22666 ||| JJ
SCF  ||| S:22666 E:22670 ||| NNP
Pop1p-Pop2pcomplexes ||| S:22670 E:22690 ||| NNP
.  ||| S:22690 E:22692 ||| .
To  ||| S:22692 E:22695 ||| TO
exclude  ||| S:22695 E:22703 ||| VB
this  ||| S:22703 E:22718 ||| DT
possibility ||| S:22718 E:22729 ||| NN
,  ||| S:22729 E:22731 ||| ,
we  ||| S:22731 E:22734 ||| PRP
asked  ||| S:22734 E:22740 ||| VBD
whether  ||| S:22740 E:22748 ||| IN
distinct  ||| S:22748 E:22757 ||| FW
SCF  ||| S:22757 E:22761 ||| FW
Pop1pand  ||| S:22761 E:22770 ||| FW
SCF  ||| S:22770 E:22784 ||| FW
Pop2pcomplexes  ||| S:22784 E:22799 ||| FW
bear  ||| S:22799 E:22804 ||| FW
ubiquitin  ||| S:22804 E:22814 ||| FW
ligase  ||| S:22814 E:22821 ||| FW
activity  ||| S:22821 E:22841 ||| NN
in  ||| S:22841 E:22844 ||| IN
vitro  ||| S:22844 E:22850 ||| NN
.  ||| S:22850 E:22852 ||| .
To  ||| S:22852 E:22855 ||| TO
this  ||| S:22855 E:22860 ||| DT
end ||| S:22860 E:22863 ||| NN
,  ||| S:22863 E:22865 ||| ,
we  ||| S:22865 E:22878 ||| PRP
performed  ||| S:22878 E:22899 ||| VBD
in  ||| S:22899 E:22902 ||| IN
vitro  ||| S:22902 E:22908 ||| JJ
ubiquitylation  ||| S:22908 E:22923 ||| JJ
assays ||| S:22923 E:22929 ||| NN
.  ||| S:22929 E:22941 ||| .
Since  ||| S:22941 E:22947 ||| IN
the  ||| S:22947 E:22951 ||| DT
substrates  ||| S:22951 E:22962 ||| NN
of  ||| S:22962 E:22965 ||| IN
putative  ||| S:22965 E:22974 ||| JJ
SCF  ||| S:22974 E:22978 ||| NNP
Pop1pand  ||| S:22978 E:22987 ||| NNP
SCF  ||| S:22987 E:23001 ||| NNP
Pop2pubiquitin  ||| S:23001 E:23016 ||| NNP
ligases  ||| S:23016 E:23024 ||| NNS
are  ||| S:23024 E:23028 ||| VBP
unknown ||| S:23028 E:23035 ||| JJ
,  ||| S:23035 E:23037 ||| ,
we  ||| S:23037 E:23040 ||| PRP
adopted  ||| S:23040 E:23048 ||| VBD
a  ||| S:23048 E:23060 ||| DT
substrate-independent  ||| S:23060 E:23082 ||| JJ
assay  ||| S:23082 E:23088 ||| NNS
originally  ||| S:23088 E:23099 ||| RB
described  ||| S:23099 E:23109 ||| VBN
by  ||| S:23109 E:23122 ||| IN
Lyapina  ||| S:23122 E:23141 ||| NNP
et  ||| S:23141 E:23144 ||| FW
al  ||| S:23144 E:23147 ||| FW
.  ||| S:23147 E:23149 ||| .
[  ||| S:23149 E:23151 ||| -LRB-
27  ||| S:23151 E:23154 ||| CD
]  ||| S:23154 E:23156 ||| -RRB-
.  ||| S:23156 E:23158 ||| .
For  ||| S:23158 E:23162 ||| IN
this  ||| S:23162 E:23177 ||| DT
experiment ||| S:23177 E:23187 ||| NN
,  ||| S:23187 E:23189 ||| ,
we  ||| S:23189 E:23192 ||| PRP
again  ||| S:23192 E:23198 ||| RB
used  ||| S:23198 E:23203 ||| VBN
the  ||| S:23203 E:23207 ||| DT
strains  ||| S:23207 E:23215 ||| JJ
harboring  ||| S:23215 E:23235 ||| NNS
genomically  ||| S:23235 E:23247 ||| VBP
integrated  ||| S:23247 E:23258 ||| VBN
Myc  ||| S:23258 E:23262 ||| NNP
epitope-tagged  ||| S:23262 E:23277 ||| NNP
Pop1p  ||| S:23277 E:23283 ||| NNP
or  ||| S:23283 E:23286 ||| CC
Pop2p  ||| S:23286 E:23302 ||| CD
in  ||| S:23302 E:23305 ||| IN
a  ||| S:23305 E:23307 ||| DT
background  ||| S:23307 E:23318 ||| NN
deficient  ||| S:23318 E:23328 ||| NN
in  ||| S:23328 E:23331 ||| IN
the  ||| S:23331 E:23335 ||| DT
respective  ||| S:23335 E:23356 ||| JJ
heterooligomerization  ||| S:23356 E:23378 ||| JJ
partner  ||| S:23378 E:23386 ||| NN
(  ||| S:23386 E:23399 ||| -LRB-
Δpop2  ||| S:23399 E:23405 ||| NNP
pop1-13myc  ||| S:23405 E:23416 ||| NNP
,  ||| S:23416 E:23429 ||| ,
Δpop1  ||| S:23429 E:23435 ||| CD
pop2-13myc  ||| S:23435 E:23446 ||| CD
strains ||| S:23446 E:23453 ||| NNS
) ||| S:23453 E:23454 ||| -RRB-
.  ||| S:23454 E:23456 ||| .
Pop1p  ||| S:23456 E:23472 ||| NNP
and  ||| S:23472 E:23476 ||| CC
Pop2p  ||| S:23476 E:23482 ||| CD
complexes  ||| S:23482 E:23492 ||| NNS
were  ||| S:23492 E:23497 ||| VBD
immunopurified  ||| S:23497 E:23512 ||| VBN
with  ||| S:23512 E:23517 ||| IN
Myc  ||| S:23517 E:23531 ||| NNP
antibodies  ||| S:23531 E:23542 ||| NNS
and  ||| S:23542 E:23546 ||| CC
employed  ||| S:23546 E:23555 ||| VBN
in  ||| S:23555 E:23569 ||| IN
in  ||| S:23569 E:23572 ||| IN
vitro  ||| S:23572 E:23578 ||| JJ
ubiquitylation  ||| S:23578 E:23593 ||| JJ
assays  ||| S:23593 E:23600 ||| NN
upon  ||| S:23600 E:23615 ||| IN
addition  ||| S:23615 E:23624 ||| NN
of  ||| S:23624 E:23627 ||| IN
E1 ||| S:23627 E:23629 ||| NNP
,  ||| S:23629 E:23631 ||| ,
UBC3 ||| S:23631 E:23635 ||| NNP
,  ||| S:23635 E:23637 ||| ,
ubiquitin ||| S:23637 E:23646 ||| NN
,  ||| S:23646 E:23648 ||| ,
and  ||| S:23648 E:23652 ||| CC
ATP ||| S:23652 E:23655 ||| NNP
.  ||| S:23655 E:23657 ||| .
High  ||| S:23657 E:23662 ||| JJ
molecular  ||| S:23662 E:23682 ||| JJ
weight  ||| S:23682 E:23689 ||| NN
products  ||| S:23689 E:23698 ||| NNS
generated  ||| S:23698 E:23708 ||| VBN
in  ||| S:23708 E:23711 ||| IN
the  ||| S:23711 E:23715 ||| DT
reaction  ||| S:23715 E:23724 ||| NN
were  ||| S:23724 E:23729 ||| VBD
detected  ||| S:23729 E:23748 ||| VBN
by  ||| S:23748 E:23751 ||| IN
immunoblotting  ||| S:23751 E:23766 ||| NN
with  ||| S:23766 E:23771 ||| IN
ubiquitin  ||| S:23771 E:23781 ||| JJ
antibodies ||| S:23781 E:23791 ||| NNS
.  ||| S:23791 E:23793 ||| .
As  ||| S:23793 E:23806 ||| IN
references ||| S:23806 E:23816 ||| NNS
,  ||| S:23816 E:23818 ||| ,
we  ||| S:23818 E:23821 ||| PRP
used  ||| S:23821 E:23826 ||| VBD
strains  ||| S:23826 E:23834 ||| NNS
expressing  ||| S:23834 E:23845 ||| VBG
Myc-tagged  ||| S:23845 E:23856 ||| JJ
Pop1p  ||| S:23856 E:23872 ||| NN
or  ||| S:23872 E:23875 ||| CC
Pop2p  ||| S:23875 E:23881 ||| CD
in  ||| S:23881 E:23884 ||| IN
a  ||| S:23884 E:23886 ||| DT
wild-type  ||| S:23886 E:23896 ||| JJ
background ||| S:23896 E:23906 ||| NN
.  ||| S:23906 E:23908 ||| .
The  ||| S:23908 E:23912 ||| DT
experiment  ||| S:23912 E:23933 ||| NN
demonstrated  ||| S:23933 E:23946 ||| VBN
that  ||| S:23946 E:23951 ||| IN
Pop1p  ||| S:23951 E:23957 ||| NNP
and  ||| S:23957 E:23961 ||| CC
Pop2p  ||| S:23961 E:23967 ||| CD
each  ||| S:23967 E:23972 ||| DT
associate  ||| S:23972 E:23982 ||| NN
with  ||| S:23982 E:23997 ||| IN
polyubiquitylation  ||| S:23997 E:24016 ||| JJ
activity  ||| S:24016 E:24025 ||| NN
even  ||| S:24025 E:24030 ||| RB
in  ||| S:24030 E:24033 ||| IN
the  ||| S:24033 E:24037 ||| DT
absence  ||| S:24037 E:24045 ||| NN
of  ||| S:24045 E:24048 ||| IN
their  ||| S:24048 E:24064 ||| PRP$
respective  ||| S:24064 E:24075 ||| JJ
heterooligomerizing  ||| S:24075 E:24095 ||| JJ
F-box  ||| S:24095 E:24101 ||| JJ
proteins  ||| S:24101 E:24110 ||| NNS
( ||| S:24110 E:24111 ||| -LRB-
Fig.  ||| S:24111 E:24116 ||| NNP
7C ||| S:24116 E:24118 ||| NNP
) ||| S:24118 E:24119 ||| -RRB-
.  ||| S:24119 E:24131 ||| .
Thus  ||| S:24131 E:24136 ||| RB
Pop1p  ||| S:24136 E:24142 ||| CD
and  ||| S:24142 E:24146 ||| CC
Pop2p  ||| S:24146 E:24152 ||| NNP
appear  ||| S:24152 E:24159 ||| VBP
to  ||| S:24159 E:24162 ||| TO
assemble  ||| S:24162 E:24171 ||| VB
into  ||| S:24171 E:24176 ||| IN
distinct  ||| S:24176 E:24185 ||| FW
SCF  ||| S:24185 E:24199 ||| FW
complexes  ||| S:24199 E:24209 ||| FW
bearing  ||| S:24209 E:24217 ||| FW
ubiquitin  ||| S:24217 E:24227 ||| FW
ligase  ||| S:24227 E:24234 ||| FW
activity  ||| S:24234 E:24254 ||| NN
in  ||| S:24254 E:24257 ||| IN
vitro  ||| S:24257 E:24263 ||| NN
.  ||| S:24263 E:24296 ||| .
Discussion  ||| S:24296 E:24326 ||| NNP
Molecular  ||| S:24326 E:24336 ||| NNP
architecture  ||| S:24336 E:24349 ||| NN
of  ||| S:24349 E:24352 ||| IN
SCF  ||| S:24352 E:24356 ||| NNP
Popcomplexes  ||| S:24356 E:24379 ||| NNP
The  ||| S:24379 E:24383 ||| DT
phenomenon  ||| S:24383 E:24394 ||| NN
of  ||| S:24394 E:24397 ||| IN
F-box  ||| S:24397 E:24403 ||| JJ
protein  ||| S:24403 E:24411 ||| NN
oligomerization  ||| S:24411 E:24427 ||| NN
is  ||| S:24427 E:24430 ||| VBZ
not  ||| S:24430 E:24444 ||| RB
unique  ||| S:24444 E:24451 ||| JJ
to  ||| S:24451 E:24454 ||| TO
SCF  ||| S:24454 E:24458 ||| NNP
Pop ||| S:24458 E:24461 ||| NNP
.  ||| S:24461 E:24463 ||| .
Although  ||| S:24463 E:24472 ||| IN
the  ||| S:24472 E:24476 ||| DT
crystal  ||| S:24476 E:24484 ||| NN
structure  ||| S:24484 E:24494 ||| NN
of  ||| S:24494 E:24497 ||| IN
the  ||| S:24497 E:24511 ||| DT
SKP1-SKP2  ||| S:24511 E:24521 ||| JJ
complex ||| S:24521 E:24528 ||| NN
,  ||| S:24528 E:24530 ||| ,
derived  ||| S:24530 E:24538 ||| VBN
from  ||| S:24538 E:24543 ||| IN
bacterially  ||| S:24543 E:24555 ||| NN
expressed  ||| S:24555 E:24575 ||| VBD
proteins ||| S:24575 E:24583 ||| NNS
,  ||| S:24583 E:24585 ||| ,
revealed  ||| S:24585 E:24594 ||| VBD
a  ||| S:24594 E:24596 ||| DT
single  ||| S:24596 E:24603 ||| JJ
SKP2  ||| S:24603 E:24608 ||| NN
monomer  ||| S:24608 E:24616 ||| VBZ
bound  ||| S:24616 E:24622 ||| VBN
to  ||| S:24622 E:24625 ||| TO
SKP1  ||| S:24625 E:24630 ||| CD
[  ||| S:24630 E:24642 ||| -LRB-
28  ||| S:24642 E:24645 ||| CD
]  ||| S:24645 E:24647 ||| -RRB-
,  ||| S:24647 E:24649 ||| ,
biochemical  ||| S:24649 E:24661 ||| JJ
studies  ||| S:24661 E:24669 ||| NNS
showed  ||| S:24669 E:24676 ||| VBD
that  ||| S:24676 E:24681 ||| IN
budding  ||| S:24681 E:24689 ||| VBG
yeast  ||| S:24689 E:24705 ||| NN
Cdc4p ||| S:24705 E:24710 ||| NN
,  ||| S:24710 E:24712 ||| ,
a  ||| S:24712 E:24714 ||| DT
close  ||| S:24714 E:24720 ||| JJ
homologue  ||| S:24720 E:24730 ||| NN
of  ||| S:24730 E:24733 ||| IN
Pop1p\Pop2p ||| S:24733 E:24744 ||| NNP
,  ||| S:24744 E:24746 ||| ,
forms  ||| S:24746 E:24762 ||| NNS
homooligomers  ||| S:24762 E:24776 ||| VBP
when  ||| S:24776 E:24781 ||| WRB
expressed  ||| S:24781 E:24791 ||| VBN
in  ||| S:24791 E:24794 ||| IN
insect  ||| S:24794 E:24801 ||| JJ
cells  ||| S:24801 E:24807 ||| NNS
( ||| S:24807 E:24808 ||| -LRB-
Correll  ||| S:24808 E:24816 ||| NNP
and  ||| S:24816 E:24830 ||| CC
Deshaies ||| S:24830 E:24838 ||| NNP
,  ||| S:24838 E:24840 ||| ,
personal  ||| S:24840 E:24849 ||| JJ
communication ||| S:24849 E:24862 ||| NN
) ||| S:24862 E:24863 ||| -RRB-
.  ||| S:24863 E:24865 ||| .
Similarly ||| S:24865 E:24874 ||| RB
,  ||| S:24874 E:24876 ||| ,
β-TRCP1  ||| S:24876 E:24884 ||| NNP
and  ||| S:24884 E:24898 ||| CC
2 ||| S:24898 E:24899 ||| CD
,  ||| S:24899 E:24901 ||| ,
which  ||| S:24901 E:24907 ||| WDT
target  ||| S:24907 E:24914 ||| VBP
IκBα  ||| S:24914 E:24919 ||| JJ
for  ||| S:24919 E:24923 ||| IN
degradation  ||| S:24923 E:24935 ||| NN
as  ||| S:24935 E:24938 ||| IN
homooligomers ||| S:24938 E:24951 ||| NN
,  ||| S:24951 E:24963 ||| ,
form  ||| S:24963 E:24968 ||| NN
heterooligomers  ||| S:24968 E:24984 ||| NN
that  ||| S:24984 E:24989 ||| IN
each  ||| S:24989 E:24994 ||| DT
bind  ||| S:24994 E:24999 ||| NN
SCF  ||| S:24999 E:25003 ||| NNP
core  ||| S:25003 E:25008 ||| NN
subunits ||| S:25008 E:25016 ||| NN
,  ||| S:25016 E:25028 ||| ,
although  ||| S:25028 E:25037 ||| IN
no  ||| S:25037 E:25040 ||| DT
biochemical  ||| S:25040 E:25052 ||| JJ
activity  ||| S:25052 E:25061 ||| NN
for  ||| S:25061 E:25065 ||| IN
this  ||| S:25065 E:25080 ||| DT
heterooligomeric  ||| S:25080 E:25097 ||| JJ
complex  ||| S:25097 E:25105 ||| NN
was  ||| S:25105 E:25109 ||| VBD
demonstrated  ||| S:25109 E:25122 ||| VBN
[  ||| S:25122 E:25124 ||| -LRB-
29  ||| S:25124 E:25127 ||| CD
]  ||| S:25127 E:25129 ||| -RRB-
.  ||| S:25129 E:25141 ||| .
Finally ||| S:25141 E:25148 ||| RB
,  ||| S:25148 E:25150 ||| ,
Pop1p  ||| S:25150 E:25156 ||| NNP
and  ||| S:25156 E:25160 ||| CC
Pop2p  ||| S:25160 E:25166 ||| CD
homooligomerize ||| S:25166 E:25181 ||| NN
,  ||| S:25181 E:25183 ||| ,
at  ||| S:25183 E:25186 ||| IN
least  ||| S:25186 E:25192 ||| JJS
when  ||| S:25192 E:25207 ||| WRB
overexpressed  ||| S:25207 E:25221 ||| NNS
[  ||| S:25221 E:25223 ||| -LRB-
18  ||| S:25223 E:25226 ||| CD
]  ||| S:25226 E:25228 ||| -RRB-
,  ||| S:25228 E:25230 ||| ,
indicating  ||| S:25230 E:25241 ||| VBG
that  ||| S:25241 E:25246 ||| IN
both  ||| S:25246 E:25251 ||| DT
F-box  ||| S:25251 E:25267 ||| JJ
proteins  ||| S:25267 E:25276 ||| NNS
may  ||| S:25276 E:25280 ||| MD
also  ||| S:25280 E:25285 ||| RB
be  ||| S:25285 E:25288 ||| VB
present  ||| S:25288 E:25296 ||| JJ
as  ||| S:25296 E:25299 ||| IN
homooligomers  ||| S:25299 E:25313 ||| NN
in  ||| S:25313 E:25326 ||| IN
individual  ||| S:25326 E:25337 ||| JJ
SCF  ||| S:25337 E:25341 ||| NNP
Pop1pand  ||| S:25341 E:25350 ||| NNP
SCF  ||| S:25350 E:25354 ||| NNP
Pop2p ||| S:25354 E:25359 ||| NNP
,  ||| S:25359 E:25361 ||| ,
respectively ||| S:25361 E:25373 ||| RB
.  ||| S:25373 E:25385 ||| .
A  ||| S:25385 E:25387 ||| DT
surprising  ||| S:25387 E:25398 ||| JJ
finding  ||| S:25398 E:25406 ||| NN
of  ||| S:25406 E:25409 ||| IN
this  ||| S:25409 E:25414 ||| DT
study  ||| S:25414 E:25420 ||| NN
was  ||| S:25420 E:25424 ||| VBD
that  ||| S:25424 E:25429 ||| IN
the  ||| S:25429 E:25433 ||| DT
F-box  ||| S:25433 E:25449 ||| JJ
of  ||| S:25449 E:25452 ||| IN
Pop2p  ||| S:25452 E:25458 ||| NNP
is  ||| S:25458 E:25461 ||| VBZ
dispensable  ||| S:25461 E:25473 ||| VBN
for  ||| S:25473 E:25477 ||| IN
Rum1p  ||| S:25477 E:25483 ||| CD
degradation  ||| S:25483 E:25495 ||| NNS
and  ||| S:25495 E:25499 ||| CC
ploidy  ||| S:25499 E:25516 ||| JJ
control ||| S:25516 E:25523 ||| NN
,  ||| S:25523 E:25525 ||| ,
while  ||| S:25525 E:25531 ||| IN
the  ||| S:25531 E:25535 ||| DT
F-box  ||| S:25535 E:25541 ||| JJ
of  ||| S:25541 E:25544 ||| IN
Pop1p  ||| S:25544 E:25550 ||| NNP
is  ||| S:25550 E:25553 ||| VBZ
essential  ||| S:25553 E:25563 ||| JJ
for  ||| S:25563 E:25567 ||| IN
both  ||| S:25567 E:25582 ||| DT
functions  ||| S:25582 E:25592 ||| NNS
( ||| S:25592 E:25593 ||| -LRB-
Fig.  ||| S:25593 E:25598 ||| CD
4Dand  ||| S:25598 E:25604 ||| CD
5 ||| S:25604 E:25605 ||| CD
) ||| S:25605 E:25606 ||| -RRB-
.  ||| S:25606 E:25608 ||| .
The  ||| S:25608 E:25612 ||| DT
Pop2p  ||| S:25612 E:25618 ||| NNP
F-box  ||| S:25618 E:25624 ||| NNP
is  ||| S:25624 E:25627 ||| VBZ
unlikely  ||| S:25627 E:25636 ||| JJ
to  ||| S:25636 E:25649 ||| TO
be  ||| S:25649 E:25652 ||| VB
a  ||| S:25652 E:25654 ||| DT
degenerate ||| S:25654 E:25664 ||| NN
,  ||| S:25664 E:25666 ||| ,
non-functional ||| S:25666 E:25680 ||| NNP
,  ||| S:25680 E:25682 ||| ,
and  ||| S:25682 E:25686 ||| CC
hence  ||| S:25686 E:25692 ||| RB
dispensable ||| S:25692 E:25703 ||| JJ
,  ||| S:25703 E:25715 ||| ,
motif ||| S:25715 E:25720 ||| NN
,  ||| S:25720 E:25722 ||| ,
as  ||| S:25722 E:25725 ||| IN
it  ||| S:25725 E:25728 ||| PRP
carries  ||| S:25728 E:25736 ||| VBZ
all  ||| S:25736 E:25740 ||| DT
signature  ||| S:25740 E:25750 ||| NN
residues  ||| S:25750 E:25759 ||| NNS
of  ||| S:25759 E:25762 ||| IN
the  ||| S:25762 E:25766 ||| DT
F-box  ||| S:25766 E:25782 ||| JJ
( ||| S:25782 E:25783 ||| -LRB-
Fig.  ||| S:25783 E:25788 ||| NNP
4A ||| S:25788 E:25790 ||| NNP
) ||| S:25790 E:25791 ||| -RRB-
.  ||| S:25791 E:25793 ||| .
In  ||| S:25793 E:25796 ||| IN
addition ||| S:25796 E:25804 ||| NN
,  ||| S:25804 E:25806 ||| ,
Pop2p ||| S:25806 E:25811 ||| NNP
,  ||| S:25811 E:25813 ||| ,
in  ||| S:25813 E:25816 ||| IN
the  ||| S:25816 E:25820 ||| DT
absence  ||| S:25820 E:25828 ||| NN
of  ||| S:25828 E:25831 ||| IN
Pop1p ||| S:25831 E:25836 ||| NNP
,  ||| S:25836 E:25848 ||| ,
assembles  ||| S:25848 E:25858 ||| VBG
into  ||| S:25858 E:25863 ||| IN
a  ||| S:25863 E:25865 ||| DT
complex  ||| S:25865 E:25873 ||| JJ
containing  ||| S:25873 E:25884 ||| VBG
all  ||| S:25884 E:25888 ||| DT
SCF  ||| S:25888 E:25892 ||| NNP
core  ||| S:25892 E:25897 ||| NN
subunits  ||| S:25897 E:25916 ||| VBZ
identified  ||| S:25916 E:25927 ||| VBN
here  ||| S:25927 E:25932 ||| RB
( ||| S:25932 E:25933 ||| -LRB-
Fig.  ||| S:25933 E:25938 ||| NNP
7A ||| S:25938 E:25940 ||| NNP
) ||| S:25940 E:25941 ||| -RRB-
.  ||| S:25941 E:25943 ||| .
At  ||| S:25943 E:25946 ||| IN
present ||| S:25946 E:25953 ||| JJ
,  ||| S:25953 E:25955 ||| ,
we  ||| S:25955 E:25958 ||| PRP
cannot  ||| S:25958 E:25965 ||| RB
exclude  ||| S:25965 E:25983 ||| VB
that  ||| S:25983 E:25988 ||| DT
residues  ||| S:25988 E:25997 ||| NN
outside  ||| S:25997 E:26005 ||| IN
the  ||| S:26005 E:26009 ||| DT
F-box  ||| S:26009 E:26015 ||| JJ
mediate  ||| S:26015 E:26023 ||| JJ
binding  ||| S:26023 E:26031 ||| NN
of  ||| S:26031 E:26034 ||| IN
F-box  ||| S:26034 E:26050 ||| JJ
deleted  ||| S:26050 E:26058 ||| JJ
Pop2p  ||| S:26058 E:26064 ||| NN
to  ||| S:26064 E:26067 ||| TO
Psh1p  ||| S:26067 E:26073 ||| CD
and  ||| S:26073 E:26077 ||| CC
other  ||| S:26077 E:26083 ||| JJ
core  ||| S:26083 E:26088 ||| NN
subunits ||| S:26088 E:26096 ||| NN
.  ||| S:26096 E:26108 ||| .
Consistent  ||| S:26108 E:26119 ||| JJ
with  ||| S:26119 E:26124 ||| IN
this  ||| S:26124 E:26129 ||| DT
idea ||| S:26129 E:26133 ||| NN
,  ||| S:26133 E:26135 ||| ,
biochemical  ||| S:26135 E:26147 ||| JJ
studies  ||| S:26147 E:26155 ||| NNS
based  ||| S:26155 E:26161 ||| VBN
on  ||| S:26161 E:26174 ||| IN
the  ||| S:26174 E:26178 ||| DT
crystal  ||| S:26178 E:26186 ||| NN
structure  ||| S:26186 E:26196 ||| NN
of  ||| S:26196 E:26199 ||| IN
the  ||| S:26199 E:26203 ||| DT
human  ||| S:26203 E:26209 ||| JJ
SKP1-SKP2  ||| S:26209 E:26219 ||| CD
complex  ||| S:26219 E:26237 ||| JJ
revealed  ||| S:26237 E:26246 ||| JJ
cooperation  ||| S:26246 E:26258 ||| NN
of  ||| S:26258 E:26261 ||| IN
the  ||| S:26261 E:26265 ||| DT
SKP2  ||| S:26265 E:26270 ||| JJ
F-box  ||| S:26270 E:26276 ||| NN
with  ||| S:26276 E:26281 ||| IN
an  ||| S:26281 E:26284 ||| DT
adjacent  ||| S:26284 E:26303 ||| JJ
region  ||| S:26303 E:26310 ||| NN
in  ||| S:26310 E:26313 ||| IN
binding  ||| S:26313 E:26321 ||| VBG
of  ||| S:26321 E:26324 ||| IN
SKP1  ||| S:26324 E:26329 ||| NNP
[  ||| S:26329 E:26331 ||| -LRB-
28  ||| S:26331 E:26334 ||| CD
]  ||| S:26334 E:26336 ||| -RRB-
.  ||| S:26336 E:26338 ||| .
Consistent  ||| S:26338 E:26349 ||| JJ
with  ||| S:26349 E:26354 ||| IN
this  ||| S:26354 E:26369 ||| DT
finding ||| S:26369 E:26376 ||| NN
,  ||| S:26376 E:26378 ||| ,
certain  ||| S:26378 E:26386 ||| JJ
truncation  ||| S:26386 E:26397 ||| JJ
mutants  ||| S:26397 E:26405 ||| NN
of  ||| S:26405 E:26408 ||| IN
the  ||| S:26408 E:26412 ||| DT
budding  ||| S:26412 E:26420 ||| JJ
yeast  ||| S:26420 E:26436 ||| NN
F-box  ||| S:26436 E:26442 ||| JJ
proteins  ||| S:26442 E:26451 ||| NNS
Grr1p  ||| S:26451 E:26457 ||| NNP
and  ||| S:26457 E:26461 ||| CC
Cdc4p  ||| S:26461 E:26467 ||| NNP
interact  ||| S:26467 E:26476 ||| VBD
poorly  ||| S:26476 E:26483 ||| RB
with  ||| S:26483 E:26498 ||| IN
Skp1p ||| S:26498 E:26503 ||| NNP
,  ||| S:26503 E:26505 ||| ,
despite  ||| S:26505 E:26513 ||| IN
the  ||| S:26513 E:26517 ||| DT
retainment  ||| S:26517 E:26528 ||| NN
of  ||| S:26528 E:26531 ||| IN
their  ||| S:26531 E:26537 ||| PRP$
F-boxes  ||| S:26537 E:26545 ||| JJ
[  ||| S:26545 E:26547 ||| -LRB-
30  ||| S:26547 E:26550 ||| CD
31  ||| S:26550 E:26553 ||| CD
]  ||| S:26553 E:26565 ||| -RRB-
.  ||| S:26565 E:26567 ||| .
On  ||| S:26567 E:26570 ||| IN
the  ||| S:26570 E:26574 ||| DT
other  ||| S:26574 E:26580 ||| JJ
hand ||| S:26580 E:26584 ||| NN
,  ||| S:26584 E:26586 ||| ,
the  ||| S:26586 E:26590 ||| DT
F-box  ||| S:26590 E:26596 ||| JJ
of  ||| S:26596 E:26599 ||| IN
Pop1p  ||| S:26599 E:26605 ||| NNP
is  ||| S:26605 E:26608 ||| VBZ
essential  ||| S:26608 E:26618 ||| JJ
for  ||| S:26618 E:26632 ||| IN
Rum1p  ||| S:26632 E:26638 ||| CD
degradation  ||| S:26638 E:26650 ||| NNS
( ||| S:26650 E:26651 ||| -LRB-
Fig.  ||| S:26651 E:26656 ||| CD
5 ||| S:26656 E:26657 ||| CD
) ||| S:26657 E:26658 ||| -RRB-
,  ||| S:26658 E:26660 ||| ,
arguing  ||| S:26660 E:26668 ||| VBG
that  ||| S:26668 E:26673 ||| DT
residues  ||| S:26673 E:26682 ||| NN
outside  ||| S:26682 E:26700 ||| IN
the  ||| S:26700 E:26704 ||| DT
F-box  ||| S:26704 E:26710 ||| NNS
are  ||| S:26710 E:26714 ||| VBP
insufficient  ||| S:26714 E:26727 ||| JJ
to  ||| S:26727 E:26730 ||| TO
mediate  ||| S:26730 E:26738 ||| VB
recruitment  ||| S:26738 E:26750 ||| VBN
of  ||| S:26750 E:26753 ||| IN
Pop  ||| S:26753 E:26767 ||| NNP
proteins  ||| S:26767 E:26776 ||| NNS
into  ||| S:26776 E:26781 ||| IN
SCF  ||| S:26781 E:26785 ||| NNP
complexes ||| S:26785 E:26794 ||| NNS
.  ||| S:26794 E:26806 ||| .
Based  ||| S:26806 E:26812 ||| VBN
on  ||| S:26812 E:26815 ||| IN
the  ||| S:26815 E:26819 ||| DT
non-essential  ||| S:26819 E:26833 ||| JJ
function  ||| S:26833 E:26842 ||| NN
of  ||| S:26842 E:26845 ||| IN
the  ||| S:26845 E:26849 ||| DT
Pop2p  ||| S:26849 E:26865 ||| NNP
F-box ||| S:26865 E:26870 ||| NNP
,  ||| S:26870 E:26872 ||| ,
we  ||| S:26872 E:26875 ||| PRP
propose  ||| S:26875 E:26883 ||| VBP
a  ||| S:26883 E:26885 ||| DT
molecular  ||| S:26885 E:26895 ||| JJ
architecture  ||| S:26895 E:26908 ||| NN
of  ||| S:26908 E:26911 ||| IN
SCF  ||| S:26911 E:26925 ||| NNP
Pop1p-Pop2p ||| S:26925 E:26936 ||| NNP
,  ||| S:26936 E:26938 ||| ,
in  ||| S:26938 E:26941 ||| IN
which  ||| S:26941 E:26947 ||| WDT
Pop2p  ||| S:26947 E:26953 ||| NNP
is  ||| S:26953 E:26956 ||| VBZ
tethered  ||| S:26956 E:26965 ||| VBN
to  ||| S:26965 E:26968 ||| TO
the  ||| S:26968 E:26972 ||| DT
core  ||| S:26972 E:26987 ||| NN
subunits  ||| S:26987 E:26996 ||| NN
through  ||| S:26996 E:27004 ||| IN
interaction  ||| S:27004 E:27016 ||| NN
with  ||| S:27016 E:27021 ||| IN
Pop1p ||| S:27021 E:27026 ||| CD
.  ||| S:27026 E:27028 ||| .
Although  ||| S:27028 E:27037 ||| IN
we  ||| S:27037 E:27040 ||| PRP
have  ||| S:27040 E:27055 ||| VBP
no  ||| S:27055 E:27058 ||| DT
direct  ||| S:27058 E:27065 ||| JJ
biochemical  ||| S:27065 E:27077 ||| JJ
evidence  ||| S:27077 E:27086 ||| NN
to  ||| S:27086 E:27089 ||| TO
confirm  ||| S:27089 E:27097 ||| VB
this  ||| S:27097 E:27112 ||| DT
proposition ||| S:27112 E:27123 ||| NN
,  ||| S:27123 E:27125 ||| ,
which  ||| S:27125 E:27131 ||| WDT
would  ||| S:27131 E:27137 ||| MD
require  ||| S:27137 E:27145 ||| VB
Pop2p  ||| S:27145 E:27151 ||| CD
point  ||| S:27151 E:27157 ||| NN
mutants  ||| S:27157 E:27175 ||| NN
deficient  ||| S:27175 E:27185 ||| NN
in  ||| S:27185 E:27188 ||| IN
Pop1p  ||| S:27188 E:27194 ||| CD
binding ||| S:27194 E:27201 ||| NN
,  ||| S:27201 E:27203 ||| ,
our  ||| S:27203 E:27207 ||| PRP$
data  ||| S:27207 E:27212 ||| NNS
show  ||| S:27212 E:27217 ||| VBP
that  ||| S:27217 E:27222 ||| IN
severely  ||| S:27222 E:27241 ||| RB
truncated  ||| S:27241 E:27251 ||| JJ
N-terminal  ||| S:27251 E:27262 ||| JJ
fragments  ||| S:27262 E:27272 ||| NNS
of  ||| S:27272 E:27275 ||| IN
Pop1p  ||| S:27275 E:27281 ||| NNP
and  ||| S:27281 E:27285 ||| CC
Pop2p  ||| S:27285 E:27291 ||| RB
lacking  ||| S:27291 E:27309 ||| VBG
both  ||| S:27309 E:27314 ||| DT
F-boxes  ||| S:27314 E:27322 ||| JJ
and  ||| S:27322 E:27326 ||| CC
WD  ||| S:27326 E:27329 ||| NNP
repeat  ||| S:27329 E:27336 ||| NN
domains  ||| S:27336 E:27344 ||| NNS
are  ||| S:27344 E:27348 ||| VBP
sufficient  ||| S:27348 E:27359 ||| JJ
to  ||| S:27359 E:27372 ||| TO
mediate  ||| S:27372 E:27380 ||| VB
their  ||| S:27380 E:27386 ||| PRP$
interaction  ||| S:27386 E:27398 ||| NNS
( ||| S:27398 E:27399 ||| -LRB-
Fig.  ||| S:27399 E:27404 ||| NNP
6B ||| S:27404 E:27406 ||| NNP
) ||| S:27406 E:27407 ||| -RRB-
.  ||| S:27407 E:27409 ||| .
Similarly ||| S:27409 E:27418 ||| RB
,  ||| S:27418 E:27430 ||| ,
dimerization  ||| S:27430 E:27443 ||| VBG
of  ||| S:27443 E:27446 ||| IN
β-TRCP  ||| S:27446 E:27453 ||| JJ
proteins  ||| S:27453 E:27462 ||| NNS
is  ||| S:27462 E:27465 ||| VBZ
mediated  ||| S:27465 E:27474 ||| VBN
by  ||| S:27474 E:27477 ||| IN
N-terminal  ||| S:27477 E:27498 ||| JJ
"D-domains ||| S:27498 E:27508 ||| NN
"  ||| S:27508 E:27510 ||| ''
lacking  ||| S:27510 E:27518 ||| VBG
binding  ||| S:27518 E:27526 ||| NN
of  ||| S:27526 E:27529 ||| IN
SKP1  ||| S:27529 E:27534 ||| NNP
and  ||| S:27534 E:27538 ||| CC
other  ||| S:27538 E:27544 ||| JJ
SCF  ||| S:27544 E:27548 ||| NNP
core  ||| S:27548 E:27563 ||| NN
subunits  ||| S:27563 E:27572 ||| NNS
[  ||| S:27572 E:27574 ||| -LRB-
29  ||| S:27574 E:27577 ||| CD
]  ||| S:27577 E:27579 ||| -RRB-
.  ||| S:27579 E:27581 ||| .
According  ||| S:27581 E:27591 ||| VBG
to  ||| S:27591 E:27594 ||| TO
our  ||| S:27594 E:27598 ||| PRP$
model ||| S:27598 E:27603 ||| NN
,  ||| S:27603 E:27605 ||| ,
the  ||| S:27605 E:27609 ||| DT
F-box  ||| S:27609 E:27615 ||| JJ
of  ||| S:27615 E:27628 ||| IN
Pop2p  ||| S:27628 E:27634 ||| NNP
would  ||| S:27634 E:27640 ||| MD
be  ||| S:27640 E:27643 ||| VB
essential  ||| S:27643 E:27653 ||| JJ
only  ||| S:27653 E:27658 ||| JJ
for  ||| S:27658 E:27662 ||| IN
the  ||| S:27662 E:27666 ||| DT
Pop1p-independent  ||| S:27666 E:27694 ||| CD
activities  ||| S:27694 E:27705 ||| NNS
of  ||| S:27705 E:27708 ||| IN
Pop2p ||| S:27708 E:27713 ||| NNP
,  ||| S:27713 E:27715 ||| ,
for  ||| S:27715 E:27719 ||| IN
which  ||| S:27719 E:27725 ||| WDT
we  ||| S:27725 E:27728 ||| PRP
provide  ||| S:27728 E:27736 ||| VBP
tentative  ||| S:27736 E:27756 ||| JJ
evidence  ||| S:27756 E:27765 ||| NN
by  ||| S:27765 E:27768 ||| IN
demonstrating  ||| S:27768 E:27782 ||| VBG
the  ||| S:27782 E:27797 ||| DT
in  ||| S:27797 E:27800 ||| IN
vivo  ||| S:27800 E:27805 ||| JJ
assembly  ||| S:27805 E:27814 ||| NN
of  ||| S:27814 E:27817 ||| IN
SCF  ||| S:27817 E:27831 ||| NNP
Pop2pcomplexes  ||| S:27831 E:27846 ||| NNP
( ||| S:27846 E:27847 ||| -LRB-
Fig.  ||| S:27847 E:27852 ||| NNP
7A ||| S:27852 E:27854 ||| NNP
) ||| S:27854 E:27855 ||| -RRB-
.  ||| S:27855 E:27857 ||| .
These  ||| S:27857 E:27863 ||| DT
complexes  ||| S:27863 E:27873 ||| NNS
bear  ||| S:27873 E:27878 ||| VBP
ubiquitin  ||| S:27878 E:27898 ||| JJ
ligase  ||| S:27898 E:27905 ||| JJ
activity  ||| S:27905 E:27914 ||| NN
in  ||| S:27914 E:27917 ||| IN
a  ||| S:27917 E:27919 ||| DT
substrate-independent  ||| S:27919 E:27952 ||| JJ
in  ||| S:27952 E:27955 ||| IN
vitro  ||| S:27955 E:27961 ||| JJ
assay  ||| S:27961 E:27967 ||| NNS
( ||| S:27967 E:27968 ||| -LRB-
Fig.  ||| S:27968 E:27973 ||| NNP
7C ||| S:27973 E:27975 ||| NNP
) ||| S:27975 E:27976 ||| -RRB-
.  ||| S:27976 E:27978 ||| .
To  ||| S:27978 E:27981 ||| TO
what  ||| S:27981 E:27996 ||| WP
extent  ||| S:27996 E:28003 ||| VBD
this  ||| S:28003 E:28008 ||| DT
assay  ||| S:28008 E:28014 ||| NN
reflects  ||| S:28014 E:28023 ||| VBZ
the  ||| S:28023 E:28038 ||| DT
in  ||| S:28038 E:28041 ||| IN
vivo  ||| S:28041 E:28046 ||| JJ
activity  ||| S:28046 E:28055 ||| NN
of  ||| S:28055 E:28058 ||| IN
SCF  ||| S:28058 E:28062 ||| NNP
Pop2pwill  ||| S:28062 E:28082 ||| VBZ
become  ||| S:28082 E:28089 ||| VBN
testable ||| S:28089 E:28097 ||| NN
,  ||| S:28097 E:28099 ||| ,
once  ||| S:28099 E:28104 ||| RB
the  ||| S:28104 E:28108 ||| DT
putative  ||| S:28108 E:28117 ||| JJ
substrates  ||| S:28117 E:28128 ||| NN
of  ||| S:28128 E:28131 ||| IN
SCF  ||| S:28131 E:28145 ||| NNP
Pop2pare  ||| S:28145 E:28154 ||| NNP
identified ||| S:28154 E:28164 ||| VBD
.  ||| S:28164 E:28194 ||| .
Subcellular  ||| S:28194 E:28206 ||| JJ
compartmentalization  ||| S:28206 E:28227 ||| NN
of  ||| S:28227 E:28230 ||| IN
SCF  ||| S:28230 E:28234 ||| NNP
Popas  ||| S:28234 E:28240 ||| NNP
a  ||| S:28240 E:28252 ||| DT
potential  ||| S:28252 E:28262 ||| JJ
mechanism  ||| S:28262 E:28272 ||| NN
for  ||| S:28272 E:28276 ||| IN
substrate  ||| S:28276 E:28286 ||| JJ
selection  ||| S:28286 E:28306 ||| NN
Another  ||| S:28306 E:28314 ||| DT
surprising  ||| S:28314 E:28325 ||| JJ
observation  ||| S:28325 E:28337 ||| NN
of  ||| S:28337 E:28340 ||| IN
this  ||| S:28340 E:28345 ||| DT
study  ||| S:28345 E:28351 ||| NN
was  ||| S:28351 E:28355 ||| VBD
that  ||| S:28355 E:28370 ||| IN
Pop1p  ||| S:28370 E:28376 ||| NNP
is  ||| S:28376 E:28379 ||| VBZ
primarily  ||| S:28379 E:28389 ||| RB
localized  ||| S:28389 E:28399 ||| VBN
to  ||| S:28399 E:28402 ||| TO
the  ||| S:28402 E:28406 ||| DT
nucleus ||| S:28406 E:28413 ||| NN
,  ||| S:28413 E:28415 ||| ,
whereas  ||| S:28415 E:28433 ||| IN
Pop2p  ||| S:28433 E:28439 ||| NNP
is  ||| S:28439 E:28442 ||| VBZ
present  ||| S:28442 E:28450 ||| JJ
in  ||| S:28450 E:28453 ||| IN
both  ||| S:28453 E:28458 ||| PDT
the  ||| S:28458 E:28462 ||| DT
cytoplasm  ||| S:28462 E:28472 ||| NN
and  ||| S:28472 E:28476 ||| CC
the  ||| S:28476 E:28480 ||| DT
nucleus  ||| S:28480 E:28498 ||| NN
( ||| S:28498 E:28499 ||| -LRB-
Fig.  ||| S:28499 E:28504 ||| CD
3 ||| S:28504 E:28505 ||| CD
) ||| S:28505 E:28506 ||| -RRB-
.  ||| S:28506 E:28508 ||| .
While ||| S:28508 E:28513 ||| IN
,  ||| S:28513 E:28515 ||| ,
nuclear  ||| S:28515 E:28523 ||| JJ
localization  ||| S:28523 E:28536 ||| NN
was  ||| S:28536 E:28540 ||| VBD
expected ||| S:28540 E:28548 ||| VBN
,  ||| S:28548 E:28550 ||| ,
since  ||| S:28550 E:28566 ||| IN
both  ||| S:28566 E:28571 ||| DT
known  ||| S:28571 E:28577 ||| JJ
substrates  ||| S:28577 E:28588 ||| NN
of  ||| S:28588 E:28591 ||| IN
SCF  ||| S:28591 E:28595 ||| NNP
Pop1p-Pop2p ||| S:28595 E:28606 ||| NNP
,  ||| S:28606 E:28608 ||| ,
Cdc18p  ||| S:28608 E:28615 ||| NNP
and  ||| S:28615 E:28629 ||| CC
Rum1p ||| S:28629 E:28634 ||| NNP
,  ||| S:28634 E:28636 ||| ,
are  ||| S:28636 E:28640 ||| VBP
primarily  ||| S:28640 E:28650 ||| RB
nuclear  ||| S:28650 E:28658 ||| JJ
proteins ||| S:28658 E:28666 ||| NNS
,  ||| S:28666 E:28668 ||| ,
the  ||| S:28668 E:28672 ||| DT
cytoplasmic  ||| S:28672 E:28694 ||| JJ
localization  ||| S:28694 E:28707 ||| NN
of  ||| S:28707 E:28710 ||| IN
Pop2p  ||| S:28710 E:28716 ||| NNP
suggests  ||| S:28716 E:28725 ||| VBZ
an  ||| S:28725 E:28728 ||| DT
activity  ||| S:28728 E:28737 ||| NN
of  ||| S:28737 E:28740 ||| IN
SCF  ||| S:28740 E:28754 ||| NNP
Pop2pdirected  ||| S:28754 E:28768 ||| NNP
toward  ||| S:28768 E:28775 ||| IN
unknown  ||| S:28775 E:28783 ||| JJ
cytoplasmic  ||| S:28783 E:28795 ||| JJ
substrates ||| S:28795 E:28805 ||| NN
.  ||| S:28805 E:28807 ||| .
In  ||| S:28807 E:28820 ||| IN
support  ||| S:28820 E:28828 ||| NN
of  ||| S:28828 E:28831 ||| IN
this  ||| S:28831 E:28836 ||| DT
notion ||| S:28836 E:28842 ||| NN
,  ||| S:28842 E:28844 ||| ,
as  ||| S:28844 E:28847 ||| RB
with  ||| S:28847 E:28852 ||| IN
human  ||| S:28852 E:28858 ||| JJ
SCF  ||| S:28858 E:28862 ||| NN
subunits  ||| S:28862 E:28871 ||| NNS
[  ||| S:28871 E:28873 ||| -LRB-
32  ||| S:28873 E:28876 ||| CD
]  ||| S:28876 E:28888 ||| -RRB-
,  ||| S:28888 E:28890 ||| ,
fission  ||| S:28890 E:28898 ||| JJ
yeast  ||| S:28898 E:28904 ||| NN
SCF  ||| S:28904 E:28908 ||| NNP
core  ||| S:28908 E:28913 ||| NN
subunits  ||| S:28913 E:28922 ||| NNS
are  ||| S:28922 E:28926 ||| VBP
also  ||| S:28926 E:28931 ||| RB
present  ||| S:28931 E:28939 ||| VB
in  ||| S:28939 E:28942 ||| IN
the  ||| S:28942 E:28956 ||| DT
cytoplasm ||| S:28956 E:28965 ||| NN
,  ||| S:28965 E:28967 ||| ,
as  ||| S:28967 E:28970 ||| RB
shown  ||| S:28970 E:28976 ||| VBN
here  ||| S:28976 E:28981 ||| RB
for  ||| S:28981 E:28985 ||| IN
overexpressed  ||| S:28985 E:28999 ||| JJ
GFP-fusions  ||| S:28999 E:29021 ||| NN
( ||| S:29021 E:29022 ||| -LRB-
Fig.  ||| S:29022 E:29027 ||| NNP
3A ||| S:29027 E:29029 ||| NNP
) ||| S:29029 E:29030 ||| -RRB-
,  ||| S:29030 E:29032 ||| ,
and  ||| S:29032 E:29036 ||| CC
for  ||| S:29036 E:29040 ||| IN
endogenous  ||| S:29040 E:29051 ||| JJ
Pcu1p  ||| S:29051 E:29057 ||| NN
by  ||| S:29057 E:29060 ||| IN
immunostaining  ||| S:29060 E:29075 ||| NN
in  ||| S:29075 E:29088 ||| IN
a  ||| S:29088 E:29090 ||| DT
previous  ||| S:29090 E:29099 ||| JJ
report  ||| S:29099 E:29106 ||| NN
[  ||| S:29106 E:29108 ||| -LRB-
24  ||| S:29108 E:29111 ||| CD
]  ||| S:29111 E:29113 ||| -RRB-
.  ||| S:29113 E:29125 ||| .
By  ||| S:29125 E:29128 ||| IN
analogy ||| S:29128 E:29135 ||| NN
,  ||| S:29135 E:29137 ||| ,
additional  ||| S:29137 E:29148 ||| JJ
nuclear  ||| S:29148 E:29156 ||| JJ
substrates  ||| S:29156 E:29167 ||| NN
of  ||| S:29167 E:29170 ||| IN
SCF  ||| S:29170 E:29184 ||| NNP
Pop1pmay  ||| S:29184 E:29193 ||| NNP
exist ||| S:29193 E:29198 ||| VBP
.  ||| S:29198 E:29200 ||| .
For  ||| S:29200 E:29204 ||| IN
example ||| S:29204 E:29211 ||| NN
,  ||| S:29211 E:29213 ||| ,
Pop1p  ||| S:29213 E:29219 ||| NNP
is  ||| S:29219 E:29222 ||| VBZ
involved  ||| S:29222 E:29231 ||| VBN
in  ||| S:29231 E:29234 ||| IN
the  ||| S:29234 E:29248 ||| DT
control  ||| S:29248 E:29256 ||| NN
of  ||| S:29256 E:29259 ||| IN
the  ||| S:29259 E:29263 ||| DT
RNA  ||| S:29263 E:29267 ||| NNP
levels  ||| S:29267 E:29274 ||| NNS
of  ||| S:29274 E:29277 ||| IN
the  ||| S:29277 E:29281 ||| DT
cyclin  ||| S:29281 E:29288 ||| JJ
Cig2p  ||| S:29288 E:29294 ||| NNP
[  ||| S:29294 E:29296 ||| -LRB-
33  ||| S:29296 E:29299 ||| CD
]  ||| S:29299 E:29301 ||| -RRB-
.  ||| S:29301 E:29313 ||| .
While  ||| S:29313 E:29319 ||| IN
it  ||| S:29319 E:29322 ||| PRP
is  ||| S:29322 E:29325 ||| VBZ
unclear  ||| S:29325 E:29333 ||| JJ
whether  ||| S:29333 E:29341 ||| IN
this  ||| S:29341 E:29346 ||| DT
effect  ||| S:29346 E:29353 ||| NN
is  ||| S:29353 E:29356 ||| VBZ
mediated  ||| S:29356 E:29365 ||| VBN
at  ||| S:29365 E:29378 ||| IN
the  ||| S:29378 E:29382 ||| DT
level  ||| S:29382 E:29388 ||| NN
of  ||| S:29388 E:29391 ||| IN
transcription  ||| S:29391 E:29405 ||| NN
or  ||| S:29405 E:29408 ||| CC
mRNA  ||| S:29408 E:29413 ||| JJ
stability ||| S:29413 E:29422 ||| NN
,  ||| S:29422 E:29424 ||| ,
the  ||| S:29424 E:29428 ||| DT
budding  ||| S:29428 E:29446 ||| JJ
yeast  ||| S:29446 E:29452 ||| NN
F-box  ||| S:29452 E:29458 ||| JJ
protein  ||| S:29458 E:29466 ||| NN
Met30p  ||| S:29466 E:29473 ||| NN
was  ||| S:29473 E:29477 ||| VBD
recently  ||| S:29477 E:29486 ||| RB
shown  ||| S:29486 E:29492 ||| VBN
to  ||| S:29492 E:29495 ||| TO
regulate  ||| S:29495 E:29514 ||| VB
the  ||| S:29514 E:29518 ||| DT
ubiquitylation  ||| S:29518 E:29533 ||| NN
and  ||| S:29533 E:29537 ||| CC
activity ||| S:29537 E:29545 ||| NN
,  ||| S:29545 E:29547 ||| ,
but  ||| S:29547 E:29551 ||| CC
not  ||| S:29551 E:29555 ||| RB
degradation ||| S:29555 E:29566 ||| JJ
,  ||| S:29566 E:29568 ||| ,
of  ||| S:29568 E:29581 ||| IN
the  ||| S:29581 E:29585 ||| DT
transcription  ||| S:29585 E:29599 ||| JJ
factor  ||| S:29599 E:29606 ||| NN
Met4p  ||| S:29606 E:29612 ||| NNP
[  ||| S:29612 E:29614 ||| -LRB-
34  ||| S:29614 E:29617 ||| CD
]  ||| S:29617 E:29619 ||| -RRB-
.  ||| S:29619 E:29621 ||| .
In  ||| S:29621 E:29624 ||| IN
addition ||| S:29624 E:29632 ||| NN
,  ||| S:29632 E:29645 ||| ,
pop1  ||| S:29645 E:29650 ||| CD
mutants  ||| S:29650 E:29658 ||| NNS
display  ||| S:29658 E:29666 ||| VBP
an  ||| S:29666 E:29669 ||| DT
increased  ||| S:29669 E:29689 ||| JJ
rate  ||| S:29689 E:29694 ||| NN
of  ||| S:29694 E:29697 ||| IN
chromosome  ||| S:29697 E:29708 ||| NN
loss ||| S:29708 E:29712 ||| NN
,  ||| S:29712 E:29714 ||| ,
a  ||| S:29714 E:29716 ||| DT
phenotype  ||| S:29716 E:29726 ||| NN
that  ||| S:29726 E:29731 ||| WDT
is  ||| S:29731 E:29734 ||| VBZ
not  ||| S:29734 E:29738 ||| RB
easily  ||| S:29738 E:29755 ||| RB
explained  ||| S:29755 E:29765 ||| VBN
by  ||| S:29765 E:29768 ||| IN
accumulation  ||| S:29768 E:29781 ||| NN
of  ||| S:29781 E:29784 ||| IN
Rum1p  ||| S:29784 E:29790 ||| NNP
and  ||| S:29790 E:29794 ||| CC
Cdc18p  ||| S:29794 E:29801 ||| NNP
[  ||| S:29801 E:29803 ||| -LRB-
23  ||| S:29803 E:29806 ||| CD
]  ||| S:29806 E:29808 ||| -RRB-
.  ||| S:29808 E:29820 ||| .
Finally ||| S:29820 E:29827 ||| RB
,  ||| S:29827 E:29840 ||| ,
pop1  ||| S:29840 E:29845 ||| CD
mutants  ||| S:29845 E:29853 ||| NNS
are  ||| S:29853 E:29857 ||| VBP
sensitive  ||| S:29857 E:29867 ||| JJ
to  ||| S:29867 E:29870 ||| TO
UV  ||| S:29870 E:29883 ||| NNP
irradiation ||| S:29883 E:29894 ||| NN
,  ||| S:29894 E:29896 ||| ,
whereas  ||| S:29896 E:29915 ||| IN
pop2  ||| S:29915 E:29920 ||| CD
mutants  ||| S:29920 E:29928 ||| NNS
are  ||| S:29928 E:29932 ||| VBP
not  ||| S:29932 E:29936 ||| RB
( ||| S:29936 E:29937 ||| -LRB-
D ||| S:29937 E:29938 ||| NNP
.  ||| S:29938 E:29940 ||| .
Griffiths  ||| S:29940 E:29960 ||| NNP
and  ||| S:29960 E:29964 ||| CC
D.A.W. ||| S:29964 E:29970 ||| NNP
,  ||| S:29970 E:29972 ||| ,
unpublished  ||| S:29972 E:29984 ||| JJ
observation ||| S:29984 E:29995 ||| NN
) ||| S:29995 E:29996 ||| -RRB-
.  ||| S:29996 E:29998 ||| .
It  ||| S:29998 E:30001 ||| PRP
is  ||| S:30001 E:30004 ||| VBZ
therefore  ||| S:30004 E:30024 ||| RB
likely  ||| S:30024 E:30031 ||| JJ
that  ||| S:30031 E:30036 ||| IN
other  ||| S:30036 E:30042 ||| JJ
substrates  ||| S:30042 E:30053 ||| NN
of  ||| S:30053 E:30056 ||| IN
Pop1p  ||| S:30056 E:30062 ||| NNP
and  ||| S:30062 E:30066 ||| CC
Pop2p ||| S:30066 E:30071 ||| NNP
,  ||| S:30071 E:30073 ||| ,
in  ||| S:30073 E:30086 ||| IN
addition  ||| S:30086 E:30095 ||| NN
to  ||| S:30095 E:30098 ||| TO
their  ||| S:30098 E:30104 ||| PRP$
common  ||| S:30104 E:30111 ||| JJ
substrates  ||| S:30111 E:30122 ||| JJ
Cdc18p  ||| S:30122 E:30129 ||| NN
and  ||| S:30129 E:30133 ||| CC
Rum1p ||| S:30133 E:30138 ||| NNP
,  ||| S:30138 E:30140 ||| ,
do  ||| S:30140 E:30153 ||| VBP
exist ||| S:30153 E:30158 ||| VBN
.  ||| S:30158 E:30170 ||| .
The  ||| S:30170 E:30174 ||| DT
idea  ||| S:30174 E:30179 ||| NN
developed  ||| S:30179 E:30189 ||| VBN
above  ||| S:30189 E:30195 ||| IN
that  ||| S:30195 E:30200 ||| DT
F-box  ||| S:30200 E:30206 ||| JJ
protein  ||| S:30206 E:30224 ||| NN
compartmentalization  ||| S:30224 E:30245 ||| NN
contributes  ||| S:30245 E:30257 ||| VBZ
to  ||| S:30257 E:30260 ||| TO
substrate  ||| S:30260 E:30270 ||| VB
selection  ||| S:30270 E:30290 ||| NN
was  ||| S:30290 E:30294 ||| VBD
recently  ||| S:30294 E:30303 ||| RB
confirmed  ||| S:30303 E:30313 ||| VBD
directly  ||| S:30313 E:30322 ||| RB
for  ||| S:30322 E:30326 ||| IN
Cdc4p-mediated  ||| S:30326 E:30351 ||| CD
degradation  ||| S:30351 E:30363 ||| NN
of  ||| S:30363 E:30366 ||| IN
Far1p  ||| S:30366 E:30372 ||| CD
in  ||| S:30372 E:30375 ||| IN
budding  ||| S:30375 E:30383 ||| VBG
yeast  ||| S:30383 E:30389 ||| NN
[  ||| S:30389 E:30391 ||| -LRB-
35  ||| S:30391 E:30394 ||| CD
]  ||| S:30394 E:30396 ||| -RRB-
.  ||| S:30396 E:30398 ||| .
Both ||| S:30398 E:30402 ||| DT
,  ||| S:30402 E:30414 ||| ,
Cdc4p  ||| S:30414 E:30420 ||| NNP
and  ||| S:30420 E:30424 ||| CC
Far1p  ||| S:30424 E:30430 ||| NNP
are  ||| S:30430 E:30434 ||| VBP
nuclear  ||| S:30434 E:30442 ||| JJ
proteins  ||| S:30442 E:30451 ||| NNS
in  ||| S:30451 E:30454 ||| IN
vegetative  ||| S:30454 E:30465 ||| JJ
cells ||| S:30465 E:30470 ||| NNS
,  ||| S:30470 E:30482 ||| ,
owing  ||| S:30482 E:30488 ||| VBG
to  ||| S:30488 E:30491 ||| TO
the  ||| S:30491 E:30495 ||| DT
presence  ||| S:30495 E:30504 ||| NN
of  ||| S:30504 E:30507 ||| IN
nuclear  ||| S:30507 E:30515 ||| JJ
localization  ||| S:30515 E:30528 ||| JJ
signals  ||| S:30528 E:30546 ||| NNS
( ||| S:30546 E:30547 ||| -LRB-
NLS ||| S:30547 E:30550 ||| NNP
) ||| S:30550 E:30551 ||| -RRB-
.  ||| S:30551 E:30553 ||| .
Fusion  ||| S:30553 E:30560 ||| NN
of  ||| S:30560 E:30563 ||| IN
Cdc4p  ||| S:30563 E:30569 ||| CD
with  ||| S:30569 E:30574 ||| IN
a  ||| S:30574 E:30576 ||| DT
nuclear  ||| S:30576 E:30584 ||| JJ
export  ||| S:30584 E:30591 ||| NN
signal  ||| S:30591 E:30608 ||| NN
( ||| S:30608 E:30609 ||| -LRB-
NES-Cdc4p ||| S:30609 E:30618 ||| NNP
)  ||| S:30618 E:30620 ||| -RRB-
prevented  ||| S:30620 E:30630 ||| VBD
its  ||| S:30630 E:30634 ||| PRP$
nuclear  ||| S:30634 E:30642 ||| JJ
localization  ||| S:30642 E:30655 ||| NN
and  ||| S:30655 E:30659 ||| CC
its  ||| S:30659 E:30673 ||| PRP$
ability  ||| S:30673 E:30681 ||| NN
to  ||| S:30681 E:30684 ||| TO
direct  ||| S:30684 E:30691 ||| VB
the  ||| S:30691 E:30695 ||| DT
degradation  ||| S:30695 E:30707 ||| NN
of  ||| S:30707 E:30710 ||| IN
nuclear  ||| S:30710 E:30718 ||| JJ
Far1p ||| S:30718 E:30723 ||| NN
.  ||| S:30723 E:30725 ||| .
When  ||| S:30725 E:30740 ||| WRB
Far1p  ||| S:30740 E:30746 ||| NNP
also  ||| S:30746 E:30751 ||| RB
was  ||| S:30751 E:30755 ||| VBD
targeted  ||| S:30755 E:30764 ||| VBN
to  ||| S:30764 E:30767 ||| TO
the  ||| S:30767 E:30771 ||| DT
cytoplasm  ||| S:30771 E:30781 ||| NN
by  ||| S:30781 E:30784 ||| IN
disrupting  ||| S:30784 E:30805 ||| VBG
its  ||| S:30805 E:30809 ||| PRP$
NLS ||| S:30809 E:30812 ||| NNP
,  ||| S:30812 E:30814 ||| ,
NES-Cdc4p  ||| S:30814 E:30824 ||| CD
degraded  ||| S:30824 E:30833 ||| CD
ΔNLS-Far1p  ||| S:30833 E:30844 ||| CD
in  ||| S:30844 E:30847 ||| IN
the  ||| S:30847 E:30851 ||| DT
cytoplasm  ||| S:30851 E:30861 ||| NN
[  ||| S:30861 E:30873 ||| -LRB-
35  ||| S:30873 E:30876 ||| CD
]  ||| S:30876 E:30878 ||| -RRB-
.  ||| S:30878 E:30890 ||| .
A  ||| S:30890 E:30892 ||| DT
putative  ||| S:30892 E:30901 ||| JJ
NLS  ||| S:30901 E:30905 ||| NNP
is  ||| S:30905 E:30908 ||| VBZ
also  ||| S:30908 E:30913 ||| RB
present  ||| S:30913 E:30921 ||| VB
in  ||| S:30921 E:30924 ||| IN
the  ||| S:30924 E:30928 ||| DT
N-terminus  ||| S:30928 E:30939 ||| JJ
of  ||| S:30939 E:30952 ||| IN
Pop1p  ||| S:30952 E:30958 ||| CD
located  ||| S:30958 E:30966 ||| VBN
between  ||| S:30966 E:30974 ||| IN
the  ||| S:30974 E:30978 ||| DT
F-box  ||| S:30978 E:30984 ||| JJ
and  ||| S:30984 E:30988 ||| CC
the  ||| S:30988 E:30992 ||| DT
WD-repeat  ||| S:30992 E:31002 ||| JJ
domain  ||| S:31002 E:31019 ||| NN
(  ||| S:31019 E:31021 ||| -LRB-
393PEKIKRC ||| S:31021 E:31031 ||| NNP
) ||| S:31031 E:31032 ||| -RRB-
.  ||| S:31032 E:31034 ||| .
An  ||| S:31034 E:31037 ||| DT
N-terminal  ||| S:31037 E:31048 ||| JJ
Pop1p  ||| S:31048 E:31054 ||| CD
fragment  ||| S:31054 E:31063 ||| NN
containing  ||| S:31063 E:31084 ||| VBG
this  ||| S:31084 E:31089 ||| DT
motif ||| S:31089 E:31094 ||| NN
,  ||| S:31094 E:31096 ||| ,
when  ||| S:31096 E:31101 ||| WRB
fused  ||| S:31101 E:31107 ||| JJ
to  ||| S:31107 E:31110 ||| TO
the  ||| S:31110 E:31114 ||| DT
WD-repeat  ||| S:31114 E:31124 ||| JJ
region  ||| S:31124 E:31131 ||| NN
of  ||| S:31131 E:31134 ||| IN
Pop2p ||| S:31134 E:31139 ||| NNP
,  ||| S:31139 E:31151 ||| ,
is  ||| S:31151 E:31154 ||| VBZ
targeted  ||| S:31154 E:31163 ||| VBN
exclusively  ||| S:31163 E:31175 ||| RB
to  ||| S:31175 E:31178 ||| TO
the  ||| S:31178 E:31182 ||| DT
nucleus  ||| S:31182 E:31190 ||| NN
( ||| S:31190 E:31191 ||| -LRB-
R.L.  ||| S:31191 E:31196 ||| NNP
&  ||| S:31196 E:31208 ||| CC
D.A.W. ||| S:31208 E:31214 ||| NNP
,  ||| S:31214 E:31216 ||| ,
unpublished  ||| S:31216 E:31228 ||| JJ
observation ||| S:31228 E:31239 ||| NN
) ||| S:31239 E:31240 ||| -RRB-
.  ||| S:31240 E:31242 ||| .
Like  ||| S:31242 E:31247 ||| IN
wild-type  ||| S:31247 E:31257 ||| NNP
Pop2p ||| S:31257 E:31262 ||| NNP
,  ||| S:31262 E:31274 ||| ,
the  ||| S:31274 E:31278 ||| DT
reverse  ||| S:31278 E:31286 ||| FW
Pop2p-N ||| S:31286 E:31293 ||| FW
/ ||| S:31293 E:31294 ||| FW
Pop1p-C  ||| S:31294 E:31302 ||| FW
chimera  ||| S:31302 E:31310 ||| FW
localizes  ||| S:31310 E:31320 ||| FW
to  ||| S:31320 E:31323 ||| TO
both  ||| S:31323 E:31328 ||| PDT
the  ||| S:31328 E:31342 ||| DT
nucleus  ||| S:31342 E:31350 ||| NN
and  ||| S:31350 E:31354 ||| CC
the  ||| S:31354 E:31358 ||| DT
cytoplasm ||| S:31358 E:31367 ||| NN
,  ||| S:31367 E:31369 ||| ,
again  ||| S:31369 E:31375 ||| RB
indicating  ||| S:31375 E:31386 ||| VBG
that  ||| S:31386 E:31391 ||| IN
Pop1p ||| S:31391 E:31396 ||| NNP
,  ||| S:31396 E:31408 ||| ,
but  ||| S:31408 E:31412 ||| CC
not  ||| S:31412 E:31416 ||| RB
Pop2p ||| S:31416 E:31421 ||| CD
,  ||| S:31421 E:31423 ||| ,
has  ||| S:31423 E:31427 ||| VBZ
a  ||| S:31427 E:31429 ||| DT
functional  ||| S:31429 E:31440 ||| JJ
NLS  ||| S:31440 E:31444 ||| NN
in  ||| S:31444 E:31447 ||| IN
its  ||| S:31447 E:31451 ||| PRP$
N-terminus  ||| S:31451 E:31472 ||| JJ
( ||| S:31472 E:31473 ||| -LRB-
R.L.  ||| S:31473 E:31478 ||| NNP
&  ||| S:31478 E:31480 ||| CC
D.A.W. ||| S:31480 E:31486 ||| NNP
,  ||| S:31486 E:31488 ||| ,
unpublished  ||| S:31488 E:31500 ||| JJ
observation ||| S:31500 E:31511 ||| NN
) ||| S:31511 E:31512 ||| -RRB-
.  ||| S:31512 E:31514 ||| .
It  ||| S:31514 E:31517 ||| PRP
is  ||| S:31517 E:31530 ||| VBZ
unclear ||| S:31530 E:31537 ||| JJ
,  ||| S:31537 E:31539 ||| ,
at  ||| S:31539 E:31542 ||| IN
present ||| S:31542 E:31549 ||| JJ
,  ||| S:31549 E:31551 ||| ,
what  ||| S:31551 E:31556 ||| WP
regulates  ||| S:31556 E:31566 ||| VBZ
Pop2p  ||| S:31566 E:31572 ||| CD
distribution ||| S:31572 E:31584 ||| NN
.  ||| S:31584 E:31596 ||| .
One  ||| S:31596 E:31600 ||| CD
possibility  ||| S:31600 E:31612 ||| NN
is  ||| S:31612 E:31615 ||| VBZ
that  ||| S:31615 E:31620 ||| IN
Pop2p  ||| S:31620 E:31626 ||| NNP
is  ||| S:31626 E:31629 ||| VBZ
co-imported  ||| S:31629 E:31641 ||| JJ
in  ||| S:31641 E:31644 ||| IN
a  ||| S:31644 E:31646 ||| DT
complex  ||| S:31646 E:31664 ||| NN
with  ||| S:31664 E:31669 ||| IN
other  ||| S:31669 E:31675 ||| JJ
SCF  ||| S:31675 E:31679 ||| NNP
subunits  ||| S:31679 E:31688 ||| NN
that  ||| S:31688 E:31693 ||| WDT
is  ||| S:31693 E:31696 ||| VBZ
preformed  ||| S:31696 E:31706 ||| VBN
in  ||| S:31706 E:31709 ||| IN
the  ||| S:31709 E:31723 ||| DT
cytoplasm ||| S:31723 E:31732 ||| NN
.  ||| S:31732 E:31734 ||| .
Since  ||| S:31734 E:31740 ||| IN
Pop2p  ||| S:31740 E:31746 ||| CD
distribution  ||| S:31746 E:31759 ||| NN
is  ||| S:31759 E:31762 ||| VBZ
independent  ||| S:31762 E:31774 ||| JJ
of  ||| S:31774 E:31787 ||| IN
Pop1p  ||| S:31787 E:31793 ||| NNP
( ||| S:31793 E:31794 ||| -LRB-
Fig.  ||| S:31794 E:31799 ||| NNP
3E ||| S:31799 E:31801 ||| NNP
) ||| S:31801 E:31802 ||| -RRB-
,  ||| S:31802 E:31804 ||| ,
SCF  ||| S:31804 E:31808 ||| NNP
core  ||| S:31808 E:31813 ||| NN
subunits  ||| S:31813 E:31822 ||| NNS
are  ||| S:31822 E:31826 ||| VBP
the  ||| S:31826 E:31830 ||| DT
most  ||| S:31830 E:31835 ||| RBS
likely  ||| S:31835 E:31852 ||| JJ
candidates  ||| S:31852 E:31863 ||| NNS
for  ||| S:31863 E:31867 ||| IN
such  ||| S:31867 E:31872 ||| PDT
a  ||| S:31872 E:31874 ||| DT
function ||| S:31874 E:31882 ||| NN
.  ||| S:31882 E:31884 ||| .
In  ||| S:31884 E:31887 ||| IN
line  ||| S:31887 E:31892 ||| NN
with  ||| S:31892 E:31897 ||| IN
this  ||| S:31897 E:31912 ||| DT
suggestion ||| S:31912 E:31922 ||| NN
,  ||| S:31922 E:31924 ||| ,
it  ||| S:31924 E:31927 ||| PRP
was  ||| S:31927 E:31931 ||| VBD
previously  ||| S:31931 E:31942 ||| RB
demonstrated  ||| S:31942 E:31955 ||| VBN
that  ||| S:31955 E:31970 ||| IN
HRT1 ||| S:31970 E:31974 ||| NNP
/ ||| S:31974 E:31975 ||| NNP
ROC1 ||| S:31975 E:31979 ||| NNP
/ ||| S:31979 E:31980 ||| NNP
RBX1  ||| S:31980 E:31985 ||| NNP
promotes  ||| S:31985 E:31994 ||| VBZ
nuclear  ||| S:31994 E:32002 ||| JJ
accumulation  ||| S:32002 E:32015 ||| NN
of  ||| S:32015 E:32018 ||| IN
CUL1  ||| S:32018 E:32023 ||| NNP
[  ||| S:32023 E:32025 ||| -LRB-
32  ||| S:32025 E:32038 ||| CD
]  ||| S:32038 E:32040 ||| -RRB-
.  ||| S:32040 E:32073 ||| .
Conclusion  ||| S:32073 E:32092 ||| VBG
Our  ||| S:32092 E:32096 ||| PRP$
data  ||| S:32096 E:32101 ||| NNS
suggest  ||| S:32101 E:32109 ||| VBP
homo-  ||| S:32109 E:32115 ||| JJ
and  ||| S:32115 E:32119 ||| CC
heterooligomerization  ||| S:32119 E:32141 ||| NN
of  ||| S:32141 E:32144 ||| IN
the  ||| S:32144 E:32156 ||| DT
F-box  ||| S:32156 E:32162 ||| JJ
proteins  ||| S:32162 E:32171 ||| NNS
Pop1p  ||| S:32171 E:32177 ||| NNP
and  ||| S:32177 E:32181 ||| CC
Pop2p  ||| S:32181 E:32187 ||| CD
as  ||| S:32187 E:32190 ||| IN
a  ||| S:32190 E:32192 ||| DT
mechanism  ||| S:32192 E:32202 ||| NN
for  ||| S:32202 E:32214 ||| IN
generating  ||| S:32214 E:32225 ||| VBG
combinatorial  ||| S:32225 E:32239 ||| JJ
diversity  ||| S:32239 E:32249 ||| NN
of  ||| S:32249 E:32252 ||| IN
SCF  ||| S:32252 E:32256 ||| NNP
function  ||| S:32256 E:32265 ||| NN
in  ||| S:32265 E:32276 ||| IN
fission  ||| S:32276 E:32284 ||| JJ
yeast ||| S:32284 E:32289 ||| NN
.  ||| S:32289 E:32291 ||| .
A  ||| S:32291 E:32293 ||| DT
heterooligomeric  ||| S:32293 E:32310 ||| FW
SCF  ||| S:32310 E:32314 ||| FW
Pop1p-Pop2pcomplex  ||| S:32314 E:32341 ||| FW
mediates  ||| S:32341 E:32350 ||| FW
polyubiquitylation  ||| S:32350 E:32369 ||| FW
of  ||| S:32369 E:32372 ||| IN
phosphorylated  ||| S:32372 E:32387 ||| CD
Rum1p ||| S:32387 E:32392 ||| CD
.  ||| S:32392 E:32394 ||| .
In  ||| S:32394 E:32405 ||| IN
addition ||| S:32405 E:32413 ||| NN
,  ||| S:32413 E:32415 ||| ,
compartmentalization  ||| S:32415 E:32436 ||| VBG
of  ||| S:32436 E:32439 ||| IN
homooligomeric  ||| S:32439 E:32454 ||| JJ
SCF  ||| S:32454 E:32466 ||| NNP
Pop1pand  ||| S:32466 E:32475 ||| NNP
SCF  ||| S:32475 E:32479 ||| NNP
Pop2pcomplexes  ||| S:32479 E:32494 ||| NNP
may  ||| S:32494 E:32498 ||| MD
direct  ||| S:32498 E:32505 ||| VB
the  ||| S:32505 E:32509 ||| DT
ubiquitylation  ||| S:32509 E:32532 ||| NN
of  ||| S:32532 E:32535 ||| IN
unknown  ||| S:32535 E:32543 ||| JJ
nuclear  ||| S:32543 E:32551 ||| JJ
and  ||| S:32551 E:32555 ||| CC
cytoplasmic  ||| S:32555 E:32567 ||| JJ
substrates ||| S:32567 E:32577 ||| NN
.  ||| S:32577 E:32601 ||| .
Methods  ||| S:32601 E:32628 ||| NNP
Plasmids  ||| S:32628 E:32637 ||| NNP
and  ||| S:32637 E:32641 ||| CC
yeast  ||| S:32641 E:32647 ||| NN
strains  ||| S:32647 E:32676 ||| NNS
S.  ||| S:32676 E:32679 ||| NNP
pombe  ||| S:32679 E:32685 ||| NN
genes  ||| S:32685 E:32691 ||| NNS
for  ||| S:32691 E:32706 ||| IN
psh1  ||| S:32706 E:32711 ||| NNP
and  ||| S:32711 E:32726 ||| CC
pip1  ||| S:32726 E:32731 ||| NNP
were  ||| S:32731 E:32736 ||| VBD
identified  ||| S:32736 E:32747 ||| VBN
in  ||| S:32747 E:32750 ||| IN
the  ||| S:32750 E:32754 ||| DT
Sanger  ||| S:32754 E:32771 ||| NNP
Centre  ||| S:32771 E:32789 ||| NNP
S.  ||| S:32789 E:32792 ||| NNP
pombe  ||| S:32792 E:32798 ||| VBD
sequence  ||| S:32798 E:32807 ||| JJ
database  ||| S:32807 E:32816 ||| NN
based  ||| S:32816 E:32822 ||| VBN
on  ||| S:32822 E:32835 ||| IN
their  ||| S:32835 E:32841 ||| PRP$
homology  ||| S:32841 E:32850 ||| NN
to  ||| S:32850 E:32853 ||| TO
the  ||| S:32853 E:32857 ||| DT
respective  ||| S:32857 E:32868 ||| JJ
human  ||| S:32868 E:32874 ||| JJ
and  ||| S:32874 E:32878 ||| CC
budding  ||| S:32878 E:32886 ||| JJ
yeast  ||| S:32886 E:32902 ||| NN
proteins ||| S:32902 E:32910 ||| NNS
.  ||| S:32910 E:32912 ||| .
Complementary  ||| S:32912 E:32926 ||| NNP
DNAs  ||| S:32926 E:32931 ||| NNP
were  ||| S:32931 E:32936 ||| VBD
amplified  ||| S:32936 E:32946 ||| VBN
by  ||| S:32946 E:32949 ||| IN
PCR ||| S:32949 E:32952 ||| NNP
,  ||| S:32952 E:32964 ||| ,
subcloned  ||| S:32964 E:32974 ||| VBG
into  ||| S:32974 E:32979 ||| IN
pREp81.6xHis-Myc ||| S:32979 E:32995 ||| NNP
,  ||| S:32995 E:32997 ||| ,
pRep3.6His-Myc ||| S:32997 E:33011 ||| NNP
,  ||| S:33011 E:33013 ||| ,
or  ||| S:33013 E:33026 ||| CC
pRep4.HA ||| S:33026 E:33034 ||| NNP
,  ||| S:33034 E:33036 ||| ,
and  ||| S:33036 E:33040 ||| CC
sequenced ||| S:33040 E:33049 ||| NN
.  ||| S:33049 E:33051 ||| .
Deletion  ||| S:33051 E:33060 ||| JJ
strains  ||| S:33060 E:33068 ||| NNS
and  ||| S:33068 E:33082 ||| CC
epitope-tagged  ||| S:33082 E:33097 ||| JJ
stains  ||| S:33097 E:33104 ||| NNS
were  ||| S:33104 E:33109 ||| VBD
constructed  ||| S:33109 E:33121 ||| VBN
by  ||| S:33121 E:33124 ||| IN
one-step  ||| S:33124 E:33133 ||| JJ
gene  ||| S:33133 E:33148 ||| NN
replacement  ||| S:33148 E:33160 ||| NN
using  ||| S:33160 E:33166 ||| VBG
PCR-generated  ||| S:33166 E:33180 ||| JJ
fragments  ||| S:33180 E:33190 ||| NNS
containing  ||| S:33190 E:33211 ||| VBG
kanamycin  ||| S:33211 E:33221 ||| NNS
or  ||| S:33221 E:33235 ||| CC
ura4  ||| S:33235 E:33240 ||| CD
cassettes  ||| S:33240 E:33250 ||| NNS
[  ||| S:33250 E:33252 ||| -LRB-
36  ||| S:33252 E:33255 ||| CD
]  ||| S:33255 E:33257 ||| -RRB-
.  ||| S:33257 E:33259 ||| .
Growth  ||| S:33259 E:33276 ||| NN
media ||| S:33276 E:33281 ||| NNS
,  ||| S:33281 E:33283 ||| ,
flow  ||| S:33283 E:33288 ||| NN
cytometry ||| S:33288 E:33297 ||| NN
,  ||| S:33297 E:33299 ||| ,
and  ||| S:33299 E:33303 ||| CC
all  ||| S:33303 E:33307 ||| DT
other  ||| S:33307 E:33313 ||| JJ
relevant  ||| S:33313 E:33333 ||| JJ
S.  ||| S:33333 E:33336 ||| NNP
pombe  ||| S:33336 E:33342 ||| NN
techniques  ||| S:33342 E:33353 ||| NNS
were  ||| S:33353 E:33358 ||| VBD
described  ||| S:33358 E:33378 ||| VBN
previously  ||| S:33378 E:33389 ||| RB
[  ||| S:33389 E:33391 ||| -LRB-
37  ||| S:33391 E:33394 ||| CD
]  ||| S:33394 E:33396 ||| -RRB-
.  ||| S:33396 E:33408 ||| .
To  ||| S:33408 E:33411 ||| TO
generate  ||| S:33411 E:33420 ||| VB
the  ||| S:33420 E:33435 ||| DT
pop1 ||| S:33435 E:33439 ||| NNP
: ||| S:33439 E:33440 ||| :
: ||| S:33440 E:33441 ||| :
ura4  ||| S:33441 E:33446 ||| CD
pop2-13myc-kan  ||| S:33446 E:33461 ||| CD
strain ||| S:33461 E:33467 ||| NN
,  ||| S:33467 E:33479 ||| ,
an  ||| S:33479 E:33493 ||| DT
h  ||| S:33493 E:33495 ||| JJ
+  ||| S:33495 E:33508 ||| CD
pop1 ||| S:33508 E:33512 ||| CD
: ||| S:33512 E:33513 ||| :
: ||| S:33513 E:33514 ||| :
ura4  ||| S:33514 E:33519 ||| CD
ura4-d18  ||| S:33519 E:33528 ||| CD
leul-32  ||| S:33528 E:33546 ||| CD
pRep81.pop1  ||| S:33546 E:33558 ||| CD
strain  ||| S:33558 E:33565 ||| NN
was  ||| S:33565 E:33569 ||| VBD
crossed  ||| S:33569 E:33577 ||| VBN
with  ||| S:33577 E:33582 ||| IN
a  ||| S:33582 E:33595 ||| DT
h  ||| S:33595 E:33597 ||| NN
-  ||| S:33597 E:33610 ||| :
leul-32  ||| S:33610 E:33618 ||| CD
ura4-d18  ||| S:33618 E:33637 ||| CD
pop2-13myc-kan  ||| S:33637 E:33652 ||| CD
strain ||| S:33652 E:33658 ||| NN
,  ||| S:33658 E:33660 ||| ,
followed  ||| S:33660 E:33669 ||| VBN
by  ||| S:33669 E:33672 ||| IN
selection  ||| S:33672 E:33682 ||| NN
of  ||| S:33682 E:33695 ||| IN
spores  ||| S:33695 E:33702 ||| NNS
on  ||| S:33702 E:33705 ||| IN
G418 ||| S:33705 E:33709 ||| FW
/ ||| S:33709 E:33710 ||| FW
ura  ||| S:33710 E:33714 ||| FW
-EMM  ||| S:33714 E:33719 ||| FW
plates ||| S:33719 E:33725 ||| FW
.  ||| S:33725 E:33727 ||| .
The  ||| S:33727 E:33731 ||| DT
pRep81.  ||| S:33731 E:33750 ||| NNP
pop1  ||| S:33750 E:33755 ||| NNP
plasmid  ||| S:33755 E:33763 ||| VBD
required  ||| S:33763 E:33772 ||| VBN
to  ||| S:33772 E:33775 ||| TO
complement  ||| S:33775 E:33796 ||| VB
the  ||| S:33796 E:33800 ||| DT
sterility  ||| S:33800 E:33810 ||| NN
of  ||| S:33810 E:33813 ||| IN
the  ||| S:33813 E:33828 ||| DT
pop1  ||| S:33828 E:33833 ||| JJ
deletion  ||| S:33833 E:33842 ||| JJ
strain  ||| S:33842 E:33849 ||| NN
was  ||| S:33849 E:33853 ||| VBD
lost  ||| S:33853 E:33858 ||| VBN
by  ||| S:33858 E:33871 ||| IN
growth  ||| S:33871 E:33878 ||| NN
in  ||| S:33878 E:33881 ||| IN
non-selective  ||| S:33881 E:33895 ||| JJ
media  ||| S:33895 E:33901 ||| NNS
( ||| S:33901 E:33902 ||| -LRB-
YES ||| S:33902 E:33905 ||| NNP
)  ||| S:33905 E:33907 ||| -RRB-
for  ||| S:33907 E:33911 ||| IN
several  ||| S:33911 E:33929 ||| JJ
generations ||| S:33929 E:33940 ||| NNS
.  ||| S:33940 E:33942 ||| .
The  ||| S:33942 E:33946 ||| DT
resulting  ||| S:33946 E:33956 ||| JJ
strain  ||| S:33956 E:33963 ||| NN
was  ||| S:33963 E:33967 ||| VBD
verified  ||| S:33967 E:33976 ||| VBN
by  ||| S:33976 E:33979 ||| IN
PCR  ||| S:33979 E:33983 ||| NNP
and  ||| S:33983 E:33997 ||| CC
immunoblotting ||| S:33997 E:34011 ||| NN
.  ||| S:34011 E:34013 ||| .
The  ||| S:34013 E:34028 ||| DT
pop2 ||| S:34028 E:34032 ||| NNP
: ||| S:34032 E:34033 ||| :
: ||| S:34033 E:34034 ||| :
ura4  ||| S:34034 E:34039 ||| CD
pop1-13myc-kan  ||| S:34039 E:34054 ||| CD
strain  ||| S:34054 E:34071 ||| NN
was  ||| S:34071 E:34075 ||| VBD
generated  ||| S:34075 E:34085 ||| VBN
in  ||| S:34085 E:34088 ||| IN
an  ||| S:34088 E:34091 ||| DT
analogous  ||| S:34091 E:34101 ||| JJ
fashion ||| S:34101 E:34108 ||| NN
.  ||| S:34108 E:34138 ||| .
Antibodies  ||| S:34138 E:34159 ||| NNP
Rabbit  ||| S:34159 E:34166 ||| NNP
antisera  ||| S:34166 E:34175 ||| NN
were  ||| S:34175 E:34180 ||| VBD
raised  ||| S:34180 E:34187 ||| VBN
at  ||| S:34187 E:34190 ||| IN
Josman  ||| S:34190 E:34197 ||| NNP
LCC  ||| S:34197 E:34201 ||| NNP
( ||| S:34201 E:34202 ||| -LRB-
Napa ||| S:34202 E:34206 ||| NNP
,  ||| S:34206 E:34208 ||| ,
CA ||| S:34208 E:34210 ||| NNP
)  ||| S:34210 E:34222 ||| -RRB-
against  ||| S:34222 E:34230 ||| IN
bacterially  ||| S:34230 E:34242 ||| NN
expressed  ||| S:34242 E:34252 ||| VBD
MBP-Psh1p ||| S:34252 E:34261 ||| CD
,  ||| S:34261 E:34263 ||| ,
GST-Pcu1p ||| S:34263 E:34272 ||| NNP
,  ||| S:34272 E:34284 ||| ,
GST-Pip1p ||| S:34284 E:34293 ||| NNP
,  ||| S:34293 E:34295 ||| ,
and  ||| S:34295 E:34299 ||| CC
GST-Pop1p ||| S:34299 E:34308 ||| NNP
.  ||| S:34308 E:34310 ||| .
Sera  ||| S:34310 E:34315 ||| NNP
were  ||| S:34315 E:34320 ||| VBD
affinity  ||| S:34320 E:34329 ||| JJ
purified  ||| S:34329 E:34338 ||| NN
on  ||| S:34338 E:34351 ||| IN
affinity  ||| S:34351 E:34360 ||| FW
matrices  ||| S:34360 E:34369 ||| FW
containing  ||| S:34369 E:34380 ||| FW
immobilized  ||| S:34380 E:34392 ||| FW
GST-Psh1p ||| S:34392 E:34401 ||| FW
,  ||| S:34401 E:34413 ||| ,
MBP-Pcu1p ||| S:34413 E:34422 ||| NNP
,  ||| S:34422 E:34424 ||| ,
MBP-Pip1p ||| S:34424 E:34433 ||| NNP
,  ||| S:34433 E:34435 ||| ,
and  ||| S:34435 E:34439 ||| CC
MBP-Pop1p ||| S:34439 E:34448 ||| NNP
.  ||| S:34448 E:34450 ||| .
Column  ||| S:34450 E:34457 ||| NN
eluates  ||| S:34457 E:34465 ||| NNS
were  ||| S:34465 E:34480 ||| VBD
concentrated  ||| S:34480 E:34493 ||| VBN
to  ||| S:34493 E:34496 ||| TO
~1mg ||| S:34496 E:34500 ||| CD
/ ||| S:34500 E:34501 ||| CD
ml  ||| S:34501 E:34504 ||| NNS
and  ||| S:34504 E:34508 ||| CC
tittered  ||| S:34508 E:34517 ||| NN
by  ||| S:34517 E:34520 ||| IN
immunoblotting ||| S:34520 E:34534 ||| NN
.  ||| S:34534 E:34546 ||| .
Rabbit  ||| S:34546 E:34553 ||| JJ
antisera  ||| S:34553 E:34562 ||| NN
against  ||| S:34562 E:34570 ||| IN
Pop2p  ||| S:34570 E:34576 ||| NNP
and  ||| S:34576 E:34580 ||| CC
Rum1p  ||| S:34580 E:34586 ||| NNP
were  ||| S:34586 E:34591 ||| VBD
described  ||| S:34591 E:34611 ||| VBN
before  ||| S:34611 E:34618 ||| IN
[  ||| S:34618 E:34620 ||| -LRB-
20  ||| S:34620 E:34623 ||| CD
]  ||| S:34623 E:34625 ||| -RRB-
.  ||| S:34625 E:34627 ||| .
Monoclonal  ||| S:34627 E:34638 ||| NNP
Myc  ||| S:34638 E:34642 ||| NNP
and  ||| S:34642 E:34646 ||| CC
HA  ||| S:34646 E:34649 ||| NNP
antibodies  ||| S:34649 E:34660 ||| NNS
were  ||| S:34660 E:34675 ||| VBD
purified  ||| S:34675 E:34684 ||| VBN
from  ||| S:34684 E:34689 ||| IN
9E10  ||| S:34689 E:34694 ||| NNP
and  ||| S:34694 E:34698 ||| CC
12CA5  ||| S:34698 E:34704 ||| CD
tissue  ||| S:34704 E:34711 ||| NN
culture  ||| S:34711 E:34719 ||| NN
supernatants  ||| S:34719 E:34742 ||| NN
by  ||| S:34742 E:34745 ||| IN
binding  ||| S:34745 E:34753 ||| VBG
to  ||| S:34753 E:34756 ||| TO
protein  ||| S:34756 E:34764 ||| VB
A.  ||| S:34764 E:34795 ||| NNP
Immunoprecipitation  ||| S:34795 E:34815 ||| NNP
and  ||| S:34815 E:34819 ||| CC
immunoblotting  ||| S:34819 E:34844 ||| JJ
Protein  ||| S:34844 E:34852 ||| JJ
lysates  ||| S:34852 E:34860 ||| NN
for  ||| S:34860 E:34864 ||| IN
immunoblotting  ||| S:34864 E:34879 ||| NN
were  ||| S:34879 E:34884 ||| VBD
prepared  ||| S:34884 E:34893 ||| VBN
by  ||| S:34893 E:34906 ||| IN
bead  ||| S:34906 E:34911 ||| JJ
lysis  ||| S:34911 E:34917 ||| NN
in  ||| S:34917 E:34920 ||| IN
a  ||| S:34920 E:34922 ||| DT
Fastprep  ||| S:34922 E:34931 ||| JJ
device  ||| S:34931 E:34938 ||| NN
( ||| S:34938 E:34939 ||| -LRB-
Bio  ||| S:34939 E:34943 ||| NNP
101 ||| S:34943 E:34946 ||| CD
)  ||| S:34946 E:34948 ||| -RRB-
in  ||| S:34948 E:34951 ||| IN
the  ||| S:34951 E:34955 ||| DT
presence  ||| S:34955 E:34974 ||| NN
of  ||| S:34974 E:34977 ||| IN
proteinase  ||| S:34977 E:34988 ||| JJ
inhibitors ||| S:34988 E:34998 ||| NN
,  ||| S:34998 E:35000 ||| ,
followed  ||| S:35000 E:35009 ||| VBN
by  ||| S:35009 E:35012 ||| IN
boiling  ||| S:35012 E:35020 ||| VBG
in  ||| S:35020 E:35023 ||| IN
SDS  ||| S:35023 E:35037 ||| NNP
sample  ||| S:35037 E:35044 ||| NN
buffer ||| S:35044 E:35050 ||| NN
.  ||| S:35050 E:35052 ||| .
Cell  ||| S:35052 E:35057 ||| NN
lysates  ||| S:35057 E:35065 ||| NN
for  ||| S:35065 E:35069 ||| IN
small  ||| S:35069 E:35075 ||| JJ
scale  ||| S:35075 E:35091 ||| NN
immunoprecipitations  ||| S:35091 E:35112 ||| NNS
were  ||| S:35112 E:35117 ||| VBD
prepared  ||| S:35117 E:35126 ||| VBN
by  ||| S:35126 E:35129 ||| IN
disrupting  ||| S:35129 E:35140 ||| JJ
cells  ||| S:35140 E:35146 ||| NNS
in  ||| S:35146 E:35159 ||| IN
immunoprecipitation  ||| S:35159 E:35179 ||| JJ
buffer  ||| S:35179 E:35186 ||| NN
( ||| S:35186 E:35187 ||| -LRB-
20  ||| S:35187 E:35190 ||| CD
mM  ||| S:35190 E:35193 ||| JJ
Tris ||| S:35193 E:35197 ||| NNP
/ ||| S:35197 E:35198 ||| NNP
HC1 ||| S:35198 E:35201 ||| NNP
,  ||| S:35201 E:35203 ||| ,
pH7.4 ||| S:35203 E:35208 ||| NNP
;  ||| S:35208 E:35210 ||| :
150  ||| S:35210 E:35214 ||| CD
mM  ||| S:35214 E:35227 ||| JJ
NaC1 ||| S:35227 E:35231 ||| NN
;  ||| S:35231 E:35233 ||| :
0.5 ||| S:35233 E:35236 ||| CD
%  ||| S:35236 E:35238 ||| NN
Triton  ||| S:35238 E:35245 ||| NNP
X-100 ||| S:35245 E:35250 ||| NNP
,  ||| S:35250 E:35252 ||| ,
10  ||| S:35252 E:35255 ||| CD
ug ||| S:35255 E:35257 ||| CD
/ ||| S:35257 E:35258 ||| CD
ml  ||| S:35258 E:35261 ||| JJ
leupeptin ||| S:35261 E:35270 ||| NN
,  ||| S:35270 E:35272 ||| ,
10  ||| S:35272 E:35275 ||| CD
ug ||| S:35275 E:35277 ||| CD
/ ||| S:35277 E:35278 ||| CD
ml  ||| S:35278 E:35291 ||| JJ
pepstatin ||| S:35291 E:35300 ||| NN
,  ||| S:35300 E:35302 ||| ,
17  ||| S:35302 E:35305 ||| CD
ug ||| S:35305 E:35307 ||| CD
/ ||| S:35307 E:35308 ||| CD
ml  ||| S:35308 E:35311 ||| JJ
aprotinin ||| S:35311 E:35320 ||| NN
,  ||| S:35320 E:35322 ||| ,
1  ||| S:35322 E:35324 ||| CD
mM  ||| S:35324 E:35327 ||| JJ
PMSF ||| S:35327 E:35331 ||| NNP
) ||| S:35331 E:35332 ||| -RRB-
.  ||| S:35332 E:35334 ||| .
Lysates  ||| S:35334 E:35342 ||| NNP
were  ||| S:35342 E:35357 ||| VBD
cleared  ||| S:35357 E:35365 ||| VBN
and  ||| S:35365 E:35369 ||| CC
precipitated  ||| S:35369 E:35382 ||| VBD
with  ||| S:35382 E:35387 ||| IN
the  ||| S:35387 E:35391 ||| DT
respective  ||| S:35391 E:35402 ||| JJ
antisera ||| S:35402 E:35410 ||| NN
.  ||| S:35410 E:35422 ||| .
Immunocomplexes  ||| S:35422 E:35438 ||| NNP
were  ||| S:35438 E:35443 ||| VBD
collected  ||| S:35443 E:35453 ||| VBN
by  ||| S:35453 E:35456 ||| IN
binding  ||| S:35456 E:35464 ||| VBG
to  ||| S:35464 E:35467 ||| TO
protein  ||| S:35467 E:35475 ||| VB
A  ||| S:35475 E:35477 ||| DT
or  ||| S:35477 E:35490 ||| CC
G  ||| S:35490 E:35492 ||| NNP
beads ||| S:35492 E:35497 ||| NN
,  ||| S:35497 E:35499 ||| ,
washed  ||| S:35499 E:35506 ||| VBN
and  ||| S:35506 E:35510 ||| CC
analyzed  ||| S:35510 E:35519 ||| VBD
by  ||| S:35519 E:35522 ||| IN
immunoblotting  ||| S:35522 E:35537 ||| VBG
as  ||| S:35537 E:35550 ||| RB
described  ||| S:35550 E:35560 ||| VBN
[  ||| S:35560 E:35562 ||| -LRB-
37  ||| S:35562 E:35565 ||| CD
]  ||| S:35565 E:35567 ||| -RRB-
.  ||| S:35567 E:35579 ||| .
Large  ||| S:35579 E:35585 ||| JJ
scale  ||| S:35585 E:35591 ||| NN
lysates  ||| S:35591 E:35599 ||| NN
for  ||| S:35599 E:35603 ||| IN
gel  ||| S:35603 E:35607 ||| JJ
filtration  ||| S:35607 E:35618 ||| NN
and  ||| S:35618 E:35622 ||| CC
subsequent  ||| S:35622 E:35643 ||| JJ
immunoprecipitation  ||| S:35643 E:35663 ||| NN
were  ||| S:35663 E:35668 ||| VBD
obtained  ||| S:35668 E:35677 ||| VBN
by  ||| S:35677 E:35680 ||| IN
bead  ||| S:35680 E:35685 ||| JJ
beater  ||| S:35685 E:35692 ||| JJ
lysis ||| S:35692 E:35697 ||| NN
.  ||| S:35697 E:35709 ||| .
Approximately  ||| S:35709 E:35723 ||| RB
5  ||| S:35723 E:35725 ||| CD
mg  ||| S:35725 E:35728 ||| NN
of  ||| S:35728 E:35731 ||| IN
total  ||| S:35731 E:35737 ||| JJ
cell  ||| S:35737 E:35742 ||| NN
lysates  ||| S:35742 E:35750 ||| NNS
was  ||| S:35750 E:35754 ||| VBD
separated  ||| S:35754 E:35764 ||| VBN
by  ||| S:35764 E:35777 ||| IN
gel  ||| S:35777 E:35781 ||| JJ
filtration  ||| S:35781 E:35792 ||| NN
on  ||| S:35792 E:35795 ||| IN
a  ||| S:35795 E:35797 ||| DT
16 ||| S:35797 E:35799 ||| CD
/ ||| S:35799 E:35800 ||| CD
60  ||| S:35800 E:35803 ||| CD
S300  ||| S:35803 E:35808 ||| CD
column  ||| S:35808 E:35815 ||| NN
( ||| S:35815 E:35816 ||| -LRB-
Amersham  ||| S:35816 E:35825 ||| NNP
Pharmacia  ||| S:35825 E:35845 ||| NNP
Biotech ||| S:35845 E:35852 ||| NNP
) ||| S:35852 E:35853 ||| -RRB-
,  ||| S:35853 E:35855 ||| ,
and  ||| S:35855 E:35859 ||| CC
1  ||| S:35859 E:35861 ||| CD
ml  ||| S:35861 E:35864 ||| CD
fractions  ||| S:35864 E:35874 ||| NNS
were  ||| S:35874 E:35879 ||| VBD
immunoprecipitated  ||| S:35879 E:35898 ||| VBN
with  ||| S:35898 E:35913 ||| IN
Pip1p  ||| S:35913 E:35919 ||| CD
antibodies ||| S:35919 E:35929 ||| NNS
.  ||| S:35929 E:35931 ||| .
Precipitates  ||| S:35931 E:35944 ||| NNP
were  ||| S:35944 E:35949 ||| VBD
fractionated  ||| S:35949 E:35962 ||| VBN
by  ||| S:35962 E:35965 ||| IN
SDS  ||| S:35965 E:35979 ||| NNP
PAGE  ||| S:35979 E:35984 ||| NNP
and  ||| S:35984 E:35988 ||| CC
assayed  ||| S:35988 E:35996 ||| NN
by  ||| S:35996 E:35999 ||| IN
immunoblotting  ||| S:35999 E:36014 ||| NN
with  ||| S:36014 E:36019 ||| IN
the  ||| S:36019 E:36023 ||| DT
respective  ||| S:36023 E:36044 ||| JJ
antisera ||| S:36044 E:36052 ||| NN
.  ||| S:36052 E:36082 ||| .
Indirect  ||| S:36082 E:36091 ||| JJ
immunofluorescence  ||| S:36091 E:36120 ||| JJ
Indirect  ||| S:36120 E:36129 ||| JJ
immunofluorescence  ||| S:36129 E:36148 ||| JJ
staining  ||| S:36148 E:36157 ||| NN
was  ||| S:36157 E:36161 ||| VBD
performed  ||| S:36161 E:36181 ||| VBN
exactly  ||| S:36181 E:36189 ||| RB
as  ||| S:36189 E:36192 ||| RB
described  ||| S:36192 E:36202 ||| VBN
[  ||| S:36202 E:36204 ||| -LRB-
25  ||| S:36204 E:36207 ||| CD
]  ||| S:36207 E:36209 ||| -RRB-
.  ||| S:36209 E:36239 ||| .
In  ||| S:36239 E:36242 ||| IN
vitroubiquitylation  ||| S:36242 E:36262 ||| JJ
assay  ||| S:36262 E:36278 ||| NN
For  ||| S:36278 E:36282 ||| IN
ubiquitylation  ||| S:36282 E:36297 ||| JJ
reactions ||| S:36297 E:36306 ||| NNS
,  ||| S:36306 E:36308 ||| ,
Pip1p  ||| S:36308 E:36314 ||| CD
complexes  ||| S:36314 E:36324 ||| NNS
were  ||| S:36324 E:36339 ||| VBD
immunoprecipitated  ||| S:36339 E:36358 ||| VBN
from  ||| S:36358 E:36363 ||| IN
100  ||| S:36363 E:36367 ||| CD
-  ||| S:36367 E:36369 ||| :
200  ||| S:36369 E:36373 ||| CD
ug  ||| S:36373 E:36376 ||| CD
total  ||| S:36376 E:36382 ||| JJ
cell  ||| S:36382 E:36387 ||| NN
lysates  ||| S:36387 E:36405 ||| VBZ
prepared  ||| S:36405 E:36414 ||| VBN
as  ||| S:36414 E:36417 ||| RB
described  ||| S:36417 E:36427 ||| VBN
above ||| S:36427 E:36432 ||| IN
.  ||| S:36432 E:36434 ||| .
Precipitates  ||| S:36434 E:36447 ||| NNP
were  ||| S:36447 E:36452 ||| VBD
washed  ||| S:36452 E:36469 ||| VBN
four  ||| S:36469 E:36474 ||| CD
times  ||| S:36474 E:36480 ||| NNS
in  ||| S:36480 E:36483 ||| IN
20  ||| S:36483 E:36486 ||| CD
mM  ||| S:36486 E:36489 ||| JJ
Tris ||| S:36489 E:36493 ||| NNP
/ ||| S:36493 E:36494 ||| NNP
HCI ||| S:36494 E:36497 ||| NNP
,  ||| S:36497 E:36499 ||| ,
pH  ||| S:36499 E:36502 ||| JJ
7.4 ||| S:36502 E:36505 ||| CD
;  ||| S:36505 E:36507 ||| :
150  ||| S:36507 E:36511 ||| CD
mM  ||| S:36511 E:36514 ||| JJ
NaCl ||| S:36514 E:36518 ||| NN
;  ||| S:36518 E:36520 ||| :
0.5 ||| S:36520 E:36523 ||| CD
%  ||| S:36523 E:36535 ||| NN
Triton  ||| S:36535 E:36542 ||| NNP
X-100 ||| S:36542 E:36547 ||| NNP
,  ||| S:36547 E:36549 ||| ,
10  ||| S:36549 E:36552 ||| CD
μg ||| S:36552 E:36554 ||| CD
/ ||| S:36554 E:36555 ||| CD
ml  ||| S:36555 E:36558 ||| JJ
leupeptin ||| S:36558 E:36567 ||| NN
,  ||| S:36567 E:36569 ||| ,
10  ||| S:36569 E:36572 ||| CD
μg ||| S:36572 E:36574 ||| CD
/ ||| S:36574 E:36575 ||| CD
ml  ||| S:36575 E:36578 ||| JJ
pepstatin ||| S:36578 E:36587 ||| NN
,  ||| S:36587 E:36589 ||| ,
5  ||| S:36589 E:36601 ||| CD
μg ||| S:36601 E:36603 ||| CD
/ ||| S:36603 E:36604 ||| CD
ml  ||| S:36604 E:36607 ||| JJ
aprotinin ||| S:36607 E:36616 ||| NN
,  ||| S:36616 E:36618 ||| ,
1  ||| S:36618 E:36620 ||| CD
mM  ||| S:36620 E:36623 ||| JJ
PMSF ||| S:36623 E:36627 ||| NNP
,  ||| S:36627 E:36629 ||| ,
and  ||| S:36629 E:36633 ||| CC
equilibrated  ||| S:36633 E:36646 ||| NN
in  ||| S:36646 E:36649 ||| IN
20  ||| S:36649 E:36652 ||| CD
mM  ||| S:36652 E:36665 ||| JJ
HEPES ||| S:36665 E:36670 ||| NNP
,  ||| S:36670 E:36672 ||| ,
pH  ||| S:36672 E:36675 ||| JJ
7.4 ||| S:36675 E:36678 ||| CD
,  ||| S:36678 E:36680 ||| ,
100  ||| S:36680 E:36684 ||| CD
mM  ||| S:36684 E:36687 ||| JJ
potassium  ||| S:36687 E:36697 ||| JJ
acetate ||| S:36697 E:36704 ||| NN
,  ||| S:36704 E:36706 ||| ,
1  ||| S:36706 E:36708 ||| CD
mM  ||| S:36708 E:36711 ||| JJ
DTT ||| S:36711 E:36714 ||| NNP
.  ||| S:36714 E:36716 ||| .
A  ||| S:36716 E:36728 ||| DT
cocktail  ||| S:36728 E:36737 ||| NN
was  ||| S:36737 E:36741 ||| VBD
added  ||| S:36741 E:36747 ||| VBN
that  ||| S:36747 E:36752 ||| IN
contained  ||| S:36752 E:36762 ||| CD
8  ||| S:36762 E:36764 ||| CD
μM  ||| S:36764 E:36767 ||| JJ
ubiquitin ||| S:36767 E:36776 ||| NN
,  ||| S:36776 E:36778 ||| ,
ATP  ||| S:36778 E:36792 ||| NNP
regenerating  ||| S:36792 E:36805 ||| JJ
system  ||| S:36805 E:36812 ||| NN
( ||| S:36812 E:36813 ||| -LRB-
2  ||| S:36813 E:36815 ||| CD
mM  ||| S:36815 E:36818 ||| JJ
HEPES  ||| S:36818 E:36824 ||| NN
at  ||| S:36824 E:36827 ||| IN
pH  ||| S:36827 E:36830 ||| JJ
7.4 ||| S:36830 E:36833 ||| CD
,  ||| S:36833 E:36835 ||| ,
1  ||| S:36835 E:36837 ||| CD
mM  ||| S:36837 E:36840 ||| JJ
ATP ||| S:36840 E:36843 ||| NNP
,  ||| S:36843 E:36845 ||| ,
30  ||| S:36845 E:36858 ||| CD
mM  ||| S:36858 E:36861 ||| JJ
creatine  ||| S:36861 E:36870 ||| JJ
phosphate ||| S:36870 E:36879 ||| NN
,  ||| S:36879 E:36881 ||| ,
1  ||| S:36881 E:36883 ||| CD
mM  ||| S:36883 E:36886 ||| JJ
magnesium  ||| S:36886 E:36896 ||| JJ
acetate ||| S:36896 E:36903 ||| NN
,  ||| S:36903 E:36905 ||| ,
0.15  ||| S:36905 E:36910 ||| FW
mg ||| S:36910 E:36912 ||| FW
/ ||| S:36912 E:36913 ||| FW
ml  ||| S:36913 E:36926 ||| FW
creatine  ||| S:36926 E:36935 ||| FW
kinase ||| S:36935 E:36941 ||| FW
) ||| S:36941 E:36942 ||| -RRB-
,  ||| S:36942 E:36944 ||| ,
reaction  ||| S:36944 E:36953 ||| NN
buffer  ||| S:36953 E:36960 ||| NN
( ||| S:36960 E:36961 ||| -LRB-
4  ||| S:36961 E:36963 ||| CD
mM  ||| S:36963 E:36966 ||| JJ
magnesium  ||| S:36966 E:36986 ||| JJ
acetate ||| S:36986 E:36993 ||| NN
,  ||| S:36993 E:36995 ||| ,
1mM  ||| S:36995 E:36999 ||| NNP
DTT ||| S:36999 E:37002 ||| NNP
) ||| S:37002 E:37003 ||| -RRB-
,  ||| S:37003 E:37005 ||| ,
500  ||| S:37005 E:37009 ||| CD
nM  ||| S:37009 E:37012 ||| JJ
bacterially  ||| S:37012 E:37024 ||| NN
expressed  ||| S:37024 E:37034 ||| VBD
6  ||| S:37034 E:37036 ||| CD
×  ||| S:37036 E:37048 ||| CD
His-UBCs ||| S:37048 E:37056 ||| NN
,  ||| S:37056 E:37058 ||| ,
100  ||| S:37058 E:37062 ||| CD
nM  ||| S:37062 E:37065 ||| JJ
6  ||| S:37065 E:37067 ||| CD
×  ||| S:37067 E:37069 ||| CD
His-tagged  ||| S:37069 E:37080 ||| JJ
human  ||| S:37080 E:37086 ||| JJ
E1 ||| S:37086 E:37088 ||| NN
,  ||| S:37088 E:37090 ||| ,
0.5  ||| S:37090 E:37094 ||| CD
μM  ||| S:37094 E:37107 ||| JJ
ubiquitin  ||| S:37107 E:37117 ||| JJ
aldehyde  ||| S:37117 E:37126 ||| NN
in  ||| S:37126 E:37129 ||| IN
a  ||| S:37129 E:37131 ||| DT
volume  ||| S:37131 E:37138 ||| NN
of  ||| S:37138 E:37141 ||| IN
15  ||| S:37141 E:37144 ||| CD
ul ||| S:37144 E:37146 ||| NNS
.  ||| S:37146 E:37148 ||| .
The  ||| S:37148 E:37152 ||| DT
reaction  ||| S:37152 E:37161 ||| NN
was  ||| S:37161 E:37175 ||| VBD
started  ||| S:37175 E:37183 ||| VBN
by  ||| S:37183 E:37186 ||| IN
addition  ||| S:37186 E:37195 ||| NN
of  ||| S:37195 E:37198 ||| IN
phosphorylated  ||| S:37198 E:37213 ||| CD
Rum1p ||| S:37213 E:37218 ||| CD
.  ||| S:37218 E:37220 ||| .
After  ||| S:37220 E:37226 ||| IN
90  ||| S:37226 E:37229 ||| CD
min  ||| S:37229 E:37243 ||| NN
at  ||| S:37243 E:37246 ||| IN
30°C ||| S:37246 E:37250 ||| NNP
,  ||| S:37250 E:37252 ||| ,
the  ||| S:37252 E:37256 ||| DT
reaction  ||| S:37256 E:37265 ||| NN
was  ||| S:37265 E:37269 ||| VBD
terminated  ||| S:37269 E:37280 ||| VBN
by  ||| S:37280 E:37283 ||| IN
the  ||| S:37283 E:37287 ||| DT
addition  ||| S:37287 E:37296 ||| NN
5  ||| S:37296 E:37298 ||| CD
×  ||| S:37298 E:37310 ||| CD
SDS  ||| S:37310 E:37314 ||| JJ
sample  ||| S:37314 E:37321 ||| NN
buffer ||| S:37321 E:37327 ||| NN
.  ||| S:37327 E:37329 ||| .
Samples  ||| S:37329 E:37337 ||| NNS
were  ||| S:37337 E:37342 ||| VBD
separated  ||| S:37342 E:37352 ||| VBN
on  ||| S:37352 E:37355 ||| IN
11  ||| S:37355 E:37358 ||| CD
%  ||| S:37358 E:37370 ||| NN
SDS-polyacrylamide  ||| S:37370 E:37389 ||| JJ
gels  ||| S:37389 E:37394 ||| NN
and  ||| S:37394 E:37398 ||| CC
analyzed  ||| S:37398 E:37407 ||| VBD
by  ||| S:37407 E:37420 ||| IN
autoradiography ||| S:37420 E:37435 ||| NN
.  ||| S:37435 E:37447 ||| .
Substrate-independent  ||| S:37447 E:37480 ||| JJ
in  ||| S:37480 E:37483 ||| IN
vitro  ||| S:37483 E:37489 ||| JJ
ubiquitylation  ||| S:37489 E:37504 ||| JJ
activity  ||| S:37504 E:37523 ||| NN
was  ||| S:37523 E:37527 ||| VBD
determined  ||| S:37527 E:37538 ||| VBN
by  ||| S:37538 E:37541 ||| IN
immunoprecipitating  ||| S:37541 E:37561 ||| JJ
Pop1p-13Myc  ||| S:37561 E:37573 ||| NN
or  ||| S:37573 E:37586 ||| CC
Pop2p-13Myc  ||| S:37586 E:37598 ||| CD
with  ||| S:37598 E:37603 ||| IN
Myc  ||| S:37603 E:37607 ||| NNP
antibodies ||| S:37607 E:37617 ||| NNS
.  ||| S:37617 E:37619 ||| .
The  ||| S:37619 E:37623 ||| DT
same  ||| S:37623 E:37628 ||| JJ
cocktail  ||| S:37628 E:37637 ||| NN
as  ||| S:37637 E:37650 ||| IN
described  ||| S:37650 E:37660 ||| VBN
above  ||| S:37660 E:37666 ||| RB
was  ||| S:37666 E:37670 ||| VBD
added  ||| S:37670 E:37676 ||| VBN
to  ||| S:37676 E:37679 ||| TO
the  ||| S:37679 E:37683 ||| DT
precipitates ||| S:37683 E:37695 ||| NN
.  ||| S:37695 E:37697 ||| .
Reaction  ||| S:37697 E:37716 ||| NN
products  ||| S:37716 E:37725 ||| NNS
were  ||| S:37725 E:37730 ||| VBD
determined  ||| S:37730 E:37741 ||| VBN
by  ||| S:37741 E:37744 ||| IN
immunoblotting  ||| S:37744 E:37759 ||| NN
with  ||| S:37759 E:37764 ||| IN
ubiquitin  ||| S:37764 E:37784 ||| JJ
antibodies  ||| S:37784 E:37795 ||| NNS
( ||| S:37795 E:37796 ||| -LRB-
Zymed ||| S:37796 E:37801 ||| NNP
) ||| S:37801 E:37802 ||| -RRB-
.  ||| S:37802 E:37832 ||| .
Subcellular  ||| S:37832 E:37844 ||| FW
fractionation  ||| S:37844 E:37868 ||| FW
Cells  ||| S:37868 E:37874 ||| FW
grown  ||| S:37874 E:37880 ||| VBN
in  ||| S:37880 E:37883 ||| IN
YES  ||| S:37883 E:37887 ||| NNP
were  ||| S:37887 E:37892 ||| VBD
harvested  ||| S:37892 E:37902 ||| VBN
and  ||| S:37902 E:37906 ||| CC
washed  ||| S:37906 E:37913 ||| VBN
in  ||| S:37913 E:37916 ||| IN
buffer  ||| S:37916 E:37933 ||| JJ
S  ||| S:37933 E:37935 ||| NNP
( ||| S:37935 E:37936 ||| -LRB-
1.4  ||| S:37936 E:37940 ||| CD
M  ||| S:37940 E:37942 ||| NNP
sorbitol ||| S:37942 E:37950 ||| NN
,  ||| S:37950 E:37952 ||| ,
40  ||| S:37952 E:37955 ||| CD
mM  ||| S:37955 E:37958 ||| JJ
HEPES  ||| S:37958 E:37964 ||| NNP
( ||| S:37964 E:37965 ||| -LRB-
pH  ||| S:37965 E:37968 ||| NNP
=  ||| S:37968 E:37970 ||| SYM
7.2 ||| S:37970 E:37973 ||| CD
) ||| S:37973 E:37974 ||| -RRB-
,  ||| S:37974 E:37976 ||| ,
0.5  ||| S:37976 E:37980 ||| CD
mM  ||| S:37980 E:37983 ||| JJ
MgCl  ||| S:37983 E:37999 ||| JJ
2  ||| S:37999 E:38001 ||| CD
) ||| S:38001 E:38002 ||| -RRB-
.  ||| S:38002 E:38004 ||| .
Cells  ||| S:38004 E:38010 ||| NNS
were  ||| S:38010 E:38015 ||| VBD
resuspended  ||| S:38015 E:38027 ||| VBN
in  ||| S:38027 E:38030 ||| IN
buffer  ||| S:38030 E:38047 ||| JJ
S ||| S:38047 E:38048 ||| NNP
,  ||| S:38048 E:38050 ||| ,
1  ||| S:38050 E:38052 ||| CD
mM  ||| S:38052 E:38055 ||| JJ
PMSF ||| S:38055 E:38059 ||| NNP
,  ||| S:38059 E:38061 ||| ,
10  ||| S:38061 E:38064 ||| CD
mM  ||| S:38064 E:38067 ||| JJ
β-mercaptoethanol  ||| S:38067 E:38085 ||| JJ
and  ||| S:38085 E:38089 ||| CC
incubated  ||| S:38089 E:38099 ||| NN
for  ||| S:38099 E:38113 ||| IN
10  ||| S:38113 E:38116 ||| CD
min  ||| S:38116 E:38120 ||| NN
at  ||| S:38120 E:38123 ||| IN
30°C ||| S:38123 E:38127 ||| CD
.  ||| S:38127 E:38129 ||| .
Cells  ||| S:38129 E:38135 ||| NNS
were  ||| S:38135 E:38140 ||| VBD
pelleted ||| S:38140 E:38148 ||| CD
,  ||| S:38148 E:38150 ||| ,
resuspended  ||| S:38150 E:38162 ||| VBG
in  ||| S:38162 E:38165 ||| IN
4  ||| S:38165 E:38177 ||| CD
pellet  ||| S:38177 E:38184 ||| CD
volumes  ||| S:38184 E:38192 ||| NNS
of  ||| S:38192 E:38195 ||| IN
buffer  ||| S:38195 E:38202 ||| JJ
S ||| S:38202 E:38203 ||| NNP
,  ||| S:38203 E:38205 ||| ,
1  ||| S:38205 E:38207 ||| CD
mM  ||| S:38207 E:38210 ||| JJ
PMSF ||| S:38210 E:38214 ||| NNP
,  ||| S:38214 E:38216 ||| ,
Zymolyase  ||| S:38216 E:38226 ||| NNP
( ||| S:38226 E:38227 ||| -LRB-
100  ||| S:38227 E:38241 ||| CD
ug ||| S:38241 E:38243 ||| CD
/ ||| S:38243 E:38244 ||| CD
ml ||| S:38244 E:38246 ||| CD
)  ||| S:38246 E:38248 ||| -RRB-
and  ||| S:38248 E:38252 ||| CC
incubated  ||| S:38252 E:38262 ||| NN
at  ||| S:38262 E:38265 ||| IN
30°C  ||| S:38265 E:38270 ||| CD
for  ||| S:38270 E:38274 ||| IN
40  ||| S:38274 E:38277 ||| CD
min ||| S:38277 E:38280 ||| NNS
.  ||| S:38280 E:38282 ||| .
Cells  ||| S:38282 E:38288 ||| NNS
were  ||| S:38288 E:38303 ||| VBD
diluted  ||| S:38303 E:38311 ||| VBN
in  ||| S:38311 E:38314 ||| IN
buffer  ||| S:38314 E:38321 ||| JJ
S  ||| S:38321 E:38323 ||| NNP
and  ||| S:38323 E:38327 ||| CC
pelleted  ||| S:38327 E:38336 ||| NN
by  ||| S:38336 E:38339 ||| IN
centrifugation  ||| S:38339 E:38354 ||| NN
and  ||| S:38354 E:38368 ||| CC
resuspended  ||| S:38368 E:38380 ||| NN
in  ||| S:38380 E:38383 ||| IN
buffer  ||| S:38383 E:38390 ||| JJ
F  ||| S:38390 E:38392 ||| NN
( ||| S:38392 E:38393 ||| -LRB-
18  ||| S:38393 E:38396 ||| CD
%  ||| S:38396 E:38398 ||| NN
Ficoll  ||| S:38398 E:38405 ||| NNP
400 ||| S:38405 E:38408 ||| CD
,  ||| S:38408 E:38410 ||| ,
w ||| S:38410 E:38411 ||| FW
/ ||| S:38411 E:38412 ||| FW
v ||| S:38412 E:38413 ||| FW
;  ||| S:38413 E:38415 ||| :
20  ||| S:38415 E:38418 ||| CD
mM  ||| S:38418 E:38431 ||| JJ
HEPES  ||| S:38431 E:38437 ||| NNP
( ||| S:38437 E:38438 ||| -LRB-
pH  ||| S:38438 E:38441 ||| NNP
=  ||| S:38441 E:38443 ||| SYM
7.2 ||| S:38443 E:38446 ||| CD
) ||| S:38446 E:38447 ||| -RRB-
,  ||| S:38447 E:38449 ||| ,
0.5  ||| S:38449 E:38453 ||| CD
mM  ||| S:38453 E:38456 ||| JJ
MgCl  ||| S:38456 E:38472 ||| JJ
2  ||| S:38472 E:38474 ||| CD
and  ||| S:38474 E:38478 ||| CC
protease  ||| S:38478 E:38487 ||| JJ
inhibitors ||| S:38487 E:38497 ||| NN
.  ||| S:38497 E:38499 ||| .
Cells  ||| S:38499 E:38505 ||| NNS
were  ||| S:38505 E:38520 ||| VBD
lysed  ||| S:38520 E:38526 ||| VBN
by  ||| S:38526 E:38529 ||| IN
homogenization  ||| S:38529 E:38544 ||| NNS
using  ||| S:38544 E:38550 ||| VBG
a  ||| S:38550 E:38552 ||| DT
teflon  ||| S:38552 E:38559 ||| JJ
pestel  ||| S:38559 E:38566 ||| JJ
fitted  ||| S:38566 E:38573 ||| NN
into  ||| S:38573 E:38588 ||| IN
a  ||| S:38588 E:38590 ||| DT
microfuge  ||| S:38590 E:38600 ||| JJ
tube ||| S:38600 E:38604 ||| NN
.  ||| S:38604 E:38606 ||| .
Cell  ||| S:38606 E:38611 ||| NN
lysis  ||| S:38611 E:38617 ||| NNS
was  ||| S:38617 E:38621 ||| VBD
monitored  ||| S:38621 E:38631 ||| VBN
by  ||| S:38631 E:38634 ||| IN
microscopy ||| S:38634 E:38644 ||| NN
.  ||| S:38644 E:38656 ||| .
Unlysed  ||| S:38656 E:38664 ||| JJ
cells  ||| S:38664 E:38670 ||| NNS
were  ||| S:38670 E:38675 ||| VBD
pelleted  ||| S:38675 E:38684 ||| VBN
by  ||| S:38684 E:38687 ||| IN
gentle  ||| S:38687 E:38694 ||| JJ
centrifugation ||| S:38694 E:38708 ||| NN
.  ||| S:38708 E:38710 ||| .
The  ||| S:38710 E:38724 ||| DT
lysate  ||| S:38724 E:38731 ||| NN
was  ||| S:38731 E:38735 ||| VBD
placed  ||| S:38735 E:38742 ||| VBN
on  ||| S:38742 E:38745 ||| IN
top  ||| S:38745 E:38749 ||| JJ
of  ||| S:38749 E:38752 ||| IN
buffer  ||| S:38752 E:38759 ||| JJ
GF  ||| S:38759 E:38762 ||| NNP
( ||| S:38762 E:38763 ||| -LRB-
7 ||| S:38763 E:38764 ||| CD
%  ||| S:38764 E:38766 ||| NN
Ficoll  ||| S:38766 E:38773 ||| NNP
400 ||| S:38773 E:38776 ||| CD
,  ||| S:38776 E:38788 ||| ,
w ||| S:38788 E:38789 ||| FW
/ ||| S:38789 E:38790 ||| FW
v ||| S:38790 E:38791 ||| FW
,  ||| S:38791 E:38793 ||| ,
20 ||| S:38793 E:38795 ||| CD
%  ||| S:38795 E:38797 ||| NN
glycerol ||| S:38797 E:38805 ||| NN
,  ||| S:38805 E:38807 ||| ,
20  ||| S:38807 E:38810 ||| CD
mM  ||| S:38810 E:38813 ||| JJ
HEPES  ||| S:38813 E:38819 ||| NNP
( ||| S:38819 E:38820 ||| -LRB-
pH  ||| S:38820 E:38823 ||| NNP
=  ||| S:38823 E:38825 ||| SYM
7.2 ||| S:38825 E:38828 ||| CD
) ||| S:38828 E:38829 ||| -RRB-
,  ||| S:38829 E:38831 ||| ,
0.5  ||| S:38831 E:38835 ||| CD
mM  ||| S:38835 E:38838 ||| JJ
MgCl  ||| S:38838 E:38854 ||| JJ
2  ||| S:38854 E:38856 ||| CD
) ||| S:38856 E:38857 ||| -RRB-
.  ||| S:38857 E:38859 ||| .
Nuclei  ||| S:38859 E:38866 ||| NNP
were  ||| S:38866 E:38871 ||| VBD
pelleted  ||| S:38871 E:38880 ||| VBN
by  ||| S:38880 E:38883 ||| IN
spinning  ||| S:38883 E:38902 ||| NN
at  ||| S:38902 E:38905 ||| IN
7000  ||| S:38905 E:38910 ||| CD
rpm  ||| S:38910 E:38914 ||| NN
in  ||| S:38914 E:38917 ||| IN
a  ||| S:38917 E:38919 ||| DT
microfuge ||| S:38919 E:38928 ||| NN
.  ||| S:38928 E:38930 ||| .
The  ||| S:38930 E:38934 ||| DT
cytoplasmic  ||| S:38934 E:38946 ||| JJ
fraction  ||| S:38946 E:38955 ||| NN
was  ||| S:38955 E:38969 ||| VBD
removed  ||| S:38969 E:38977 ||| VBN
and  ||| S:38977 E:38981 ||| CC
mixed  ||| S:38981 E:38987 ||| VBN
with  ||| S:38987 E:38992 ||| IN
SDS  ||| S:38992 E:38996 ||| NNP
sample  ||| S:38996 E:39003 ||| NN
buffer ||| S:39003 E:39009 ||| NN
.  ||| S:39009 E:39011 ||| .
The  ||| S:39011 E:39015 ||| DT
nuclear  ||| S:39015 E:39033 ||| JJ
pellet  ||| S:39033 E:39040 ||| NN
was  ||| S:39040 E:39044 ||| VBD
resolved  ||| S:39044 E:39053 ||| VBN
in  ||| S:39053 E:39056 ||| IN
an  ||| S:39056 E:39059 ||| DT
equal  ||| S:39059 E:39065 ||| JJ
volume  ||| S:39065 E:39072 ||| NN
of  ||| S:39072 E:39075 ||| IN
SDS  ||| S:39075 E:39079 ||| NNP
sample  ||| S:39079 E:39096 ||| NN
buffer ||| S:39096 E:39102 ||| NN
.  ||| S:39102 E:39104 ||| .
Fractions  ||| S:39104 E:39114 ||| NNP
were  ||| S:39114 E:39119 ||| VBD
analyzed  ||| S:39119 E:39128 ||| VBN
by  ||| S:39128 E:39131 ||| IN
immunoblotting  ||| S:39131 E:39146 ||| VBG
as  ||| S:39146 E:39159 ||| RB
described  ||| S:39159 E:39169 ||| VBN
in  ||| S:39169 E:39172 ||| IN
Fig.  ||| S:39172 E:39177 ||| CD
3 ||| S:39177 E:39178 ||| CD
.  ||| S:39178 E:39211 ||| .
Abbreviations  ||| S:39211 E:39233 ||| NNP
SCF ||| S:39233 E:39236 ||| NNP
:  ||| S:39236 E:39238 ||| :
SKP1 ||| S:39238 E:39242 ||| CD
/ ||| S:39242 E:39243 ||| CD
CUL1 ||| S:39243 E:39247 ||| CD
/ ||| S:39247 E:39248 ||| CD
F-box  ||| S:39248 E:39254 ||| JJ
protein  ||| S:39254 E:39270 ||| NN
UBC ||| S:39270 E:39273 ||| NNP
:  ||| S:39273 E:39275 ||| :
ubiquitin-conjugating  ||| S:39275 E:39297 ||| JJ
enzyme  ||| S:39297 E:39312 ||| JJ
HA ||| S:39312 E:39314 ||| NNP
:  ||| S:39314 E:39316 ||| :
hemagglutinin  ||| S:39316 E:39338 ||| JJ
NLS ||| S:39338 E:39341 ||| NNP
:  ||| S:39341 E:39343 ||| :
nuclear  ||| S:39343 E:39351 ||| JJ
localization  ||| S:39351 E:39364 ||| JJ
signal  ||| S:39364 E:39379 ||| NN
NES ||| S:39379 E:39382 ||| NNP
:  ||| S:39382 E:39384 ||| :
nuclear  ||| S:39384 E:39392 ||| JJ
export  ||| S:39392 E:39399 ||| NN
signal  ||| S:39399 E:39428 ||| NN
Authors ||| S:39428 E:39435 ||| NNP
'  ||| S:39435 E:39437 ||| POS
contributions  ||| S:39437 E:39459 ||| NNS
All  ||| S:39459 E:39463 ||| DT
experiments  ||| S:39463 E:39475 ||| NNS
were  ||| S:39475 E:39480 ||| VBD
performed  ||| S:39480 E:39490 ||| VBN
by  ||| S:39490 E:39493 ||| IN
VS.  ||| S:39493 E:39497 ||| CD
with  ||| S:39497 E:39502 ||| IN
the  ||| S:39502 E:39506 ||| DT
following  ||| S:39506 E:39524 ||| JJ
exceptions ||| S:39524 E:39534 ||| NNS
:  ||| S:39534 E:39536 ||| :
Building  ||| S:39536 E:39545 ||| NNP
on  ||| S:39545 E:39548 ||| IN
reagents  ||| S:39548 E:39557 ||| VBG
prepared  ||| S:39557 E:39566 ||| VBN
by  ||| S:39566 E:39569 ||| IN
VS. ||| S:39569 E:39572 ||| NNP
,  ||| S:39572 E:39574 ||| ,
CP.  ||| S:39574 E:39586 ||| NNP
performed  ||| S:39586 E:39596 ||| VBD
the  ||| S:39596 E:39600 ||| DT
experiments  ||| S:39600 E:39612 ||| NNS
shown  ||| S:39612 E:39618 ||| VBN
in  ||| S:39618 E:39621 ||| IN
Figs.  ||| S:39621 E:39627 ||| CD
2B ||| S:39627 E:39629 ||| CD
,  ||| S:39629 E:39631 ||| ,
4A ||| S:39631 E:39633 ||| NNP
,  ||| S:39633 E:39635 ||| ,
and  ||| S:39635 E:39639 ||| CC
7 ||| S:39639 E:39640 ||| CD
.  ||| S:39640 E:39642 ||| .
IS.  ||| S:39642 E:39654 ||| NNP
performed  ||| S:39654 E:39664 ||| VBD
the  ||| S:39664 E:39668 ||| DT
experiments  ||| S:39668 E:39680 ||| NNS
shown  ||| S:39680 E:39686 ||| VBN
in  ||| S:39686 E:39689 ||| IN
Fig.  ||| S:39689 E:39694 ||| CD
4D ||| S:39694 E:39696 ||| CD
,  ||| S:39696 E:39698 ||| ,
5 ||| S:39698 E:39699 ||| CD
,  ||| S:39699 E:39701 ||| ,
and  ||| S:39701 E:39705 ||| CC
6A ||| S:39705 E:39707 ||| NNP
.  ||| S:39707 E:39709 ||| .
ER.  ||| S:39709 E:39721 ||| NNP
performed  ||| S:39721 E:39731 ||| VBD
the  ||| S:39731 E:39735 ||| DT
immunostaining  ||| S:39735 E:39750 ||| JJ
experiments  ||| S:39750 E:39762 ||| NNS
shown  ||| S:39762 E:39768 ||| VBN
in  ||| S:39768 E:39771 ||| IN
Fig.  ||| S:39771 E:39784 ||| CD
3Cand  ||| S:39784 E:39790 ||| CD
3E ||| S:39790 E:39792 ||| CD
.  ||| S:39792 E:39794 ||| .
RL.  ||| S:39794 E:39798 ||| NNP
performed  ||| S:39798 E:39808 ||| VBD
the  ||| S:39808 E:39812 ||| DT
experiment  ||| S:39812 E:39823 ||| NN
shown  ||| S:39823 E:39829 ||| VBN
in  ||| S:39829 E:39832 ||| IN
Fig.  ||| S:39832 E:39837 ||| NNP
3Aand  ||| S:39837 E:39851 ||| NNP
contributed  ||| S:39851 E:39863 ||| VBD
data  ||| S:39863 E:39868 ||| NNS
not  ||| S:39868 E:39872 ||| RB
shown ||| S:39872 E:39877 ||| VBN
.  ||| S:39877 E:39879 ||| .
KA.  ||| S:39879 E:39883 ||| NNP
produced  ||| S:39883 E:39892 ||| VBD
recombinant  ||| S:39892 E:39904 ||| JJ
UBCs  ||| S:39904 E:39917 ||| NN
used  ||| S:39917 E:39922 ||| VBN
in  ||| S:39922 E:39925 ||| IN
Fig.  ||| S:39925 E:39930 ||| CD
2D ||| S:39930 E:39932 ||| CD
.  ||| S:39932 E:39934 ||| .
CZ.  ||| S:39934 E:39938 ||| NNP
prepared  ||| S:39938 E:39947 ||| VBD
the  ||| S:39947 E:39960 ||| DT
csn5  ||| S:39960 E:39965 ||| NNP
mutant  ||| S:39965 E:39972 ||| VBD
used  ||| S:39972 E:39977 ||| VBN
in  ||| S:39977 E:39980 ||| IN
Fig.  ||| S:39980 E:39985 ||| CD
2D ||| S:39985 E:39987 ||| CD
,  ||| S:39987 E:39997 ||| ,
contributed  ||| S:39997 E:40009 ||| VBD
to  ||| S:40009 E:40012 ||| TO
the  ||| S:40012 E:40016 ||| DT
preparation  ||| S:40016 E:40028 ||| NN
of  ||| S:40028 E:40031 ||| IN
SCF  ||| S:40031 E:40035 ||| NNP
Popantisera  ||| S:40035 E:40047 ||| NNP
used  ||| S:40047 E:40052 ||| VBD
in  ||| S:40052 E:40063 ||| IN
Figs.  ||| S:40063 E:40069 ||| CD
1 ||| S:40069 E:40070 ||| CD
,  ||| S:40070 E:40072 ||| ,
2D ||| S:40072 E:40074 ||| NNP
,  ||| S:40074 E:40076 ||| ,
and  ||| S:40076 E:40080 ||| CC
7 ||| S:40080 E:40081 ||| CD
,  ||| S:40081 E:40083 ||| ,
and  ||| S:40083 E:40087 ||| CC
assisted  ||| S:40087 E:40096 ||| VBN
with  ||| S:40096 E:40101 ||| IN
study  ||| S:40101 E:40107 ||| NN
design ||| S:40107 E:40113 ||| NN
.  ||| S:40113 E:40115 ||| .
DAW.  ||| S:40115 E:40128 ||| NNP
performed  ||| S:40128 E:40138 ||| VBD
the  ||| S:40138 E:40142 ||| DT
experiment  ||| S:40142 E:40153 ||| NN
in  ||| S:40153 E:40156 ||| IN
Fig.  ||| S:40156 E:40161 ||| CD
6B ||| S:40161 E:40163 ||| CD
,  ||| S:40163 E:40165 ||| ,
conceived  ||| S:40165 E:40175 ||| VBD
the  ||| S:40175 E:40179 ||| DT
study ||| S:40179 E:40184 ||| NN
,  ||| S:40184 E:40194 ||| ,
drafted  ||| S:40194 E:40202 ||| VBD
the  ||| S:40202 E:40206 ||| DT
manuscript ||| S:40206 E:40216 ||| NN
,  ||| S:40216 E:40218 ||| ,
and  ||| S:40218 E:40222 ||| CC
participated  ||| S:40222 E:40235 ||| VBD
in  ||| S:40235 E:40238 ||| IN
study  ||| S:40238 E:40244 ||| NN
design  ||| S:40244 E:40259 ||| NN
and  ||| S:40259 E:40263 ||| CC
coordination ||| S:40263 E:40275 ||| NN
.  ||| S:40275 E:40277 ||| .
All  ||| S:40277 E:40281 ||| DT
authors  ||| S:40281 E:40289 ||| NNS
read  ||| S:40289 E:40294 ||| VBP
and  ||| S:40294 E:40298 ||| CC
approved  ||| S:40298 E:40307 ||| VBD
the  ||| S:40307 E:40311 ||| DT
final  ||| S:40311 E:40325 ||| JJ
manuscript ||| S:40325 E:40335 ||| NN
.  ||| S:40335 E:40352 ||| .
